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General IntroductionChapter 1 2
The alphavirus genus
Sindbis virus (SIN) and Semliki Forest virus (SFV) are positive-strand RNA
viruses belonging to the genus  Alphavirus of the family  Togaviridae  (41). The
alphavirus genus consists of about 25 different viruses.  Alphaviruses are
transmitted in nature by anthropod vectors, primarily mosquitoes. SIN has also
been isolated from mites and ticks (124). Alphaviruses can infect a wide range of
host organisms, including birds, insects, mammals, and mosquitoes. The skeletal
muscle and fibroblasts are the initial sites of infection, after which the viruses
spread to the central nervous system (41). The alphaviruses Venezuelan equine
encephalitis virus (VEE), Western equine encephalitis virus (WEE), and Eastern
equine encephalitis (EEE) are known to cause fatal encephalitis in horses and
humans, but the incidence particularly in humans is low (124). These viruses are
endemic in North and South America and cause periodic outbreaks of encephalitis
in horses. Other alphaviruses, like Ross River virus (RR), SFV, and SIN can cause
fever, rash, arthralgia, and polyarthritis in humans, but again the incidence is low
(41). SFV and SIN are among the least pathogenic alphaviruses for humans, and
therefore have been widely used as “prototypes” to study the life cycle of these
viruses. These studies take advantage of the fact that alphaviruses grow to high
titers in tissue culture cells with high PFU-to-particle ratios, properties  which
enable a detailed biochemical and structural characterization of the virus particles.
In addition, full-length cDNA clones of SFV (77), SIN (107), or VEE (21) have
made it possible to study the viral life cycle by site-specific mutagenesis of the viral
genome. In this thesis, we primarily used SIN to unravel the molecular
mechanisms involved in the cell entry process of alphaviruses.
Structure and characteristics of Sindbis virus
Alphaviruses have a uniform structure with a diameter of about 70 nm (16, 45,
100,  124). The viral genome consists of a single-stranded RNA molecule of
positive polarity. The viral RNA is assembled with the capsid protein to form the
nucleocapsid (35). The nucleocapsid is surrounded by a lipid bilayer, in which the
viral spike proteins are inserted (45).
Nucleocapsid. The nucleocapsid contains the single-stranded RNA molecule
of approximately 11,7 kb, assembled with 240 copies of the capsid protein (~30
kD). The entire genome of SIN has been sequenced (123).  Cryo-electron
microscopy (cryo-EM) and image reconstruction analysis have revealed that the
nucleocapsid has a symmetrical icosahedral structure with a triangulation number
T=4 (16, 100). The individual  capsid proteins are arranged as  pentamers and
hexamers to form a roughly spherical nucleocapsid.
Envelope. The SIN envelope consists of a lipid bilayer in which 240 copies
each of two transmembrane glycoproteins E1 and E2 are inserted (124). The lipidGeneral introduction 3
bilayer is composed of lipids derived from the plasma membrane of the host cell
during budding of the virus. The viral membrane consists of about 25%
sphingomyelin, 27%  phosphatidylcholine, 19%  phosphatidylserine, and 26%
phosphatidylethanolamine (4, 132). The cholesterol to phospholipid ratio in the
viral membrane is approximately 1:1 (70, 106).
Figure 1. Cryo-EM picture of Sindbis virus. The protruding spikes are clearly visible.
Each spike consists of a  trimer of E2/E1  heterodimers. ( courtesy of Dr. S.
Mukhopadhyay, Purdue University).
The 240 copies of the glycoproteins E2 and E1, both with a molecular mass of
about 50 kD, extend from the lipid bilayer and are organized in a T=4 lattice (16,
45). The glycoproteins form 80 hetero-oligomeric spikes, a single spike consisting
of a trimer of E2/E1 heterodimers. The E2 and E1 glycoproteins are classified as
type I membrane proteins, with the amino-terminus facing outward from the
membrane. E2 is 423 amino acid residues long, with a carboxy-terminal tail of 33
amino acids. E1 has 439 amino acid residues and a carboxy-terminal tail of only 2
amino acids. Both E2 and E1 are acylated. E2 has three acylation sites in the
carboxy-terminal tail and two in the transmembrane region (124). E1 is acylated at
one position in the transmembrane region (109). Furthermore, both E2 and E1 are
each  glycosylated at two positions in the  ectodomain of the protein (124).
Sequence analysis of the E1 glycoprotein has revealed a hydrophobic domain that
extends from residues 75 to 97; this region has been proposed to represent the
fusion peptide of the virus (35, 75).
Crystallographic and  cryo-EM studies revealed that the E1  glycoprotein is
folded to an elongated molecule that in many respects resembles the flavivirus E
protein (74). SFV E1 is composed of a central (amino-terminal) ß-barrel domain
that is flanked by a finger-like projecting domain, containing the fusion peptide,Chapter 1 4
and a carboxy-terminal Ig-like domain. In the protein crystal E1 forms a head-to-
tail linked dimer, which can be fitted in the cryo-EM density map of SFV. In
another elegant study, SIN  glycosylation mutants were used to localize the
carbohydrate moieties on the virus using cryo-EM imaging (104). Both studies
revealed that the E1 protein lies approximately parallel to the viral surface, whereas
the E2 glycoprotein forms the protruding spikes. These data indicate that the E1
glycoprotein is responsible for the icosahedral scaffold, that organizes the T=4
architecture of the mature virus particle.
The E2 glycoprotein is synthesized in the infected cell as a PE2 (PE2 is called
p62 in SFV) precursor that is cleaved into E2 and a periphal polypeptide E3 (~11
kDa). E3 is lost in mature SIN particles, but remains associated to the E2/E1
heterodimer of SFV (88). Cryo-EM and image reconstruction analysis of a mutant
PE2-containing SIN virus revealed that E3 is positioned as a bulge in the
heterodimer localized midway between the center of the spike complex and the
tips (100).
There is also a small hydrophobic peptide, produced as a linker between E2
and E1, called the 6K protein, that has been found to be associated with the virus
in low quantity (7-30 molecules per particle; 33, 82). The 6K polypeptide is
palmitoylated at positions 35, 36, 39 (124).
Replication and assembly of Sindbis virus
RNA replication of the viral genome. A schematic representation of the
genomic RNA and the translation of the viral proteins is depicted in Figure 2. The
genomic RNA of SIN can be divided into two major regions: a non-structural
domain encoding the replicase proteins and a structural domain encoding the three
major viral proteins. The non-structural proteins are translated as a polyprotein
directly from the genomic RNA. This polyprotein is cleaved in an autoproteolytic
fashion, resulting in the release of nsP1, nsP2, nsP3, and nsP4. The protease
responsible for these cleavages is encoded in the sequences at the C-terminal
domain of nsP2 (24, 44, 122). nsP1 appears to be involved in the association of the
alphavirus replicase to membranes (3). nsP2 is involved in the regulation of minus-
strand RNA synthesis (112) and in the initiation of  subgenomic 26S RNA
synthesis (126). The function of nsP3 is unknown. nsP4 has been identified as the
viral  polymerase (7, 43, 73, 111). It appears that the function of the viral
polymerase is dependent on an aromatic or histidine residue at the amino-terminal
end of nsP4 (115). In summary, the  alphavirus non-structural proteins are
responsible for replication of both positive-strand genomic RNA and minus-strand
RNA, the latter serving as a template for production of the 26S  subgenomic
mRNA and new positive-strand RNA.General introduction 5
Figure 2. RNA replication of the SIN genome. See text, for details.
The structural proteins are synthesized as a  polyprotein from the 26S
subgenomic mRNA, in the order NH2-capsid-PE2-6K-E1-COOH, and are post-
translationally processed to produce the individual polypeptides. Figure 3 gives a
schematic representation of the translation of the structural proteins, assembly and
budding of alphavirus particles.
Capsid protein synthesis and nucleocapsid assembly. The capsid protein
is autoproteolytically released from the polyprotein precursor by its serine protease
activity (6, 76). Once the capsid protein has cleaved itself from the polyprotein
chain, the proteinase is no longer active because the active site remains occupied
by the C-terminal tryptophan residue (17). Newly synthesized capsid proteins then
bind to one or more  encapsidation sequences of the  genomic RNA, and this
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Figure 3. Translation of the structural proteins of SIN, and the assembly of new virus
particles.
binding is believed to be important for the initiation of nucleocapsid formation
(139). For SIN, a signal sequence in the encoding region of nsP1 (from nucleotide
945 to 1076) has been identified as the encapsidation signal (17). Moreover, it was
found that a stretch of 18 amino acids, called helix I, in the amino-terminal region
of the capsid protein is important for nucleocapsid formation (101). After the
binding of a capsid subunit to the RNA, more capsid proteins associate with the
complex, until a T=4 symmetry is obtained (36).
Glycoprotein synthesis and folding of the viral spike proteins. Once the
capsid protein is cleaved off, a signal sequence at the amino-terminus of PE2
targets the remainder of the polyprotein for cotranslational translocation to the
rough endoplasmic reticulum (ER). In the ER the polyprotein is cotranslationally
cleaved by signal peptidases into PE2, 6K, and E1 (113).
Addition of carbohydrates.  Mannose groups are added to the PE2 and E1
polypeptides in the lumen of the ER, and these carbohydrate chains are modified
during transit of the proteins through the Golgi apparatus (113). The asparagine
residues in a consensus sequence  Asn-X-Ser/Thr in the  ectodomains of the
alphavirus  glycoproteins are  glycosylated and carry either simple or complex
oligosaccharide chains. It has been postulated that a  glycosylation site remains
PE2 cleavage
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simple when the folding of the protein renders the chain inaccessible to cellular
processing enzymes during transit through the Golgi apparatus, whereas if the
chain is accessible to cellular enzymes it is further modified to a complex type (57).
For SIN, the oligosaccharide at E1:139 may be either a complex or a simple type
of carbohydrate, while the oligosaccharide at E1:245 appears to be modified to a
complex-type. E2 is glycosylated at positions 196 and 318, the oligosaccharide at
position 318 being processed to a complex-type of carbohydrate. It is believed that
the function of carbohydrate chains at the initial stage of  glycosylation is to
increase the solubility of the protein and prevent aggregation or side reactions
from occurring. However, it appears that glycosylation of the ectodomains of SIN
glycoproteins has other distinct functions in the life cycle of alphaviruses (Chapter
6).
Addition of fatty acids. Fatty acid acylation of the structural proteins of SIN in
vertebrate cells occurs after exit of the ER but probably before arrival in the cis
Golgi (10). In most cases the fatty acid, usually palmitic acid, is covalently linked in
a thiol ester bond to the cysteine residues of the protein. Mutational analysis of the
transmembranal cysteine residues of the glycoproteins E1 (at position 430) and E2
(at positions 388, 390) revealed that these residues are  palmitoylated (109).
Moreover, it has been shown that the cytoplasmic domain of E2 is palmitoylated
at positions 396, 416, and 417 (33, 58). Site-specific mutagenesis of the 6K protein
revealed that the cysteines at positions 35, 36, and 39 are palmityolated (32, 33).
The role of acylation of the SIN glycoproteins is not quite clear, although it has
been shown that deacylation of the carboxy-terminal domain of E2 or the 6K
protein affects virus budding. For influenza virus, conflicting reports have been
published with regard to the role of envelope glycoprotein acylation in viral fusion
(28, 60, 90,  93, 103, 121). In  Chapter  7, the influence of  acylation of SIN
glycoproteins E2 and E1 on the membrane fusion process is investigated.
Folding, transport, and PE2 cleavage of the glycoproteins. The folding of the viral
glycoproteins begins immediately upon entry of the proteins into the ER. It
requires molecular chaperones, folding enzymes, energy, and the formation of
disulfide bridges (124). After folding of the glycoproteins, heterodimerization of
PE2 and E1 occurs in the ER. The PE2/E1  heterodimer matures further by
passing through the Golgi and trans-Golgi network (TGN). During transport of
the PE2/E1 heterodimer through the slightly acidic TGN, the uncleaved PE2 is
presumed to function as a chaperone, protecting the spike from premature
destabilization. The influence of PE2 on the stability of the PE2/E1 heterodimer
is further discussed in Chapter 8. In the TGN or in a post-TGN compartment,
PE2 is cleaved to form E2 and E3 (88). PE2 cleavage is mediated by a furin-like
host protease at the consensus sequence XBXBBX, where X is a hydrophobic and
B a basic amino acid (67). After PE2 cleavage the E2/E1  heterodimers are
transported to the plasma membrane of the cell, where they are used to assembleChapter 1 8
new virus particles. The spikes appear on the cell surface as trimers of E2/E1
heterodimers; it is unclear when exactly these trimers are formed.
Spike-nucleocapsid interactions and budding of virus particles. The
preformed nucleocapsids in the cytoplasm of the cell interact with the viral spike
proteins, located on the plasma membrane of the cell, which results in the budding
and release of new progeny virus particles. SFV mutagenesis studies have revealed
that particle formation requires co-expression of both the capsid and the spike
proteins (127). It has been proposed that alphavirus budding is driven by specific
interactions of the carboxy-terminal tail of E2 with the nucleocapsids at the plasma
membrane of the cell (16, 36, 71). The carboxy-terminal domain of E2 contains
two conserved regions. The first conserved region contains a tyrosine and a leucine
residue, and this region is shown to interact with aromatic residues in the capsid
protein (54, 72, 98, 119, 143). The second region consists of palmitoylated cysteine
residues, flanking the tyrosine-leucine motif, and mutations that disrupt
palmitoylation affect virus budding (33, 58). In addition, E2-E1 dimer interactions
are important for virus assembly and budding. It was found that the E2 carboxy-
terminal tail does not interact with the capsid protein unless the E2 protein is
dimerized with E1 (5).
Interestingly, it has been observed that pre-assembly of nucleocapsids in the
cell cytoplasm is not a prerequisite for budding (30, 118). Moreover, Forsell and
co-workers (31) showed that lateral spike-spike interactions are required for virus
assembly. It was observed that a capsid mutant with a large deletion (amino acid 40
to 118), which is unable to assemble into nucleocapsids in the cell cytosol, does
assemble at the plasma membrane and leads to the release of new virus particles. It
was proposed that the role of the capsid proteins is restricted to triggering the
spike proteins to undergo lateral spike-spike interactions. This, in contrast to the
assumption that spike-capsid interactions would drive virus assembly, suggests that
lateral spike-spike interactions are responsible for the envelope formation.
Moreover, based on the recent information on the positioning of E1 in the viral
envelope of  alphaviruses (74, 104), one could argue that lateral spike-spike
interactions between the E1 glycoproteins are responsible for envelope formation
(34).
It has also been shown that the 6K polypeptide is involved in virus budding
(32). Deletion analysis of 6K demonstrated that the budding efficiency of the D6K
virus was down to 10% when compared to wild-type SFV (77, 79). These
observations demonstrate that the 6K polypeptide facilitates virus assembly but
that it is not absolutely required.
Furthermore, efficient budding of SFV and SIN requires the presence of
cholesterol in the cellular membrane (80, 81, 87, 133). Transfection of viral RNA
into cholesterol-depleted cells demonstrated that, while RNA replication, spike
protein dimerization, and transport to the cell surface were normal, virus budding
was dramatically inhibited.General introduction 9
Cell entry of Sindbis virus
Entry of enveloped viruses into a host cell requires fusion of the viral envelope
with a cell membrane after attachment of the virus to the cell. Fusion of a viral
membrane with a cellular membrane is mediated by the viral spike proteins and
occurs either at the plasma membrane of the cell, or from within acidic endosomes
after cellular uptake of virus particles through a process of receptor-mediated
endocytosis, as depicted in Figure 4. In the process of plasma membrane fusion,
the interaction of a virus particle with a cellular receptor triggers conformational
changes in the viral spike protein which subsequently results in fusion of the viral
membrane with the plasma membrane of the cell. On the other hand, when the
virus is taken up by the cell through receptor-mediated endocytosis, the mildly
acidic pH in the lumen of the endosomal compartment triggers conformational
changes in the viral proteins, that are required for fusion of the viral membrane
with the endosomal membrane. There is considerable controversy as to whether
SIN infects its host cell by receptor-mediated endocytosis or plasma membrane
fusion. Before discussing the evidence for both pathways in detail, we will first
describe the receptor binding properties of alphaviruses.
Receptor binding. The first step in the entry process of alphaviruses is the
interaction of the virus particle with a receptor on the plasma membrane of the
cell. It was found that the E2  glycoprotein is primarily responsible for virus-
receptor interaction, as evidenced by the ability of anti-E2 antibodies to inhibit
binding to cells (12, 84). Anti-idiotypic antibodies, directed against E2-specific
antibodies, have been used in attempts to identify putative virus receptors on
target cells (131, 137). Furthermore, cryo-EM and image reconstruction analysis of
SIN and RR, using Fab fragments of monoclonal antibodies, revealed that the
outermost tips of the viral spike protein are involved in interaction with a cellular
receptor (120).
Identification of specific  alphavirus receptors has been difficult and, in
retrospect, may have been complicated by the use of virus strains that are adapted
to tissue cell culture (69). Because  alphaviruses have a wide host range and
replicate in a variety of different species as well as in many different cell types, the
viruses must use a ubiquitous cell surface molecule or a variety of different
molecules as receptors. The first putative receptor identified for SFV was the
major histocompatibility complex class I molecule on mouse and humans cells
(51). However, cells that do not express class I molecules can still be infected by
SFV (95). For SIN, a high-affinity  laminin receptor has been proposed as a
potential receptor on baby hamster kidney (BHK-21) cells (136).Chapter 1 10
Figure 4. Routes of cell entry of enveloped viruses. Left: receptor-mediated endocytosis
and fusion from within acidic endosomes. Right: plasma membrane fusion.
Recently, it has been shown that SIN, RR, and VEE interact with heparan
sulfate (HS), a ubiquitously expressed glycosaminoglycan on the plasma membrane
of the cell, as a cell culture adaptation (9, 12, 13, 49, 69). Passage of non-HS-
adapted SIN TR339 on BHK-21 cells results in the generation of virus mutants
which bind with high affinity to BHK-21 cells and interact with heparin (69).
Positive-charge amino acid substitutions have been identified in the mutant E2
proteins of SIN, RR, and VEE, substitutions which appear to be responsible for
interaction with HS (9, 49, 69). With regard to SIN, three loci in E2 have been
identified (E2:1; E2:70; E2:114) that mutate during the adaptation of SIN in BHK-
21 cells and can independently confer the ability to the virus to bind to cell-surface
HS (69).
SIN entry via plasma membrane fusion. A mechanism of SIN entry via
plasma membrane fusion has been first suggested on the basis of studies which
indicated that weak bases, such as chloroquine and ammonium chloride (which are
commonly used to raise the pH of intracellular compartments) have little effect on
the formation of SIN infectious centers, as detected by translation of viral RNA in
the cell cytosol (14, 18). Accordingly, it was found that SIN was able to infect a
mutant Chinese hamster ovary cell line, temperature sensitive for  endosome
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acidification, at either permissive or non-permissive  temperatures (26).
Furthermore, it was shown that attachment of SIN to cells leads to the exposure
of new transitional  epitopes on both  glycoproteins, using E1- and E2-specific
antibodies (29). In the context of these experiments, Abel and Brown (1) proposed
a model for SIN entry in which virus-receptor interaction reduces critical disulfide
bridges in the E1  glycoprotein through  thiol-disulfide exchange reactions. The
reduction of disulfide bridges would reorganize the viral spike protein of SIN,
subsequently resulting in fusion of the viral membrane with the plasma membrane
of the cell. Consistent with this model, SIN-induced polykaryon formation was
enhanced by the presence of 2-mercaptoethanol, which reduces disulfide bonds,
while SIN infection was partially inhibited by 5,5’-dithiobis(2-nitrobenzoic acid)
(DTNB), a thiol-akylating agent and exchange inhibitor (1). Moreover, it has been
observed that the infection of mosquito cells by SIN is not inhibited by
chloroquine, under conditions such that the drug prevented  endosome
acidification (55).
SIN entry via receptor-mediated endocytosis. There is also evidence that
SIN infects its host cell by receptor-mediated endocytosis and fusion from within
acidic endosomes. Glomb-Reinmund and Kielian (40) investigated the role of low
pH and disulfide shuffling in the entry process of SIN. These authors made a
direct comparison between SIN and SFV, a virus which is known to infect cells via
receptor-mediated  endocytosis and low-pH-induced fusion from within acidic
endosomes (50, 52, 53, 59, 64, 85, 86). It was found that both SIN and SFV
infection are inhibited in cells treated with ammonium chloride, during entry of the
virus, as evidenced by viral RNA translation and infection. Inhibition of viral
infection was concentration dependent and correlated with the pH threshold of
virus-induced cell-cell fusion. Bafilomycin and concanamycin, two reagents that
prevent endosome acidification by a different mechanism than the weak bases, also
inhibited cellular infection of SIN and SFV. Furthermore, the authors were unable
to detect a specific role for the reduction of disulfide bonds in SIN and SFV
infection. In another study, alphavirus infection was studied using cells expressing
a dominant-negative mutant of dynamin, which blocks the budding of clathrin-
coated pits, and it was found that SIN and SFV infection was inhibited (23). On
the basis of these studies it would appear as though SIN, like SFV, infects its host
cells by receptor-mediated endocytosis, and that exposure of the virus to the low
pH, within the lumen of the endosome, is physiologically important for activation
of the viral membrane fusion reaction. The controversy about the route of cell
entry of SIN represents the basis for the studies presented in Chapter 2, 3 and 8
of this thesis.
Nucleocapsid uncoating. Through fusion of the viral membrane with the
cellular target membrane the viral nucleocapsid gains access to the cytoplasm of
the cell. It has been demonstrated that after the fusion reaction, the nucleocapsid
remains associated with the cytosolic leaflet of the endosomal membrane (117).Chapter 1 12
The  nucleocapsid is  uncoated such that the RNA becomes accessible to
ribosomes. It has been proposed that the binding of the  nucleocapsid to the
ribosomes  triggers the  uncoating process (124). The region from amino acid
residue 94 to 106 of the capsid protein appears to be involved in the binding of the
protein to the ribosomes (140). This was found to be the same region of the
protein that interacts with viral RNA during encapsidation (37, 99). Once the RNA
is accessible to the ribosomes, RNA replication and translation of the viral proteins
are initiated. This will eventually lead to the production of new virus particles.
Membrane fusion activity of Semliki Forest virus
The basic features underlying the membrane fusion properties of enveloped
viruses have been studied extensively in virus-cell and virus-liposome systems. In
virus-cell systems, fusion is detected directly, measuring fusion of the virus with
the plasma membrane of the cell or, indirectly, on the basis of  polykaryon
formation. These assays might give a quatitative insight in the membrane fusion
reaction, but do not allow kinetic or quantitative analysis of the process. To obtain
detailed insight in the membrane fusion process of enveloped viruses, it is
necessary to follow the process in a sensitive and continuous fashion. To this end,
virus-liposome systems have been developed, which offer a number of advantages
over virus-cell assays, including the simplicity of the technique, high sensitivity,
possibility to obtain quantitative data, and the opportunity to identify target
membrane components required for viral fusion (56). Virus-liposome systems are
either based on lipid mixing between the interacting membranes or on intermixing
of the interior of the virus and the liposomal lumen. Particulary, the lipid mixing
assays provide a kinetic and quantitative insight in the membrane fusion process,
while contents mixing meets a very stringent criterion for fusion. Virus-liposome
systems have been used extensively to unravel the molecular mechanisms involved
in the membrane fusion process of SFV, as discussed in more detail below.
General features of SFV-liposome fusion. It has been demonstrated that
fusion of SFV with liposomes lacking a protein receptor is strictly dependent on
the exposure of the virus to low pH (11, 134, 141). Optimal fusion kinetics were
observed at pH 5.5. The pH threshold for fusion activation of SFV was found to
be pH 6.2 (11). The in vitro pH dependence of fusion (11) closely correlates with
the in vivo pH dependence of virus fusion with the endosomal membrane (40). The
efficient fusion kinetics of SFV with protein- and carbohydrate-free  liposomes
suggests that virus-receptor interaction is not a mechanistic requirement for
membrane fusion. SFV fusion is temperature dependent, but fusion can be
measured in a temperature range of 4 to 37 ￿C. The fusion-active conformation of
SFV is short-lived, pre-incubation of the virus alone for 30 s at pH 5.5 resulting in
a complete loss of membrane fusion activity (11). Fusion of SFV with liposomesGeneral introduction 13
requires cholesterol and sphingolipid in the target membrane, as described in detail
below.
Lipid dependence of SFV fusion. Fusion of SFV with liposomes composed
of a variety of purified lipids revealed that fusion is strictly dependent on the
presence of cholesterol (11, 134, 141) and  sphingolipid (94, 142) in the target
membrane. Optimal fusion kinetics were observed with liposomes containing 35
mol% cholesterol and 2  mol%  sphingolipid in the target membrane, with a
cholesterol to phospholipid ratio of 1:2. It was found that cholesterol is required
for low-pH-induced binding of the virus to the liposomal membrane, whereas
sphingolipid is important for the subsequent fusion process (94). Cholesterol has
also been found to be required for efficient cellular infection, SFV fusion and
infection being dramatically reduced on cholesterol-depleted mosquito cells (see
below). To date it has not yet been possible to study the role of sphingolipid
during cellular infection, since there are no viable sphingolipid-deficient cell lines
available.
To unravel the structural features of cholesterol in supporting membrane
fusion, SFV-liposome fusion studies were conducted using liposomes composed
of a variety of sterol analogs. Three major features of cholesterol are believed to be
important in its physical interactions with a membrane: the planar ring structure,
the aliphatic side chain at C-17, and the 3ß-hydroxyl group. It was observed that
the planar ring  structure, and the aliphatic side chain are not required for
membrane fusion activity of SFV (63). In contrast, the 3ß-hydroxyl group of
cholesterol was found to be essential (63, 102, 134). For example, sterols with a
modified 3ß-hydroxyl group such as 3-a-hydroxy cholesterol, cholestanone, 5a-
cholestane, cholesterol methyl ether, cholesterol acetate, and  chlorocholestene,
were inactive in supporting membrane fusion of SFV.
The structural features required for sphingolipids to mediate fusion of SFV
have been examined in a similar fashion, using liposomes containing a variety of
sphingolipid analogs. Efficient fusion of SFV was observed with  liposomes
containing either sphingomyelin, ceramide, or galactosyl ceramide, demonstrating
that the nature of the headgroup of the sphingolipid is not a crucial factor (94).
Ceramide is the minimally required  sphingolipid still supporting fusion, the
sphingosine base being inactive. The length of the acyl chain has no prominent
effect on the capacity of ceramide to induce membrane fusion of SFV, since both
C8-ceramide and C18-ceramide are active (19). In contrast, the 3ß-hydroxyl group
and the 4,5-trans double bond of the sphingosine backbone were found to be
critical (19, 46). The sphingolipid requirement is stereospecific, D-threo, L-threo, and
L-erythro  ceramides or  sphingolipids being inactive (92). In conclusion, fusion
studies with a wide variety of sphingolipids have demonstrated that the action of
sphingolipid in the membrane fusion process of SFV exhibits a remarkable
molecular specificity. In Chapter 2, it is demonstrated that fusion of SIN, like that
of SFV, also requires  sphingolipid in the target membrane. The molecularChapter 1 14
specificity of this  sphingolipid requirement differs from that of SFV fusion
(unpublished observations) and is currently under detailed investigation.
E1 conformational changes. Upon exposure of SFV to low pH,
conformational changes take place in the viral spike protein, which result in fusion
of the viral membrane with the target membrane. The fusion reaction of SFV with
liposomes can be slowed down by raising the pH of the medium or by lowering
the temperature, through which one can differentiate between different stages in
the series of conformational rearrangements that occur. Upon acidification, the
E2/E1 spike  heterodimer dissociates, as evidenced by the loss of E2-E1 co-
immunoprecipitation and co-flotation on sucrose-density gradients (11, 27, 61).
After E2/E1  heterodimer dissociation, the E1  glycoprotein undergoes several
distinct conformational changes that are independent of E2. Monoclonal antibody
binding experiments showed that previously hidden  epitopes of E1 become
accessible (2, 114). Using these Mabs, it was found that residue E1:157 becomes
exposed after low pH treatment of the virus (2). Then, the E1  glycoproteins
rearrange to form an E1  homotrimeric structure (134, 135). Treatment of
alphaviruses with heat or urea also induces conformational changes within the
spike proteins, but there is no formation of an E1  homotrimer under these
conditions (38, 91). The formation of an E1 homotrimer is strictly dependent on
the incubation of the virus at low pH (134). Analysis of the low-pH-dependent
fusion reaction in presence of Zn2+ suggests that the E1 glycoprotein inserts into
the target membrane before E1 trimerization (20). Similar results were obtained
with the SFV mutant (E1:Gly91Asp; 66). The E1 homotrimer has a very stable
configuration: it is found to be resistant to SDS treatment at 30 ￿C, urea, and
trypsin digestion (38, 134). It has been proposed that the energy derived from the
formation of the E1 homotrimer could drive the merging of the membranes. This
would imply that the formation of the E1 homotrimer occurs concomitantly with
membrane fusion. However, kinetic data suggest that E1  trimerization  occurs
before the onset of membrane fusion (11). Therefore, it appears that additional
rearrangements within or between E1 homotrimers are required to establish fusion
of the viral membrane with the target membrane. The influence of low pH on the
conformation of the spike proteins of SIN is presented in Chapter 2.
Alphavirus mutants and the effect on virus entry and
membrane fusion
Adaptation. RNA viruses are known to adapt rapidly to new growth
environments as a result of the facile generation and selection of virus mutants.
For example, rapid adaptation is the basis for the emergence of new influenza
virus variants that have the ability to escape from the immunological response
generated by the host against a prior virus variant. Also, adaptation is the basis forGeneral introduction 15
the development of resistance against  antiretroviral drugs in HIV-infected
individuals. Furthermore, the emergence of new virus variants makes it virtually
impossible to design a vaccine against HIV that would control the infection by
induction of virus-neutralizing antibodies.
The rapid generation of RNA virus mutants is directly related to the relatively
low fidelity of viral RNA replication, the error frequency being approximately 1 in
10,000  bases (125). Furthermore, viral RNA  polymerases generally lack error-
correcting mechanisms. This implies for  alphavirus RNA replication, that on
average each newly synthesized viral genome will contain a base substitution. As
these substitutions are inserted randomly throughout the genome, they will
generally go unnoticed, either because the substitution remains silent or because it
may be lethal. Only when the substitution confers a selective advantage to the
corresponding virus mutant, relative to the parent virus, it may become visible. In
this case, selective pressure will allow the virus mutant to outgrow and develop
into the predominant species (42). These selective conditions may involve
immunological pressure within the host, the presence of drugs interfering with
replication of the parent virus, changes in culture conditions, etc.
The facile emergence of adapted virus mutants has also contributed
significantly to our current understanding of the life cycle of RNA viruses. For
example, to gain a better insight in the requirement of cholesterol in the fusion and
the budding process of SFV particles, cholesterol-independent SFV mutants have
been selected by serial passage of the virus on cholesterol-depleted mosquito cells
(15, 87, 133). Likewise, Chapter 3  presents a characterization of SIN variants
adapted to efficient interaction with HS after passaging of wild-type virus on tissue
culture cells. Also, Chapter 8 deals with infectious second-site mutant SIN viruses
generated from a poorly infectious PE2 cleavage mutant virus by passaging of the
original virus on BHK-21 cells. At the same time, however, one should be aware
of the fact that propagation of virus particles in cell culture can lead to
unrecognized adaptive mutations, which may result in misinterpretation of results
and erroneous conclusions regarding the life cycle of the virus concerned (8). In
order to avoid the generation of adaptive mutations, viruses can be used derived
from an infectious cDNA clone. Infectious cDNA clones have been developed for
SFV (77), SIN (107), and VEE (22). In these clones, the viral genome has been
positioned downstream of a promotor encoding an SP6 RNA polymerase. The
viral RNA is transcribed  in vitro, and  transfected into susceptible cells, which
subsequently leads to the production of progeny virus. Thus, with this procedure,
no additional passage of the virus is required, thereby minimizing the possibility of
generating mutant viruses.
In the following paragraphs, several  alphavirus mutants are described,
generated by passage of the virus under selective pressure or by site-specific
mutagenesis of the full-length cDNA clone encoding the genome of SFV or SIN.Chapter 1 16
PE2 cleavage mutants. In SFV, cleavage of p62 (p62 is called PE2 in SIN)
was prevented by mutating the p62 cleavage site from Arg-His-Arg-Arg to Arg-
His-Arg-Leu (110). The resultant p62-mutant SFV was found to be non-infectious
in BHK-21 cells because of impairment of receptor interaction and fusion. Viral
infectivity of the p62-containing mutant virus could be restored by in vitro cleavage
of p62 with trypsin or by exposure of the virus to extremely low pH (78, 110, 135).
Analysis of the conformational changes of the viral spike proteins revealed that the
pH threshold for p62/E1  heterodimer dissociation was pH 5.0. This is
considerably lower than that for wild-type virus, in which E2/E1  heterodimer
dissociation is already observed at pH 6.2. Therefore, it appears that the block in
membrane fusion lies at the level of the dissociation of the p62/E1 heterodimer.
The role of PE2 cleavage in viral infection has also been investigated for SIN.
A chinese hamster ovary cell, RPE.40, defective in PE2 processing, was used to
generate PE2-containing SIN particles (138). The produced PE2-containing virus
particles were found to be non-infectious on RPE.40 and other cells. Viral
infectivity was regained by in vitro cleavage of PE2 by trypsin.
In contrast, a PE2-containing mutant of the SIN strain SAAR86 was found to
be as infectious as the PE2-cleaving parental virus on RPE.40 cells (108, 138). The
PE2 cleavage defect resulted from a single amino acid mutation at E2:1 in which a
Ser-to-Asn substitution created a signal for N-linked glycosylation. In a later study,
a similar amino acid substitution was introduced in the infectious clones of TRSB
(corresponding to a laboratory strain of SIN) and TR339 (containing the
consensus sequence of SIN AR339), and it was demonstrated that these mutant
viruses were non-infectious on RPE.40 cells and BHK-21 (47, 48, 68). The authors
found that infection was blocked downstream of binding of the virus to the cell
surface, but before RNA replication. This suggests that these viruses are impaired
in their capacity to induce membrane fusion. In Chapter 8, we investigated the
infectivity and fusogenic properties of these and other PE2 cleavage mutant SIN
viruses with liposomes.
Cholesterol-independent SFV and SIN mutants.  The presence of
cholesterol in the host cell membranes has been found to be required for efficient
infection, fusion, and budding of SFV and SIN, as discussed earlier. To gain a
better insight in the cholesterol dependence of these viruses,  Kielian and co-
workers have generated cholesterol-independent mutants of SFV and SIN.
Cholesterol-independent mutants of SFV were obtained by passaging wild-type
SFV on cholesterol-depleted mosquito cells (15, 87, 133). The resultant mutant,
called srf-3 (sterol requirement in function), was found to be more infectious, by
about 4 to 5 logs, on cholesterol-depleted cells, when compared to wild-type SFV
(133). It was observed that the enhanced growth of the srf-3 mutant virus on
sterol-depleted mosquito cells was due to an increased efficiency of viral entry and
exit. Analysis of the membrane fusion properties of the srf-3 virus with liposomes
revealed that both the E1 conformational changes and the membrane fusionGeneral introduction 17
activity of the mutant virus were relatively independent of cholesterol (15).
Furthermore, it was found that the srf3 virus, propagated in cholesterol-depleted
cells, was less stable to centrifugal force than wild-type SFV, which suggests a
possible role for cholesterol in stabilizing the virus  particles (133). Sequence
analysis of the E1 protein of srf-3 mutant virus revealed a single point mutation
from Pro to Ser at position 226. Introduction of this mutation into the full-length
clone of SFV resulted in a cholesterol-independent mutant, indicating that the
cholesterol dependence of SFV is indeed located at E1:226 (133). The cholesterol
dependence of SIN is also located in the E1:226 region, as evidenced by site-
specific  mutagenesis of the full-length clone of SIN (80). However, other
cholesterol-independent mutants of SFV, srf4 and srf5, have been identified which
were found to have mutations at E1:44 or E1:178, respectively (62). Thus, it
appears that several regions in E1 may be involved in the cholesterol dependence
of alphavirus cell entry and membrane fusion.
E2 virulence mutants. Sequence analysis of neurovirulent strains of SIN, and
the corresponding construction of recombinant viruses, have revealed that E2 and
E1 are important determinants of virulence (21, 83, 105). It was found that amino
acid changes in E2 which are important for virulence in mice, often affect an early
step in viral entry. For one of these mutants (E2:Gly172Arg), the attenuated
virulence in mice has been shown to correlate with a decrease in binding to neural
cells (128). Other SIN mutants, with a reduced virulence in mice, exhibit an
increased penetration rate in BHK-21 cells (21, 89, 96, 97, 108). These mutants
were generated by  passaging of wild-type SIN virus on tissue culture cells.
Sequence analysis revealed that these mutants had positive-charge amino acid
substitutions in E2 (E2:Ser114Arg or E2:Glu70Lys). In later studies, it was
observed that these amino acid changes confer the ability to the variants to bind to
cell-surface HS (69). Indeed, several mutants of SIN, VEE, and RR that bind to
HS have been found to have a reduced virulence in mice (9, 49, 68, 69). It has been
proposed that in vivo HS-adapted mutants bind non-productively to extracellular
membranes and basal laminae, and therefore may be cleared from the blood more
rapidly than wild-type viruses (9, 13, 49).
Passaging of SIN strain AR339 through neonatal and adult mouse brain
resulted in a virus mutant with a profound increase in neurovirulence. Sequence
analysis and construction of recombinant viruses revealed that the increased
virulence of this mutant is due to a single amino acid substitution, from Glu to
His, at E2 position 55 (130). This amino acid change alters viral entry and affects
early steps in replication more profoundly in neural cells than in non-neural cells
(25, 129). Since the E2 glycoprotein is found to be responsible for virus-receptor
interaction, one could argue that the amino acid change in TE influences the virus-
receptor interaction at the cell surface of neural cells. This question represents the
basis for the study presented in Chapter 5 of this thesis.Chapter 1 18
SFV fusion mutants.  The amino acids 90 to 92 ( Gly-Gly-Ala) in E1 are
strongly conserved among alphaviruses. These residues lie within the conserved
hydrophobic domain (amino acid 79 to 97) of E1, a  domain which has been
identified as the putative fusion peptide of E1. Mutation from the Gly residue at
E1 position 91 to Ala or Asp resulted in virus mutants that were affected in viral
fusion and assembly (75, 66, 116). The E1:Gly91Ala mutant was found to have a
decreased efficiency in virus-liposome association, E1 trimerization, and fusion
when compared to wild-type SFV. Both cell-cell fusion and virus-liposome fusion
studies revealed that the pH threshold for fusion of the E1:Gly91Ala mutant is
shifted to a more acidic pH. The E1:Gly91Asp mutant is completely blocked in
membrane fusion, as evidenced by lipid mixing, content mixing, and polykaryon
formation assays. It appears that the block in membrane fusion activity is after
binding of the viral to the target membrane and epitope exposure but prior to E1
trimerization. This indicates that the E1 glycoprotein inserts as an E1 monomer in
the target membrane and that E1 trimerization occurs upon interaction with the
target membrane, as indicated above. Other amino acid substitutions in the fusion
peptide of SFV revealed that the membrane fusion activity of the virus is
dependent on the length of the fusion peptide, its overall hydrophobicity, and its
specific sequence (75, 116).
Another SFV fusion mutant, called fus-1, with a lower pH threshold for
membrane fusion was isolated by selecting viruses resistant to in vitro fusion with
RNase-containing liposomes (65). The acid shift in the membrane fusion activity
of fus-1 appears to be a consequence of the more acidic pH threshold for the
initial dissociation of the E2/E1 heterodimer (39). Sequences analysis revealed that
a single amino acid substitution at E2 position 12 from Thr to Ile is responsible
for this fusion phenotype (39). This indicates that the amino-terminal end of E2
stabilizes the E2/E1 heterodimer interaction and regulates the pH dependence of
E1-catalyzed fusion by controlling the dissociation of the E1/E2 heterodimer.
Scope of this thesis
Mutational analysis of the viral spike proteins has greatly contributed to our
current understanding of the molecular mechanisms involved in the membrane
fusion process of  alphaviruses. The studies described in this thesis attempt to
further unravel the molecular basis of the membrane fusion activity of SIN, by
site-specific mutagenesis of amino acids in the E2 and E1 glycoprotein sequences.
These mutations are generated in full-length clones of SIN. The receptor
interaction and the membrane fusion characteristics of the mutants are analyzed by
cell binding assays, on-line lipid mixing assays, content mixing assays, and analysis
of the viral spike conformational changes. The first chapters deal with the general
characteristics of the membrane fusion process of SIN with  liposomes.
Subsequently, the influence of post-translational modifications, includingGeneral introduction 19
glycosylation,  palmitoylation, PE2 cleavage, of the viral  glycoproteins on the
membrane fusion process of SIN is investigated.
In Chapter 2, the basic membrane fusion characteristics of SIN with target
liposomes are investigated with emphasis on the issue as to whether receptor
interaction or low pH is the crucial factor in triggering the fusion process.
Furthermore, the role of cholesterol and sphingolipid in the membrane fusion
process of SIN is investigated. Sub-optimal conditions for fusion were used to
differentiate between different stages in the virus-liposome fusion process.
In  Chapter 3, the receptor binding properties of HS-adapted mutant SIN
versus non-adapted SIN TR339 are investigated using liposomes in which a lipid-
conjugated heparin is incorporated as a specific attachment receptor for HS-
adapted SIN. The effect of virus-receptor interaction on membrane fusion activity
is analyzed in further depth, using lipid mixing and content mixing assays. Also,
the potential adaptation of SFV to cell-surface HS is examined.    
In  Chapter 4 , the  leakiness of SIN and SFV fusion is investigated by
examining the redistribution of fluorescent dyes or  radiolabeled contents,
entrapped in the liposomal lumen during fusion. It is demonstrated that the fusion
reactions are largely non-leaky, supporting the notion that a  hemifusion
intermediate is involved.
In  Chapter 5, the cell entry properties of SIN mutants TE and 633 are
investigated. A distinction is made between binding and fusion. It is shown that
the TE virus is more infectious on neural cells than SIN mutant 633. The
enhanced infection efficiency of TE in neural cells is found to be related to an
increased ability of TE to bind to these cells rather than to an enhanced membrane
fusion capacity of this virus.
In  Chapter 6, single  deglycosylated SIN mutants are used to identify the
function of the carbohydrate chains in infectivity and membrane fusion activity of
the virus. It is shown that SIN glycosylation mutants have a reduced infectivity on
BHK-21 cells. Moreover, the deglycosylated SIN mutants are impaired in their
capacity to induce membrane fusion, indicating that the reduced infectivity of the
mutant viruses on cells lies at the level of the fusion process.
In Chapter 7, the effect of deacylation of the transmembrane domains of SIN
glycoproteins E2 and E1 on the viral membrane fusion capacity is investigated.
The mutants were generated by site-specific mutagenesis of the infectious cDNA
clone Toto1101 of SIN. It appeared that  deacylation of the  transmembrane
regions of E2 and/or E1 has no effect on the membrane fusion characteristics of
the virus.
In  Chapter 8,  the role of PE2 in the membrane fusion process of SIN
particles is investigated. It is demonstrated that PE2 cleavage mutant viruses are
non-infectious on BHK-21 cells because these mutants are impaired in viral fusion.
Furthermore, it is shown that second-site resuscitating mutations in PE2 restore
viral infection and membrane fusion, despite a sustained lack of PE2 cleavage.Chapter 1 20
In Chapter 9, the results and conclusions of this thesis are summarized and
discussed.
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Abstract
There is controversy as to whether the cell entry mechanism of Sindbis virus
(SIN) involves direct fusion of the viral envelope with the plasma membrane at
neutral pH, or uptake by receptor-mediated endocytosis and subsequent low-pH-
induced fusion from within acidic endosomes. Here, we studied the membrane
fusion activity of SIN in a  liposomal model system. Fusion was followed
fluorometrically by monitoring the dilution of  pyrene-labeled lipids from
biosynthetically labeled virus into unlabeled liposomes or from labeled liposomes
into unlabeled virus. Fusion was also assessed on the basis of degradation of the
viral core protein by trypsin encapsulated in the liposomes. SIN fused efficiently
with receptor-free  liposomes, consisting of  phospholipids and cholesterol,
indicating that receptor interaction is not a mechanistic requirement for fusion of
the virus. Fusion was optimal at pH 5.0, with a threshold at pH 6.0, and
undetectable at neutral pH, supporting a cell entry mechanism of SIN involving
fusion from within acidic endosomes. Under optimal conditions, 60-85% of the
virus fused, depending on the assay used, corresponding to all of the virus bound
to the liposomes as assessed in a direct binding assay. Preincubation of the virus
alone at pH 5.0 resulted in a rapid loss of fusion capacity. Fusion of SIN required
the presence of both cholesterol and  sphingolipid in the target  liposomes,
cholesterol being primarily involved in low-pH-induced virus-liposome binding
and the sphingolipid in the fusion process itself. Under low-pH conditions, the
E2/E1  heterodimeric envelope  glycoprotein of the virus dissociated with
formation of a trypsin-resistant E1 homotrimer, which kinetically preceded the
fusion reaction, thus suggesting that the E1 trimer represents the fusion-active
conformation of the viral spike.Low-pH-dependent fusion of Sindbis virus with liposomes 31
Introduction
Sindbis virus (SIN) is the prototype member of the genus Alphavirus of the
family of the Togaviridae. Alphaviruses are structurally well-defined viruses which
contain three major proteins, the capsid protein C, and two envelope glycoproteins
E1 and E2 (27, 54). The  glycoproteins are  organized in 80  hetero-oligomeric
spikes; a single spike consisting of a trimer of E2/E1 heterodimers. In the infected
cell, the spike heterodimer is assembled in the endoplasmic reticulum as a PE2/E1
heterodimer in which PE2 is the precursor of the E2. The PE2/E1 heterodimer is
subsequently transported through the Golgi and the trans-Golgi network to the
plasma membrane. Just before the appearance of the spike on the cell surface, the
PE2 precursor is cleaved into E2 and E3 by a cellular furin-like protease, resulting
in the formation of the mature E2/E1 form of the heterodimer (33). In some
alphaviruses including SIN, the E3 peptide is released from the virus particles (37),
whereas in others, such as Semliki Forest virus (SFV), E3 remains associated with
the E2/E1 heterodimer.
The E2/E1 heterodimer mediates the infectious entry of SIN into its host cell.
The initial step in cell entry is the interaction of the virus with a cellular receptor. A
high-affinity receptor for binding of SIN to rodent and monkey cells has been
identified as the 67-kDa protein laminin (57). Recently, it has been shown that the
widely expressed glycosaminoglycan heparan sulfate may be involved in binding of
SIN to cells (6, 30). It is the E2 component of the alphavirus spike that is primarily
involved in receptor interaction (48, 50).
Being an enveloped virus, SIN infects its host cells by a membrane fusion
reaction. In principle fusion of enveloped viruses may occur either at the plasma
membrane or from within the endosomal cell compartment after internalization of
the virus particles through receptor-mediated endocytosis. In the process of plasma
membrane fusion, the interaction of the virus with a cellular receptor mediates the
conformational changes within the viral spike protein that are required for the
fusion reaction, fusion occurring at the neutral pH of the  extracellular
environment. In the process of virus cell entry through receptor-mediated
endocytosis, it is generally the mildly acidic pH within the lumen of the endosomes
that triggers the membrane fusion reaction.
There is considerable controversy with regard to the cell entry mechanism of
SIN.  Several lines of evidence suggest that SIN may fuse directly at the cell plasma
membrane at neutral pH, mediated by interaction of the viral spike with its cellular
receptor. For example, SIN has been observed to infect cells treated with weak
bases, like chloroquine and ammonium chloride, which raise the pH of endosomes,
as evidenced by the translation of viral RNA in the cell cytosol (7, 8). This suggests
that the infection process of SIN does not involve acidic endosomes. Accordingly,
SIN has been found to infect a Chinese hamster ovary (CHO) cell mutant,
temperature-sensitive for  endosome acidification (14), although earlier          Chapter 2 32
observations involving similar CHO cell mutants had suggested that a lack of
endosome acidification does inhibit infection (39, 47). Furthermore, Flynn et al.
(17) detected conformational changes within the  glycoproteins of SIN upon
interaction of the virus with cells at neutral pH, and suggested that the virus-
receptor interaction induces the fusion-active conformation of the viral spike. Abell
and Brown (1) then proposed a model for SIN entry in which the virus-receptor
interaction enhances thiol-disulfide exchange reactions reorganizing the viral spike
protein, allowing the virus to penetrate cells by direct fusion with the plasma
membrane.
On the other hand, early (15) and quite recent evidence supports an endocytic
mechanism for cell entry by SIN. In fact, while the present study was in progress,
DeTulleo and Kirchhausen (12) reported that infection of cells by SIN is inhibited
by dominant-negative mutant forms of  dynamin, which block the budding of
clathrin-coated pits, thus suggesting that SIN infects its host cells by  clathrin-
mediated endocytosis. Furthermore, Glomb-Reinmund and Kielian (20) published
a study also providing evidence for cell entry of SIN through receptor-mediated
endocytosis and fusion from within acidic endosomes. These authors made a direct
comparison between SIN and SFV, because it is well established that SFV enters
cells through an endocytic mechanism (21, 22, 23, 24, 27, 35, 36). Upon exposure
of SFV to low pH, the viral E2/E1 heterodimeric glycoprotein dissociates and
trypsin-resistant homotrimer of the fusion protein E1 (19, 31) is formed, which
presumably represents the fusion-active conformation of the viral spike (4, 25, 29,
55, 56). SFV is also capable of fusing liposomes in a mildly acidic environment,
indicating that the sole trigger for fusion is low pH (4, 25, 42, 55, 58, 59).
Here, we studied fusion of SIN in a  liposomal model system, using virus
biosynthetically  labeled with  pyrene  phospholipids (4, 42, 55, 59). It is
demonstrated that the virus fuses rapidly with  liposomes lacking a specific
receptor, indicating that receptor binding is not essential for triggering the fusion
reaction. Fusion is strictly dependent on low pH, consistent with cellular entry of
SIN, like that of SFV, through acidic endosomes.
Materials and Methods
Lipids.  Phosphatidylcholine (PC) from egg yolk,  phosphatidylethanol-amine (PE)
prepared by transphosphatidylation of egg PC and sphingomyelin (SPM) from egg yolk
were obtained from Avanti Polar Lipids (Alabaster, AL). High-purity cholesterol (Chol)
was a generous gift from  Solvay Pharmaceuticals ( Weesp, The Netherlands). The
fluorescent fatty acid 16-(1-pyrenyl)hexadecanoic acid ( pyrene fatty acid) and 1-
hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine (pyrPC), were purchased
from Molecular Probes (Eugene, OR).
Cells and Virus. Sindbis virus strain AR339 was a generous gift of Dr. D.E. Griffin
(Johns Hopkins University, Baltimore, MD). The virus was propagated on Baby Hamster
Kidney cells (BHK-21). The cells were cultured in Glasgow’s modification of Eagle’sLow-pH-dependent fusion of Sindbis virus with liposomes 33
minimal essential medium (Gibco/BRL, Breda, The Netherlands), supplemented with 5%
foetal calf serum, 10% tryptose phosphate broth, 200 mM glutamine, 25 mM Hepes, and
7.5% sodium bicarbonate. Pyrene-labeled SIN was isolated from the medium of infected
BHK-21 cells, cultured beforehand in the presence of  pyrene fatty acid, essentially as
described before for SFV (4, 42, 55, 59). Briefly, BHK-21 cells, prior cultured for 48 h on
medium containing 15 µg/ml pyrene fatty acid, were infected with SIN at a multiplicity of
infection of 4. At 24 h post-infection, the pyrene-labeled SIN particles were harvested
from the medium by ultracentrifugation in a Beckman type 19 rotor, 2.5 h at 100,000 g, 4
°C. The virus particles were further purified on a sucrose density gradient (20-50% w/v) by
ultracentrifugation in a Beckman SW41 rotor, 16 h at 100,000 g, 4 °C. [ 35S]methionine-
labeled SIN, and unlabeled SIN were produced in a similar fashion (4, 42, 55, 59). The
purity of the SIN particles was evaluated by SDS-PAGE. Viral  phospholipid was
determined by phoshate analysis (3). Protein concentration was determined according to
Peterson (44). The  infectivity of the virus preparation was determined by titration on
BHK-21 cells in 96-well plates.
Liposomes. Large  unilamellar vesicles (LUV) were prepared by a freeze/thaw-
extrusion procedure (10, 40, 42, 59).  Briefly, lipid mixtures were dried from a
chloroform/methanol solution under a stream of nitrogen and further dried under vacuum
for at least 1 h. The lipid mixtures were hydrated in 5 mM Hepes, 150 mM NaCl, 0.1 mM
EDTA, pH 7.4 (HNE), and subjected to five cycles of freezing and thawing. Subsequently,
lipid mixtures were extruded 21 times through a Unipore polycarbonate filter with a pore
size of 0.2 µm (Nucleopore, Inc., Pleasanton, CA) in a LiposoFast mini-extruder (Avestin,
Ottawa, Canada). Smaller liposomes were prepared by an additional 81 times extrusion
through two Unipore polycarbonate filters with a pore size of 0.05 µm. The size of the
liposomes was determined by quasi-elastic light scattering analysis in a submicron particle
sizer model 370 ( Nicomp Particle Sizing Systems, Santa Barbara, CA).  Liposomes
consisted of PC/PE/SPM/Chol (molar ratio, 1:1:1:1.5), PC/PE/SPM (molar ratio, 1:1:1),
PC/PE/Chol (molar ratio, 1:1:1), PC/PE (molar ratio, 1:1), or PC/pyrPC/PE/SPM/Chol
(molar ratio, 0.85:0.15:1:1:1.5).
Trypsin-containing liposomes were also prepared by freeze/thaw-extrusion, but in this
case the lipids were dispersed in HNE in presence of  10 mg/ml  trypsin ( Boehringer,
Mannheim, FRG). The liposomes were extruded 21 times through a filter with a pore size
of 0.2  µm.  The  trypsin-containing  liposomes were separated from free  trypsin by gel
filtration on a  Sephadex G-100 column in HNE. The  phospholipid concentration of
liposome preparations was determined by phosphate analysis (3).
Fusion assays.  Fusion of  pyrene-labeled SIN with  liposomes was monitored
continuously in an AB2 fluorometer (SLM/Aminco, Urbana, IL). Briefly, pyrene-labeled
SIN (0.5 µM viral phospholipid) and liposomes (200 µM phospholipid) were mixed in a
quartz cuvette of the fluorometer in a final volume of 0.665 ml in HNE, unless indicated
otherwise. The content of the cuvette was stirred magnetically and thermostatted at the
desired temperature. After 1 min incubation, fusion was triggered by the addition of 35 µl
0.1 M MES, 0.2 M acetic acid, pretitrated with NaOH to achieve the final desired pH. The
fusion scale was calibrated such that 0% fusion corresponded to the initial  excimer
fluorescence value. The 100% fusion value was obtained through the addition of 35 µl 0.2
M octaethyleneglycol monododecyl ether (C12E8; Fluka Chemie AG, Buchs, Switzerland)
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determined from the tangent to the first part of the curve. The extent of fusion was
determined 60 s after acidification.
Fusion of  pyrPC-labeled  liposomes with SIN was measured under the same
conditions, essentially as described before for SFV (32) and vesicular stomatitis virus (VSV)
(41). For these experiments,  liposomes were prepared with a diameter of 70  nm (see
above). In the fusion reaction, liposomes (2 µM liposomal phospholipids) were mixed with
SIN (10 µM viral phospholipid), unless indicated otherwise.
Transfer of viral nucleocapsid to the liposomal lumen during SIN-liposome fusion was
measured as the degradation of the viral capsid protein by trypsin, initially encapsulated in
the liposomes (42, 58, 59). Briefly, a trace amount of [ 35S]methionine-labeled virus and
unlabeled virus (final concentration of 0.5 µM viral phospholipid) were mixed with trypsin-
containing liposomes (200 µM phospholipid) in presence of 125 µg/ml trypsin inhibitor
(Boehringer, Mannheim, FRG) in HNE. The mixture was acidified, under continuous
stirring, to the desired pH with 0.1 M MES, 0.2 M acetic acid, as above. After 30 s, samples
were neutralized by the addition of a pretitrated volume NaOH. The samples were further
incubated for 1 h at 37 °C and subsequently analyzed by SDS-PAGE. Gels were incubated
for 30 min in  1 M sodium  salycilate and dried. Protein bands were  visualized by
autoradiography. Quantification of the  capsid protein was done by  phosphorimaging
analysis using Image Quant 3.3 software (Molecular Dynamics, Sunnyvale, CA).
Virus-liposome binding assay. Virus-liposome binding was assessed by a coflotation
assay, as described before (4, 9, 40, 42, 55, 59). The reactions were carried out under the
same experimental conditions as those in the fusion experiments. A trace amount of
[35S]methionine-labeled virus and unlabeled virus (final concentration of 0.5  µM viral
phospholipid) were mixed with  liposomes (200  µM  phospholipid). The mixture was
acidified, under continuous stirring, to the desired pH with 0.1 M MES, 0.2 M acetic acid,
as above. After 60 s, samples were neutralized through the addition of a pretitrated volume
of NaOH. Subsequently, 0.1 ml of the reaction mixture was added to 1.4 ml 50% (w/v)
sucrose in HNE. On top of this, 2.0 ml of 20% (w/v) sucrose and 1.0 ml of 5% (w/v)
sucrose in HNE were layered. After centrifugation in a Beckman SW50 rotor at 150,000 g
for 2 h at 4 °C, the gradient was fractionated in ten samples, starting from the top. The
distribution of the viral radioactivity was quantified by liquid scintillation analysis. The
radioactivity in the top four fractions, relative to the total amount of radioactivity, was
taken as a measure for SIN-liposome binding.
Analysis of the conformational changes in the viral spike protein.  The
conformational changes occurring in the viral spike protein were examined under the same
conditions as in the fusion and binding experiments. After low-pH treatment, samples
were neutralized by addition of a pretitrated volume NaOH, solubilized in SDS-PAGE
buffer, and analyzed by SDS-PAGE. For the appearance of trypsin-resistant forms of E1,
samples were incubated in presence of 200  µg/ml  trypsin for 15 min at 37 °C.
Subsequently, samples were solubilized in SDS-PAGE sample buffer, heated for 4 min at
100 °C, and analyzed by SDS-PAGE. Gels were further incubated for 30 min in 1 M
sodium  salycilate and dried.  Visualization of the bands was done by  autoradiography.
Quantification was done by phosphorimaging analysis, as described above.Low-pH-dependent fusion of Sindbis virus with liposomes 35
Results
Characterization of  pyrene-labeled SIN. In this study we used SIN,
biosynthetically labeled with the fluorescent probe pyrene. The labeling procedure
involves production of the virus on BHK-21 cells cultured beforehand in the
presence of pyrene fatty acid (4, 10, 42, 59). Newly formed virus particles thus
carry the pyrene probe in their membrane phospholipids. In order to examine the
potential effect of pyrene incorporation in the viral membrane on the infectivity of
the virus, the specific  infectivities of  pyrene-labeled and unlabeled virus were
determined. Virus was isolated and purified from the medium of infected pyrene-
labeled or unlabeled BHK-21 cells, as described in Materials and Methods. Analysis
by SDS-PAGE demonstrated that the virus preparations were pure, as evidenced
by the presence of just the three major structural proteins E1, E2, and C (results
not shown). Subsequent determination of the viral titer and protein concentration
showed that, for pyrene-labeled SIN the infectious unit (IU) to particle ratio was
1/13 under the conditions of the experiment, while for unlabeled control virus the
corresponding ratio was 1/12. For the calculation, a theoretical amount of 5.45*10-
17 g protein/virus particle was used. The IU to particle ratios of unlabeled and
pyrene-labeled SIN appeared to be very similar, indicating that pyrene labeling has
no effect on the infectivity of the virus.
Low-pH-dependent fusion of pyrene-labeled SIN with liposomes. Fusion
of pyrene-labeled SIN was measured in a liposomal model system (4, 42, 55, 59).
The pyrene probe forms excimers with a fluorescence emission maximum at 480
nm, about 100 nm higher than the fluorescence maximum of pyrene monomers.
Pyrene excimer formation is dependent on the average distance between the probe
molecules. Thus, in the virus membrane, the  excimer fluorescence intensity is
proportional to the surface density of pyrene-labeled phospholipid molecules (18,
43). Upon fusion of  pyrene-labeled virus particles with  liposomes, the  pyrene
phospholipids will be diluted into the  liposomes resulting in a decrease in the
pyrene excimer fluorescence intensity, which can be monitored continuously. For
this assay  liposomes were prepared with an average diameter of 200  nm. The
diameter of the viral membrane (excluding the  glycoproteins) is about 50  nm.
Therefore, upon fusion of a virus particle with a  liposome the  pyrene
phospholipids dilute by at least an order of magnitude. In the fusion reaction,
pyrene-labeled SIN (0.5  µM viral  phospholipid) was mixed with an excess of
liposomes (200 µM phospholipid) consisting of PC/PE/SPM/Chol with a molar
ratio of 1:1:1:1.5.
Figure 1A presents the fusion kinetics of pyrene-labeled SIN with liposomes.
At pH 5.0, the virus fused rapidly and efficiently with the liposomes (curve a). By
contrast, at pH 7.4, no detectable fusion  occurred (curve c). Furthermore, the
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liposomes remained constant (curve d), demonstrating that the decrease in excimer
fluorescence intensity observed in the presence of liposomes was due to dilution of
the probe from the viral into the liposomal membrane. At pH 5.75, an intermediate
extent of fusion was observed with the initial rate substantially slower than that at
pH 5.0 (curve b).
Figure 1B shows the detailed pH dependence of SIN fusion with
PC/PE/SPM/Chol liposomes. Optimal fusion in terms of both initial rate (solid
circles) and final extents (open squares) was observed at pH 5.0, with a threshold at
pH 6.0. Under optimal conditions a decrease of excimer fluorescence intensity by
approximately 60% was observed. This corresponds to fusion of a minimum of
60% of the virus particles, since each fusion event is expected to result in a large
dilution of the pyrene probe (see above). However, upon fusion of a virus particle
with a relatively small  liposome,  a residual  excimer fluorescence intensity may
remain. This implies that the level of 60% may represent an underestimate of the
actual extent of fusion. The initial rate of fusion at pH 5.0 was very fast,
corresponding to 20-25% of the virus particles fusing within the first second after
Figure 1. Low-pH-dependent fusion of pyrene-labeled SIN with liposomes. Fusion was
measured on-line at 37 °C as a decrease of viral pyrene excimer fluorescence, as described in
Materials and Methods. Final virus and  liposome concentrations were 0.5 and 200 µM
(membrane  phospholipid), respectively.  Liposomes consisted of PC/PE/SPM/Chol (molar
ratio of 1:1:1:1.5). (A) Curve a, pH 5.0; curve b, pH 5.75; curve c, pH 7.4; curve d, pH 5.0,
without liposomes. (B) The initial rate of fusion (solid circles) was determined from the tangent
to the first part of the curve. The extent of fusion (squares) was determined 60 s after
acidification.
the acidification of the virus-liposome mixture. At pH values higher or lower than
the optimal pH 5.0, fusion exhibited slower kinetics and lower extents.
Fusion required an excess of liposomes, leading to an apparent saturation at
100-150 µM phospholipid (results not shown). In principle, it is possible that with
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liposome concentrations increasing beyond the saturating level, a single virus
particle will fuse simultaneously with multiple  liposomes. However, this is not
expected to result in a significant further decrease of the fluorescence signal since,
in general a single fusion event already produces a dilution of the pyrene probe by
at least an order of magnitude, as indicated above.
Fusion of unlabeled SIN with pyrene-labeled liposomes. We also used a
reverse variant of the pyrene lipid mixing assay in order to ascertain that the fusion
signal seen in the experiments of Figure 1 was not due to a peculiarity of the
pyrene-labeled virus used in those experiments. In the reverse assay, an excess of
unlabeled SIN was incubated with pyrPC-labeled liposomes, and dilution of the
probe from the liposomal into the viral membrane was assessed. For the fusion
reaction liposomes were prepared with a diameter of 70 nm. Given the diameter of
the viral membrane of 50 nm, fusion of a liposome with a single virus particle thus
is expected to result in a 1/3 enlargement of the liposomal membrane, with a
concomitant decrease of the pyrene excimer fluorescence by 33%.
Figure 2A shows that  pyrPC-labeled  liposomes consisting of
PC/PE/SPM/Chol under low-pH conditions fused efficiently with SIN. At pH
5.0, a decrease in pyrene excimer fluorescence by about 38% in 60 s was observed
(curve  a). Again, at neutral pH, there was no significant fusion (curve b).
Figure 2. Low-pH-dependent fusion of SIN with pyrPC-labeled liposomes. Fusion was
measured on-line at 37 °C, as a decrease of liposomal excimer fluorescence, as described in the
Materials and Methods. Fusion of pyrPC-labeled liposomes (2 µM liposomal  phospholipid)
with SIN (10  µM viral  phospholipid) was measured at pH 5.0, unless indicated otherwise.
Liposomes consisted of PC/pyrPC/PE/SPM/Chol (molar ratio 0.85:0.15:1.0:1.0:1.5). (A)
Curve a, pH 5.0; curve b, pH 7.4; curve c, pH 5.0, but in the absence of SIN. (B) The final
extent of excimer fluorescence decrease (squares) was determined, 60 s after acidification, as a
function of the viral phospholipid concentration.
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Furthermore, pyrPC-labeled liposomes in the absence of virus did not exhibit any
change in fluorescence intensity upon acidification to pH 5.0 (curve c).
In Figure 2B the extent of excimer fluorescence decrease was measured as
function of the virus concentration. When a fixed concentration of pyrPC-labeled
liposomes (2 µM phospholipid, corresponding to 4 x 1010 particles per ml) was
incubated with increasing virus concentrations, the extent of the decrease in
excimer fluorescence intensity increased in a biphasic manner. At the extrapolated
inflection point, the extent of excimer fluorescence decrease was 32%, which is
very close to the theoretical value, 33%, expected for one virus particle fusing with
a single liposome. The inflection occurred at a virus concentration of 2.5 µM viral
phospholipid, corresponding to 1011 particles per ml. Thus, we conclude that on
average each liposome fuses at least once with a single virus particle at a virus-to-
liposome particle ratio of approximately 2.5. After the inflection point, the extent
of  excimer fluorescence decrease continued to increase, consistent with one
liposome fusing simultaneously with more than one virus particle. Unlike the
condition of a labeled virus particle fusing with a considerably larger liposome,
fusion of a labeled 70-nm liposome with multiple smaller virus particles is expected
to produce a significantly greater dilution of the probe than fusion of one such
liposome with a single virus particle.  
Contents mixing during SIN-liposome fusion. In the above experiments,
the detection of SIN-liposome fusion was based on lipid mixing assays. A more
stringent criterion for fusion involves the mixing of the internal contents of the
virus with the  liposomal lumen. To demonstrate contents mixing in the SIN-
liposome system, we used an assay involving [ 35S]methionine-labeled virus and
trypsin-containing liposomes (42, 58, 59). Fusion was assayed as the degradation of
the viral capsid protein in the presence of an excess of trypsin inhibitor in the
medium. As shown in Figure 3A, incubation of SIN with an excess of trypsin-
containing PC/PE/SPM/Chol liposomes at pH 5.0 resulted in the degradation of
a substantial fraction of the capsid protein (lane a). At neutral pH, no degradation
of the capsid protein was detected (lane b). Furthermore, incubation of virus at pH
5.0 with empty liposomes under otherwise the same conditions did not result in
degradation of the capsid protein either (lane c). In these controls, the ratio of
radioactivity in the capsid band relative to the total radioactivity, as determined by
phosphorimaging, was close to 0.4, as expected on the basis of the number of
methionine residues in the viral structural proteins (46). To exclude the possibility
that the amount of trypsin was limiting under the conditions of the experiment,
Triton X-100 was added to the reaction mixture in the absence of trypsin inhibitor.
This resulted in complete degradation of the capsid protein, demonstrating that the
amount of trypsin was not limiting in the assay (results not shown).
Figure 3B presents a quantification by phosphorimaging analysis of the extent
of capsid protein degradation as a function of pH. At pH 5.0, approximately 85%
of the capsid protein was degraded, while at pH 5.5 and pH 5.75 the correspondingLow-pH-dependent fusion of Sindbis virus with liposomes 39
numbers were 64% and 41%, respectively. It appears, therefore, that qualitatively
the pH dependence of the SIN-liposome fusion process is the same in the contents
mixing assay and the lipid mixing assay. However, the extent of fusion as assessed
by the trypsin assay was consistently slightly higher than that determined from the
pyrene assay.  This underlines the conclusion that the  pyrene assay presumably
underestimates the extent of fusion, as indicated above. In addition, there may be
small differences in fusion capacity between individual virus batches.
Figure 3. Transfer of the viral  capsid into the  liposomal lumen assayed as the
degradation of the viral capsid protein. Fusion of [35S]methionine-labeled SIN (0.5 µM viral
phospholipid) with  trypsin-containing PC/PE/SPM/Chol  liposomes (200  µM  liposomal
phospholipid) in the presence of  trypsin inhibitor in the external medium at 37 °C was
determined, as described in Materials and Methods. (A) Visualization of the protein bands by
autoradiography. Lane a,  trypsin-containing  liposomes at pH 5.0; lane b,  trypsin-containing
liposomes at pH 7.4; lane c, empty liposomes at pH 5.0. (B) Quantification of the extent of
capsid protein degradation as a result of virus incubation with trypsin-containing liposomes at
different pH values as determined by phosphorimaging analysis.
Taken together, the results obtained with the lipid mixing assays involving
either  pyrene-labeled SIN or  pyrene-labeled  liposomes, and the results of the
contents mixing assay demonstrate conclusively that SIN fuses rapidly and almost
quantitatively with receptor-free liposomes in a strictly low-pH-dependent manner.
Cholesterol and sphingomyelin are required for low-pH-induced SIN-
liposome fusion. A characteristic feature of the fusion mechanism of SFV is the
specific requirement of cholesterol and sphingomyelin in the target membrane (4,
26, 42, 45, 55, 58, 59). Because of the similarity between SFV and SIN it was of
interest to determine whether SIN exhibits the same lipid dependence. As shown
in Figure 4, liposomes of various lipid compositions were examined in order to
determine the lipid dependence of SIN fusion. Under low-pH conditions pyrene-
labeled SIN fused efficiently with  liposomes consisting of PE/PC/SPM/Chol
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(curve a).  However, SIN was unable to fuse with liposomes consisting of either
PE/PC/SPM or PE/PC/Chol (curves b and c). When either PC or PE or both
were omitted from the  liposomes, SPM and  Chol being maintained, sustained
fusion activity was observed (results not shown). This demonstrates that the
presence of both cholesterol and  sphingomyelin in the target membrane are
essential for SIN-liposome fusion at low pH.
Figure 4. Effect of the target membrane lipid composition on fusion of pyrene-labeled
SIN with  liposomes. Fusion of  pyrene-labeled SIN with  liposomes of different lipid
compositions was measured at pH 5.0, 37 °C, as described in the legend to Figure 1. Curve a,
PC/PE/SPM/Chol (molar ratio 1.0:1.0:1.0:1.5) liposomes; curve b, PC/PE/SPM (molar ratio
1.0:1.0:1.0) liposomes; curve c, PC/PE/Chol (molar ratio 1.0:1.0:1.0) liposomes.
Low-pH dependent binding of SIN to liposomes. The first step in low-pH-
induced SIN-liposome fusion is binding of the virus to the liposomes. Various lipid
compositions in the liposomes were examined in order to determine the influence
of the target membrane lipids on the binding of SIN to  liposomes. Briefly, a
mixture of [ 35S]methionine-labeled SIN, unlabeled virus and  liposomes was
incubated at pH 5.0 or pH 7.4. After 60 s, the pH of the reaction mixture was
neutralized by the addition of NaOH. Liposome-bound virus was separated from
unbound virus by flotation on a sucrose density gradient. The results are shown in
Figure 5. Binding of SIN to liposomes was strictly dependent on acidic pH. At
neutral pH, there was negligible interaction between the virus and the liposomes
(open bars a-d). At pH 5.0, we found 72% of the virus particles bound to
liposomes consisting of PE/PC/SPM/Chol (bar a). By comparing the fusion data
in Figures 1 and 3 with the binding data obtained here, we conclude that all of the
particles that bound to the liposomes under these conditions also fused. In the
trypsin assay, we even observed a slightly higher extent of  capsid protein
degradation at pH 5.0 than the extent of virus-liposome binding under the same
conditions. This is presumably due to minor differences between individual virus
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batches. The association of SIN with PE/PC/Chol liposomes was less efficient,
resulting in 25% binding (bar b). However, these virus particles only bound to the
liposomes but did not fuse, fusion being undetectable with liposomes lacked SPM
(see Figure 4). SIN bound very poorly to  liposomes consisting of either
PC/PE/SPM (bar c), or PC/PE (bar d). These results indicate that cholesterol
promotes binding of the virus to the liposomes but is not sufficient for extensive
irreversible binding, as seen under comparable conditions with SFV (40). This
indicates that in the case of SIN, both cholesterol and SPM are required for
efficient irreversible binding (and fusion) of the virus to the liposomes.
Figure 5.  Influence of cholesterol and sphingomyelin on pH-dependent binding of SIN
to  liposomes.  SIN (trace of [ 35S]methionine-labeled virus and unlabeled virus, 0.5  µM
phospholipid) was incubated with liposomes (200 µM liposomal phospholipid) at pH 5.0 or pH
7.4, at 37 °C. Binding of SIN to liposomes was determined by co-flotation analysis on sucrose
density gradients, as described in Materials and Methods. Bar a, PC/PE/SPM/Chol (molar
ratio 1.0:1.0:1.0:1.5) liposomes; bar b, PC/PE/Chol (molar ratio 1.0:1.0:1.0) liposomes; bar c,
PC/PE/SPM (molar ratio 1.0:1.0:1.0) liposomes; bar d, PC/PE (molar ratio 1.0:1.0) liposomes.
Inactivation of SIN fusion capacity through pre-exposure of the virus
alone to low pH. It has been suggested recently that pre-exposure of SIN during
freezing of the virus in medium or PBS, which results in a transient lowering of the
pH, may activate the viral fusion capacity, thus possibly explaining observations
suggesting fusion of the virus under neutral pH conditions at the level of the target
cell plasma membrane (12, 16). The implicit assumption underlying this suggestion
is that virus activated by pre-exposure to low pH would remain fusion-active for a
significant period of time, e.g., several minutes. In this perspective we analyzed
whether pre-exposure to low pH of SIN alone results in sustained fusion capacity.
Notably, incubation of SFV at acidic pH in the absence of target membranes
results in a very rapid loss of the fusion capacity of the virus (4).
a b c d
Liposomes
0
20
40
80
B
i
n
d
i
n
g
 
(
%
)
pH 5.0
pH 7.4 60          Chapter 2 42
Figure 6. Inactivation of viral fusion capacity due to the pre-exposure of SIN alone to
acidic pH. Fusion was measured on-line at 37 °C, as a decrease of viral  pyrene  excimer
fluorescence, as described in the legend to Figure 1.  Pyrene-labeled SIN (0.5  µM viral
phospholipid) was incubated at pH 5.0, and at the indicated time periods liposomes (200 µM
phospholipid) consisting of PC/PE/SPM/Chol (molar ratio 1:1:1:1.5) in pH 5.0 buffer, were
added to the reaction mixture, and subsequently fusion was measured. The final extents of
fusion, at 60 s after acidification of the liposomes, were related to the extent of fusion of an
untreated control (the absolute extent for fusion of this control was 62%).
Pyrene-labeled SIN was incubated at pH 5.0 at 37 °C in the absence of target
liposomes for various periods of time. Subsequently, PC/PE/SPM/Chol
liposomes were added and the remaining fusion activity was determined. Figure 6
shows that such a preincubation of the virus alone leads to a rapid loss of fusion
activity. Preincubation of SIN at pH 5.0 for 20 s resulted in a 50% reduction of
fusion, while a preincubation for 2-3 min resulted in essentially complete loss of
fusion capacity. This indicates that fusion activation of SIN triggered by low pH is
of a transient nature, resulting in a rapid subsequent irreversible loss of fusion
capacity.
Next, we exposed SIN to low pH by slowly or rapidly freezing the virus in cell
culture medium without  Hepes buffer or in PBS, subsequently assessing the
capacity of the virus to fuse with liposomes at neutral pH. There was no detectable
fusion under these conditions (results not shown).
Conformational changes of the viral spike protein under fusion
conditions. Finally, we investigated the structural changes occurring in the SIN
envelope glycoprotein occurring in the presence of target liposomes under fusion
conditions, in an attempt to determine the viral spike conformational requirements
for fusion. To this end, the kinetics of fusion and the kinetics of the viral spike
conformational changes were determined under comparable conditions. A
complicating factor in this respect relates to the extremely high rates of the fusion
reaction upon acidification of a SIN-liposome mixture at 37 °C to the optimal pH
for fusion (pH 5.0). Therefore, for determination of the relative kinetics of virus-
0 30 60 90 120 150 180
Pre-exposure time (s)
0
20
40
60
80
100
P
e
r
c
e
n
t
a
g
e
 
o
f
 
f
i
n
a
l
 
e
x
t
e
n
tLow-pH-dependent fusion of Sindbis virus with liposomes 43
liposome fusion and the occurrence of spike conformational changes, we chose a
pH of 5.75 and a temperature of 20 °C, conditions under which the kinetics of the
process are slowed down considerably. Also, the fusion process at pH 5.75 at 20
°C exhibited a lag phase of approximately 9-10 s preceding the onset of fusion
(results not shown; see Figure 8). Furthermore, the final extent of fusion was
reduced.
Figure 7 shows the time course of the structural changes occurring in the viral
spike protein. Briefly, mixtures of [35S]methionine-labeled SIN, unlabeled SIN, and
liposomes were incubated at pH 5.75 at 20 °C. At the indicated time points, the
mixtures were  neutralized by the addition of a  pretitrated volume of  NaOH.
Subsequently, the samples were analyzed by SDS-PAGE (Figure 7A). Besides E1
and E2, another protein band became apparent. Determination of the size of the
protein, in which a set of marker proteins was used, showed that the protein band
had a molecular weight of 150 kD, indicating that a trimer of E1 was formed. To
analyze the formation of a trypsin-resistant form of the viral spike protein, we
incubated the mixtures in presence of trypsin (200 µg/ml) at 37 °C. After heating
of the trypsin-treated samples for 5 min at 100 °C, they were analyzed by SDS-
PAGE. Figure 7B shows the time course for the appearance of a trypsin-resistant
phenotype of the E1 protein. Since the kinetics of the E1 trimer formation and
that of the appearance of the trypsin-resistant phenotype of the E1 were similar, it
is likely that it is in fact the trimerization of E1 that renders it trypsin-resistant.
Figure 7.  Kinetics of the structural changes in the SIN spike protein after incubation at
low pH. SIN (trace of [35S]methionine-labeled virus and unlabeled virus, 0.5 µM phospholipid)
was incubated with  liposomes (200  µM  liposomal lipid) consisting of PC/PE/SPM/Chol
(molar ratio 1.0:1.0:1.0:1.5) at pH 5.75 at 20 °C. At the indicated time points, samples were
neutralized and  analyzed for the appearance of  E1 trimers (A), and the appearance of a
trypsin-resistant form of E1 (B), on SDS-PAGE, as described in Materials and Methods.
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Figure 8 presents a kinetic comparison of SIN-liposome binding (squares), E1
trimerization (circles), and fusion (triangles) during the initial 60 s following a pH
jump from pH 7.4 to pH 5.75 at 20 °C. The extents of virus-liposome binding,
fusion, and E1  trimerization at 60 s were 30, 14, and 56%, respectively. This
indicates that not all of the virus bound to the liposomes under these suboptimal
conditions also fused. In fact a fraction of the virus initially bound to the liposomes
may subsequently dissociate, possibly explaining the relatively high degree of E1
trimerization. We were not able to detect differences between the kinetics of virus-
liposome binding and those of E1 trimerization. However, fusion proceeded with a
significant delay after the virus-liposome binding and E1 trimerization processes.
Figure 8.  Sequence of events after acidification of a SIN-liposome mixture. The kinetics
of SIN-liposome binding (squares), E1 trimerization (circles), and fusion (triangles) are shown
after acidification to pH 5.75 at 20 °C. To compare the kinetics of these processes, the final
extents of the relative values of the three parameters were set to 100%. The absolute final
extents were 30% for SIN-liposome binding, 56% for E1 trimerization, and 14% for fusion. In
each case, SIN (0.5 µM viral phospholipid) was incubated with liposomes (200 µM liposomal
phospholipid) consisting of PC/PE/SPM/Chol (molar ratio 1.0:1.0:1.0:1.5) at pH 5.75 at 20
°C. SIN-liposome binding was determined as described in the legend to Figure 5. E1
trimerization was determined as described in the legend to Figure 7. Fusion was determined as
described in the legend to Figure 1.
Discussion
The results presented in this paper indicate that SIN has the capacity to fuse
efficiently in a model system involving  liposomes as target membranes. SIN-
liposome fusion meets a stringent criterion for membrane fusion, i.e. coalescence
of the internal encapsulated compartments of the interacting particles and a
concomitant mixing of membrane lipids. Coalescence of the viral and liposomal
internal contents was assessed on the basis of degradation of the viral core protein
by trypsin initially encapsulated in the liposomes (42, 58). Membrane lipid mixing
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was monitored continuously using two variants of a fluorescence assay, based on
incorporation of pyrene-labeled phospholipids in either the viral or the liposomal
membrane. Incorporation of the probe into the viral membrane was achieved
through a biosynthetic labeling procedure, involving production of virus from cells
cultured beforehand in the presence of pyrene-labeled fatty acid. This methodology
has been used before for labeling of SFV (4, 42, 55) and tick-borne encephalitis
(TBE) virus (11). The present results demonstrate that the procedure can also be
used reliably to produce pyrene-labeled SIN, without affecting the infectivity of the
virus.
SIN fuses efficiently with  liposomes consisting of just  phospholipids and
cholesterol, lacking a specific protein or carbohydrate receptor for virus binding
(Figures 1-4). Furthermore, SIN-liposome fusion is strictly dependent on low pH,
fusion being optimal at pH 5.0 and undetectable at neutral pH (Figures 1-3). These
characteristics of the fusion process argue strongly in  favor of a cell entry
mechanism of SIN, involving endocytosis of virus particles into endosomes and
subsequent fusion of the viral membrane with the endosomal membrane induced
by the mildly acidic pH in the lumen of the endosomes. SIN shares the capacity to
fuse to receptor-free target liposomes with a number of other enveloped viruses,
such as influenza virus (51, 52, 53), SFV (4, 25, 55, 58), TBE virus (11) and VSV
(41). In all cases, low pH appears to be a necessary and sufficient condition for
induction of the fusion process. The efficient fusion of low-pH-dependent viruses
with receptor-free liposomes suggests that receptor binding is not a mechanistic
requirement for expression of membrane fusion activity by these viruses. Receptor
binding would appear to be primarily involved in the initial binding of the viruses
to the host cell and subsequent endocytic uptake of the virus particles by the cell,
although it cannot be excluded that the receptor interaction also influences the
detailed characteristics of the subsequent fusion process from within the
endosome. In this respect, it is interesting that, in the case of SIN, virus-receptor
interaction has been found to result in conformational alterations in the viral
envelope  glycoprotein, detected on the basis of exposure of specific  epitopes
recognized by monoclonal antibodies (17, 38). These conformational changes have
been suggested to be related to the viral fusion process. Clearly, our present results
do not exclude that possibility. However, it would appear that low pH is the
essential trigger for fusion of SIN.
The conclusion that SIN infects its host cell b y entry through receptor-
mediated endocytosis and fusion from within acidic endosomes is in agreement
with recent observations of  Glomb-Reinmund and  Kielian (20). These
investigators showed that the addition of weak bases during cell entry of the virus
efficiently inhibits translation of viral RNA and infection. Previous studies had
suggested that weak bases would not inhibit cellular infection by SIN (7, 8).
Glomb-Reinmund and Kielian (20) also used balifomycin and concanamycin, two
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of weak bases, and again found that cellular infection by SIN was inhibited, in
further support of the conclusion that the infection process involves acidic
endosomes. Furthermore, the authors were unable to detect a specific role for
reduction of disulfide bridges through thiol-disulfide exchange reactions during the
SIN entry process (20). It had been suggested before that disulfide shuffling upon
interaction of SIN with its cell surface receptor would reorganize the viral spike to
mediate virus cell entry through fusion with the plasma membrane (1, 5). Thus, the
observations of Glomb-Reinmund and Kielian (20) argue against fusion with the
cell plasma membrane as the physiological infection mechanism of SIN. Recently,
DeTulleo and Kirchhausen (12) also came to the conclusion that SIN does not
infect cells by plasma membrane fusion but rather through entry via an endocytic
pathway. Specifically, these investigators employed expression of dominant-
negative mutant forms of dynamin which inhibit clathrin-dependent endocytosis,
and showed that these mutant dynamins also inhibit cellular infection by SIN.
It is not clear what the explanation is for the above discrepancy between the
observations which suggest that SIN enters cells by plasma membrane fusion and
those that argue in  favor of an  endocytic entry mechanism. One possibility,
suggested by DeTulleo and Kirchhausen (12) and Ferlenghi et al. (16), involves an
undeliberate pre-exposure of the virus to low pH during freezing in cell culture
medium or PBS. This would induce a premature conformational change in the viral
spike, allowing subsequent fusion of the virus with the cell plasma membrane at
neutral pH. Indeed, DeTulleo and Kirchhausen (12) observed that SIN, frozen
under such inadequate buffering conditions, has the capacity to enter cells via a
clathrin-independent pathway, suggestive of fusion through the plasma membrane.
We were unable to detect any fusion of SIN at neutral pH, whether or not the virus
had been frozen beforehand in PBS or medium. However, this does nor rule out
the possibility of fusion with the plasma membrane at neutral pH of virus frozen
under inadequate buffering conditions, since a low degree of fusion (on the order
of 1% relative to the control) may well go unnoticed in our assay.
The characteristics of SIN fusion in the present liposomal model system in
many respects resemble those of SFV-liposome fusion (4, 42, 55, 59). Both viruses
fuse with receptor-free liposomes in a low-pH-dependent manner, although we
note that the pH optimum (pH 5.0) for fusion of the AR339 strain of SIN used
here is lower by about 0.5 pH unit than that of SFV, in agreement with
observations of  Glomb-Reinmund and  Kielian (20). Also, for the Toto 1101
infectious clone of SIN we found a low pH optimum (pH 4.6) for fusion (49). In
cell-cell fusion studies the pH optimum for SIN AR339 has been reported to be
5.4 (2). Importantly, SIN, like SFV, requires the presence of both cholesterol and
sphingolipid in the target membrane (Figure 4). Recently, in an elegant study, Lu et
al. (34) have shown that SIN entry into cells also requires cholesterol. In the
liposome system, cholesterol is essential for the initial low-pH-dependent binding
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in the subsequent fusion reaction (42, 59). Specifically, extensive irreversible
binding of SFV occurs to liposomes consisting of PC/PE/Chol, with fusion being
undetectable; on the other hand, virtually  no binding (nor fusion) occurs with
PC/PE/SPM liposomes (42, 59). SIN appeared to behave in essentially the same
manner (Figures 4 and 5), with virus binding to PC/PE or PC/PE/SPM liposomes
being at background level and binding to PC/PE/Chol liposomes reaching 25%
(Figure 5). On the other hand, the extent of virus binding to PC/PE/Chol
liposomes was limited compared to the extent of binding to PC/PE/SPM/Chol
liposomes (72%). One explanation would be that the interaction of the virus with
PC/PE/Chol liposomes is not completely irreversible, such that in the absence of
fusion part of the virus may dissociate. In the presence of Chol and SPM in the
liposomes the interaction would become irreversible as a result of fusion
subsequent to binding. Indeed, all of the virus that binds to liposomes containing
both  Chol and SPM appears to be fused as well. Yet, even under optimal
conditions a small fraction of the virus does not seem to interact at all with the
liposomes. It is possible that, upon exposure of the virus-liposome mixture to low
pH, part of the virus may become inactivated so rapidly, that it does not have the
opportunity to productively interact with the liposomes.
The results shown in Figure 7 demonstrate that under fusion conditions, the
E1 component of the SIN spike forms a homotrimeric structure, while at the same
time E1 becomes trypsin-resistant. The relative kinetics of the E1 trimer formation
and the appearance of the  trypsin-resistant phenotype suggest that the E1
homotrimer and the trypsin-resistant form of E1 are in fact identical structures. By
analogy to the role of the E1 trimer in SFV fusion (4, 25, 55), we propose that the
SIN E1 homotrimer represents the fusion-active conformation of the viral spike.
The kinetics of virus-liposome binding and E1  homotrimer formation are
indistinguishable (Figure 8). For SFV, on the basis of early results, we have
suggested that E1  homotrimer formation  precedes virus-liposome binding (4).
However, more recent observations involving selective inhibition of SFV E1
trimerization with Zn2+ ions (10) or through a mutation in the E1 protein (28) have
shown that dissociation of the E2/E1 heterodimer at low pH suffices for initiation
of virus-liposome binding and that E1 trimer formation occurs after the binding of
the virus to the liposomes (10, 28). The results shown for SIN in Figure 8 are in
agreement with this notion. Therefore, it would appear that E1 trimer formation is
strongly facilitated by the association of the virus to the  liposomes, occurring
without any significant delay after the initial binding process. Under the conditions
of the experiment (pH 5.75, 20 °C), fusion then proceeds after a lag period. This
lag presumably represents the time required for additional rearrangements within
or between  homotrimeric E1 spikes. We propose that the target membrane
sphingolipid is critically involved in this step, leading to the actual fusion-active
structure of the virus.          Chapter 2 48
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Abstract
Passage of Sindbis virus (SIN) in BHK-21 cells has been shown to select for
virus mutants with high affinity for the glycoaminoglycan heparan sulfate (HS).
Three loci in the viral spike protein E2 have been identified (E2:1; E2:70; E2:114),
which mutate during adaptation and independently confer the ability to the virus
to bind to cell-surface HS (W.B. Klimstra et al., J. Virol. 72:7357-7366, 1998). In
this study, we used HS-adapted SIN mutants to evaluate a new model system,
involving target  liposomes containing heparin-conjugated
phosphatidylethanolamine (HepPE) as an HS receptor analog for the virus. HS-
adapted SIN viruses, but not non-adapted wild-type SIN TR339, interacted
efficiently with  HepPE-containing  liposomes at neutral pH. Binding was
competitively inhibited by soluble heparin. Despite the efficient binding of HS-
adapted SIN viruses to HepPE-containing liposomes at neutral pH, there was no
fusion under these conditions. Fusion did occur, however, at low pH, consistent
with cellular entry of the virus via acidic endosomes. At low pH, wild-type or HS-
adapted SIN viruses underwent fusion with liposomes with or without HepPE
with similar kinetics, suggesting that interaction with the HS receptor analog at
neutral pH has little influence on subsequent fusion of SIN at acidic pH. Finally,
Semliki Forest virus (SFV), passaged frequently on BHK-21 cells, also interacted
efficiently with  HepPE-containing  liposomes, indicating that SFV, like other
alphaviruses, readily adapts to cell-surface HS. In conclusion, the liposomal model
system presented in this paper may serve as a novel tool to study receptor
interactions and membrane fusion properties of HS-interacting enveloped viruses.Heparan sulfate interaction and membrane fusion of alphaviruses 55
Introduction
Alphaviruses, such as Ross River virus (RR),  Semliki Forest virus (SFV),
Sindbis virus (SIN), and Venezuelan equine encephalitis virus (VEE), are
enveloped positive-strand RNA viruses belonging to the family of Togaviridae. The
viral genome consists of a single-stranded RNA molecule, which is complexed
with 240 copies of the capsid protein (50). The nucleocapsid is surrounded by a
lipid bilayer in which the spike proteins are inserted. The viral surface contains 80
heterooligomeric spikes, a single spike consisting of a  trimer of E2/E1
heterodimers. The E1 and E2  glycoproteins mediate the infectious entry of
alphaviruses into cells. The E2 glycoprotein is primarily involved in the interaction
of the virus particle with an attachment receptor on the cell surface (7, 28, 49),
whereas E1 is required for the subsequent fusion process (19, 53).
The spike proteins of RNA viruses are capable of rapid adaptation to their
growth environment. Recently, it has been shown that viruses from different
families interact with glycoaminoglycans (GAGs), in most cases heparan sulfate
(HS), as a cell-culture adaptation. Virus families or genera that exhibit such a
GAG-adaptation include  alphaviruses (2, 21, 28),  flaviviruses (33),  pestiviruses
(25), picornaviruses (16, 43), and retroviruses (38, 41). GAGs are highly sulfated
polymers of disaccharide repeats, and hence are negatively charged. They are
ubiquitously expressed on cell surfaces, but vary with respect to their composition
and quantity on different tissues and cell types (3, 52).
In the alphavirus genus, positively charged amino-acid substitutions have been
identified in the viral spike protein E2 of SIN, RR, and VEE that are responsible
for interaction with HS (2, 21, 28). With regard to SIN, three loci in E2 have been
identified (E2:1; E2:70; E2:114) that mutate during the adaptation of SIN in BHK-
21 cells and can independently confer the ability to bind to cell-surface HS (28).
The sequence XBXBBBX or XBBXBX (where X is any residue and B is a basic
residue) is a linear binding motif that allows proteins to attach to HS (9). The
positive charge mutation at E2:1 results in the formation (although in opposite
orientation) of a linear HS interaction sequence. The HS binding motifs are not
present in the E2:70 and E2:114 regions, which suggest that these viruses interact
with HS in a conformation-dependent manner. This phenomenon is known to
occur in for foot-and-mouth disease virus type O, in which structural studies
revealed that heparin makes contacts with all three major capsid proteins VP1,
VP2, and VP3 (18). Despite the efficient interaction of the selected mutants of
SIN, VEE, and RR with HS, the viruses were found to have an attenuated
virulence in animals when compared to wild-type viruses. It has been proposed
that HS-adapted mutants could bind to non-productive cellular structures, such as
extracellular membranes and basal laminae, and therefore may be cleared from the
blood more rapidly than wild-type viruses (2, 8, 21).Chapter 3 56
In previous studies, membrane fusion activity of SIN, SFV, and Tick-borne
encephalitis virus (TBE) has been investigated using liposomes lacking a protein or
carbohydrate receptor in the target membrane (5, 13, 46, 47). This suggests that
receptor interaction is not a prerequisite for fusion. However, characteristics of
virus-liposome fusion in the presence of an attachment receptor have not been
studied. In this study, we used HS-adapted SIN mutants to evaluate a new model
system, involving target liposomes supplemented with phosphatidylethanolamine-
conjugated heparin (HepPE) as an attachment receptor analog for the virus. With
HepPE in the target membrane, we were able to directly investigate the role of HS
receptor interaction and its potential function in triggering or influencing
membrane fusion of HS-adapted SIN with target membranes. It is demonstrated
that HS-adapted SIN efficiently interacts with  liposomes supplemented with
remarkably low concentrations of HepPE in the membrane. Despite the efficient
binding at neutral pH, there was no fusion under these conditions. Fusion was
observed only at low pH, consistent with cell entry of SIN via acidic endosomes.
Finally, it is shown that SFV, either passaged frequently in baby hamster kidney
(BHK-21) cells or derived from the BHK-adapted infectious clone pSFV4,
interacts efficiently with  HepPE-containing  liposomes, indicating that SFV like
SIN readily adapts to cell-surface HS.
Materials and Methods
Viruses. The viruses were generated from cDNA clones. The construction of the
consensus Sindbis virus AR339 clone pTR339 and the HS-adapted SIN virus clones p3970
(called p39K70 in previous articles) and pTRSB has been described previously (28, 29, 36).
The construction of the SFV clone pSFV4 has been described before (31). This clone was
generated from a laboratory strain of SFV, adapted to growth on BHK-21 cells. A plaque-
purified laboratory strain of SFV, also highly adapted to growth on BHK-21 cells, was a
generous gift of Dr. Margaret Kielian (Albert Einstein College of Medicine, New York,
NY).
The viruses were produced by high-efficiency electroporation of BHK-21 cells with in
vitro transcripts of linearized cDNA clones as described before (31). Viruses released from
the cells at 20 h post-transfection were harvested, and these stocks were subsequently used
for the production of  pyrene- or [ 35S]methionine-labeled SIN or SFV particles, as
previously described (5, 46). The viruses were characterized by plaque assay on BHK-21
cells (28), phosphate analysis (4), and protein determination (42). The purity of the viruses
was confirmed by SDS-PAGE.
Liposomes. Large unilamellar vesicles were prepared by n-octyl-ß-D-glucopyranoside
(OGP; Calbiochem, Darmstadt, Germany) dialysis followed by a freeze/thaw-extrusion
protocol (5, 40,  46). This method is used, instead of the standard extrusion method,
because HepPE is not completely soluble in a chloroform-methanol solution. Liposomes
consisted of  phosphatidylcholine (PC),  phosphatidylethanolamine (PE),  sphingomyelin
(SPM), and cholesterol ( Chol) or 6-photocholesterol ( photoChol) in a molar ratio of
1:1:1:1.5, supplemented with  HepPE as indicated. Briefly, PC/PE/SPM/Chol lipidHeparan sulfate interaction and membrane fusion of alphaviruses 57
mixtures were dried from chloroform-methanol and hydrated in 100 mM OGP in 5 mM
HEPES, 150 mM NaCl, 0.1 mM EDTA, pH 7.4 (HNE). Subsequently, HepPE, was added
to the lipid-detergent mixed micelles and dialysis was initiated against HNE buffer to
generate liposomes. The liposomes were subjected to five cycles of freezing/thawing and
subsequent extrusion through 0.2-µm polycarbonate filters (Nuclepore Inc., Pleasanton,
CA, USA) in a LipoFast mini-extruder (Avestin, Ottawa, Canada). PhotoChol-containing
liposomes were prepared in subdued light. The size of the liposomes was determined by
quasi-elastic light scattering analysis in a  submicron particle  sizer model 370 ( Nicomp
Particle Sizing systems, Santa Barbara, Calif.). The  phospholipids were obtained from
Avanti Polar Lipids (Alabaster, AL, USA), and cholesterol was from Sigma (St. Louis, Mo,
USA). The photoactivatible analog of cholesterol, photoChol, was synthesized as described
before (37). The HepPE conjugate, consisting of heparin (from porcine intestinal mucosa,
MWav 10,000; Scientific Protein Laboratories,  Wannakee, WI) coupled to  dipalmitoyl-
phosphatidylethanolamine was synthesized and purified as described previously (51).
Trypsin-containing liposomes were prepared in a similar manner as outlined above, except
that this case the lipids were dispersed in 100 mM OGP in HNE containing 10 mg/ml
trypsin ( Boehringer, Mannheim, Germany). The  trypsin-containing  liposomes were
separated from free trypsin by gel filtration on a Sephadex G-100 column in HNE. The
phospholipid concentration of the liposomes was determined by phosphate analysis (4).
Bindings assays. Virus binding to BHK-21 cells and heparin-, bovine serum
albumin-  agarose beads (both from Sigma) was preformed essentially as previously
described (28, 48). In the binding assay, 105 to 106 cpm of [35S]methionine-labeled SIN or
SFV (approx. 108 to 109 virus particles) was allowed to attach to monolayers of BHK-21
cells or beads for 1 h at 4 ￿C. Subsequently, the cells or beads were washed with HNE +
1% FBS buffer. Virus binding was quantified by liquid-scintillation counting.
Binding of the virus to liposomes was assessed by a co-flotation assay, as described
before (5, 39, 46). Briefly, [35S]methionine-labeled SIN or SFV particles (ranging from 105
to 106 cpm) were mixed with liposomes (100 µM phospholipid) and incubated for 1 h at 4
ºC, unless indicated otherwise. Then, 0.1 ml of the mixture was added to 1.4 ml 50%
sucrose (wt/vol) in HNE and loaded onto a discontinuous (60-50-35-20-5%, wt/vol)
sucrose gradient. After ultracentrifugation at 4 ºC, the gradient was fractionated into 10
samples, starting from the top. The radioactivity found in the top 4 fractions, relative to
the total amount of radioactivity, was taken as a measure of virus-liposome binding. For
the heparin binding competition experiments, heparin (MWav 6,000; Sigma) was added to
the SIN particles 1 h prior to mixing with liposomes, and the mixture was incubated at 4
ºC.
Fusion assays. Fusion of pyrene-labeled SIN or SFV with liposomes was measured
on-line at 37 ºC in an AB2 fluorometer (SLM/Aminco, Urbana, USA) at excitation and
emission wavelengths of 345 and 480 nm, respectively (5, 46, 48). Briefly, pyrene-labeled
SIN or SFV (1 µM phospholipid) and liposomes (100 µM phospholipid) were mixed in
0.665 ml of HNE buffer and stirred magnetically in a quartz cuvette. At t=0 s, fusion was
triggered by injection of 35 µl 0.1 M MES (morpholinoethanesulfonic acid) and 0.2 M
acetic acid buffer, pre-titrated with NaOH to achieve the final desired pH. Fusion was
calibrated such that 0% fusion corresponded with to the initial  pyrene-excimer
fluorescence and 100 % fusion was obtained after the addition of 35 µl 0.2 M octaethylene
glycol monododecyl ether (Fluka, Buchs, Switzerland), to achieve an infinite dilution of theChapter 3 58
pyrene probe. The initial rate of fusion was determined from the tangent to the initial
phase of the curve. The extent of fusion was determined 60 s after acidification.
The mixing of the aqueous contents of interior of virus and the liposomal lumen was
determined as the degradation of the viral capsid protein by trypsin, initially encapsulated
in the liposomal lumen (54, 46, 47). Briefly, [35S]methionine-labeled SIN particles (ranging
from 105  to 106  cpm) were mixed with  trypsin-containing  liposomes (100 µM
phospholipid) in presence of 125 µg of  trypsin-inhibitor ( Boehringer, Mannheim,
Germany) per ml in HNE, at 37 ºC. The mixture was acidified to the desired pH, as
described above. After 60 s the reaction mixture was neutralized by the addition of a pre-
titrated volume of NaOH and further incubated for 1 h at 37 ºC. Control incubations were
carried out with empty liposomes, or in the presence of Triton X-100 and in absence of
trypsin inhibitor. All samples were analyzed by SDS-PAGE, the protein bands being
visualized and quantified by phosphorimaging analysis using Image Quant 3.3 software
(Molecular Dynamics, Sunnyvale, CA, USA).  Capsid degradation was determined by
relating the intensity of the capsid protein to the intensity of E1 and E2 in a control
experiment in which empty liposomes were used. This ratio was used to calculate the
expected intensity of the capsid protein from the reaction in which trypsin-containing
liposomes were used. The difference between the expected and the found intensity was
taken as a measure of the capsid degradation.
Results
Characterization of HS-adapted SIN mutants. In this study we investigated
HS interaction and membrane fusion activity of alphaviruses in a liposomal model
system using lipid-conjugated heparin. Heparin is a sulfated polysaccharide, which
is commonly used as an analog for HS in receptor-ligand assays since  ligand
interaction with heparin and analogs of HS have little qualitative difference (27).
To evaluate the new liposomal model system a comparison was made between the
HS-adapted SIN mutants 3970 and TRSB, and the non-adapted SIN TR339
(carrying the consensus sequence of SIN) (28, 29, 36). The HS-adapted SIN
Virus           nsP3:528 E2:1 E2:70 E1:72
TR339 Arg Ser Glu Ala        
3970 Arg Ser Lys Ala 
TRSB             Gln Arg Glu Val
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mutant designated 3970 differs from the TR339 clone at position E2:70 (Table 1).
The other HS-adapted SIN strain, TRSB, differs from TR339 by a positive charge
amino-acid substitution at position E2:1 and a conserved  valine for  alanine
substitution at position E1:72 (Table 1).
First, the specific infectivity of each of the viruses was determined by plaque
assay on BHK-21 cells (Table 2). In agreement with earlier data, the specific
infectivity of TR339 was much lower than the  infectivities of the HS-adapted
mutants (28, 29). Next, we determined whether the high specific infectivity of 3970
and TRSB was a result of more efficient binding to BHK-21 cells (Table 2). The
results show that the HS-adapted mutants 3970 and TRSB bind very efficiently to
monolayers of BHK-21 cells, whereas the TR339 virus binds very poorly to these
cells (Table 2). Accordingly, TRSB and 3970 virus bound efficiently to heparin-
agarose beads (Table 2). In a control, in which albumin-agarose beads were used,
none of the viruses bound to the beads (data not shown).
Binding of HS-adapted SIN to HepPE-containing liposomes. To study
the receptor interaction of HS-adapted SIN mutants, we used target liposomes in
which  HepPE was incorporated in the membrane.  Liposomes consisted of
PC/PE/SPM/Chol (molar ratio 1:1:1:1.5) with various concentrations of HepPE.
In the binding experiment, [ 35S]methionine-labeled SIN (approx. 108-109 virus
particles) was incubated with the liposomes (100 µM phospholipid) at neutral pH,
for 1 h at 4 ºC. Subsequently, the liposome-bound virus was separated from non-
bound virus by flotation on a sucrose-density gradient. Figure 1A shows the
gradient profiles. In the presence of  liposomes supplemented with 0.02  mol%
HepPE, essentially all SIN 3970 particles floated to the top of the gradient
(circles), demonstrating that the virus bound quantitatively to the liposomes. Half-
Virus          BHK specific BHK cell HS-agarose 
                   infectivitya bindingb beads bindingc
TR339     5   7 10
3970 256 42 50
TRSB 186 51 56
a (PFU/cpm)
b % cpm bound
c % cpm bound
TABLE 2. Characterization of HS adapted Sindbis virusesChapter 3 60
maximal binding was observed with  liposomes supplemented with 0.01  mol%
HepPE (diamonds). The virus did not bind to liposomes without HepPE in the
membrane (squares).
Figure 1B shows the final extent of binding of SIN 3970 to HepPE-containing
liposomes, plotted as a function of the molar ratio of HepPE to total phospholipid
in the liposomal membrane. Clearly, the binding increased steeply at a ratio of  1
HepPE molecule per 10,000 phospholipid molecules, while binding was maximal
at a ratio of 1:5000. A liposome of 200 nm diameter, consisting of phospholipid
and cholesterol in a molar ratio of 2:1, has approximately 150,000 phospholipid
molecules in its outer membrane leaflet (55). Thus, maximal binding of SIN 3970
to HepPE-containing liposomes was obtained with on average only 30 HepPE
molecules exposed on the outer surface of a target liposome, while half-maximal
binding occurred with approx.  15 surface-exposed  HepPE molecules per
liposome. It should be noted that in all likehood the liposomes used in the present
study were, on average, smaller than 200 nm, as discussed in more detail below.
This implies that the number of  HepPE molecules per  liposome was
proportionately smaller as well.
Figure 1.  Binding of HS-adapted SIN 3970 to  HepPE-containing  liposomes.
[35S]Methionine-labeled SIN (approx. 108-109 virus particles) was incubated with
PC/PE/SPM/Chol liposomes (100 µM liposomal phospholipid) at pH 7.4 for 1 h at 4 °C.
Binding was determined by co-flotation analysis on sucrose density gradients, as described in
Materials and Methods. (A) Gradient profiles obtained after incubation of virus with control
liposomes lacking HepPE (squares), liposomes supplemented with 0.01 mol% (diamonds) or
liposomes supplemented with 0.02 mol% HepPE (circles). (B) Extents of binding of SIN to
HepPE-containing liposomes as a function of the molar ratio  HepPE to total lipid in the
liposomes. Bars represent the average of triplicate binding assays.
Next, a comparison was made between the liposome binding capacity of HS-
adapted SIN 3970 and TRSB and non-adapted SIN TR339, using liposomes with
and without 0.01 mol% HepPE in the membrane. Figure 2 shows the results. For
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SIN 3970 and TRSB more than half-maximal binding to the HepPE-containing
liposomes was observed, whereas SIN TR339 bound very poorly to these
liposomes (shaded bars). There was no binding of any of the viruses to liposomes
lacking HepPE in the membrane (solid bars).
Figure 2B presents the binding of SIN to liposomes supplemented with 0.01
mol% HepPE after incubation during various periods of time either in the cold or
at 37 ºC. Binding of the HS-adapted SIN viruses was fast and efficient at various
temperatures. Complete binding of the viruses to HepPE-containing liposomes
was observed even after 1 min incubation at 37  ºC. Again, non-adapted SIN
TR339 bound poorly to the liposomes, although both at 4 ºC and at 37 ºC there
was a detectable degree of binding presumably due to a low affinity of the TR339
virus for HS (confer Table 2).
Figure 2. Binding of HS-adapted SIN 3970 or TRSB and non-adapted SIN TR339 to
liposomes supplemented with 0.01 mol% HepPE. The extent of binding was determined as
described in the legend to Fig.1, unlesss indicated otherwise. (A) Binding for 1 h at 4 °C; solid
bars, PC/PE/SPM/Chol liposomes; shaded bars, PC/PE/SPM/Chol liposomes supplemented
with 0.01 mol% HepPE. (B) Binding was measured at 1 h 4 ºC (a); 1 min 37 ºC (b); 10 min 37
ºC (c). Solid bars, TR339; shaded bars, 3970; open bars, TRSB. Bars represent the average of
triplicate binding assays.
Competition of SIN binding to HepPE-containing liposomes by soluble
heparin. To determine whether the HS-adapted SIN viruses interact specifically
with the heparin moiety on the  liposomal membrane, binding competition
experiments were carried out with soluble heparin. SIN was incubated with soluble
heparin for 1 h at 4 ºC. Subsequently, HepPE-containing liposomes were added to
the reaction mixture and incubation was continued for 1 h at 4 ºC in the presence
of the soluble heparin.  Liposome-bound virus was separated from non-bound
virus by flotation on a sucrose-density gradient..Figure 3 shows the results. In the
presence of 5 mg/ml heparin, SIN 3970 virus failed to float with the liposomes to
the top of the gradient (squares), while in the absence of soluble heparin efficient
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binding of the virus to the liposomes was observed (diamonds). Clearly, soluble
heparin blocks binding of the virus to HepPE-containing liposomes, indicating
that HS-adapted SIN specifically interacts with the heparin moiety on the
liposomal membrane. It is of interest that maximum competition of SIN 3970
binding to  HepPE-containing  liposomes was achieved only at relatively high
concentrations of soluble heparin (5 mg/ml). At lower soluble heparin
concentrations, partial competition was observed (results not shown). This
indicates that the interaction between HS-adapted SIN and  HepPE-containing
liposomes is very tight, suggesting that multiple interactions between a single virus
and several HepPE molecules on the liposomal membrane are involved.
Figure 3. Effect of soluble heparin on binding of HS-adapted SIN 3970 to
PC/PE/SPM/Chol liposomes supplemented with 0.01 mol% HepPE at pH 7.4, 1 h at 4
°C. Binding was determined as described in the legend to Fig.1. Curves: squares, binding in the
presence 5 mg/ml soluble heparin; diamonds, without soluble heparin.
Fusion activity of pyrene-labeled SIN with liposomes with or without
HepPE in the target membrane. It has been suggested that receptor interaction,
rather than low pH, triggers conformational changes in the viral spike protein of
SIN which would subsequently lead to fusion of the viral envelope with the plasma
membrane of the cell (1, 17, 24). To study the membrane fusion activity of SIN
upon interaction with the HepPE attachment receptor, fusion was measured in a
direct manner using pyrene-labeled virus, as described previously (46, 47). Pyrene-
labeled SIN 3970 or TRSB (1 µM  phospholipid) and PC/PE/SPM/Chol
liposomes supplemented with 0.01 mol% HepPE (100 µM phospholipid) were
mixed, with continuous stirring, and incubated for 1 min at 37 ºC, pH 7.4, to
achieve binding of the virus to the liposomes (see Figs. 1 and 2). While under these
conditions with 50-60% of the viruses bound to the  HepPE receptor on the
liposomal target membrane, there was no detectable fusion (Figure 4, curves b, c).
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In a control experiment, in which non-adapted SIN TR339 was used, there was no
fusion at neutral pH either (curve a). However, all three viruses fused rapidly and
efficiently with HepPE-containing liposomes at pH 5.0. Under these conditions, a
decrease of  pyrene-excimer fluorescence intensity of 50% was observed. This
indicates that SIN bound to HepPE-containing liposomes at neutral pH becomes
fusion-active only upon exposure to acidic pH.
Figure 4. Low-pH-dependent fusion of HS-adapted SIN mutants with liposomes. On-
line fusion experiments were performed at 37 °C, as described in Materials and Methods. The
final virus and  liposome concentrations were 1.0 and 100  µM (membrane  phospholipid),
respectively. (A) shows fusion curves SIN with PC/PE/SPM/Chol liposomes supplemented
with 0.01 mol% HepPE; curves a, TR339; curves b, 3970; curves c, TRSB. (B) and (C) show
the initial rate of fusion, as determined from the tangent to the first part of the curve, of SIN
TR339 (diamonds) and HS-adapted 3970 (squares) and TRSB (circles). (B)  fusion with
PC/PE/SPM/Chol liposomes supplemented with 0.01 mol% HepPE; (C) fusion with control
PC/PE/SPM/Chol liposomes without HepPE. All fusion measurements were repeated at least
three times.
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To further establish that SIN, bound to HepPE in target liposomes, retains the
capacity to fuse at low pH, fusion was measured on isolated virus-liposome
complexes.  Pyrene-labeled SIN 3970 was incubated with  HepPE-containing
liposomes for 1 h at 4 °C. Then, liposome-bound virus was separated from non-
bound virus by flotation on a sucrose-density gradient. Subsequently, the
membrane fusion activity of the virus-liposome complex was measured at pH 5.0.
Under these conditions, the liposome-bound virus fused rapidly and efficiently,
indicating that virus, pre-bound to target liposomes through the interaction with
HepPE at neutral pH, remains fully fusion-active when exposed to acidic pH (data
not shown).
Figure 4B shows the initial rates of fusion of SIN TR339, 3970, and TRSB
with liposomes supplemented with 0.01 mol% HepPE as a function of the pH of
the medium. Similar fusion kinetics were observed for the HS-adapted SIN 3970
and TRSB versus the non-adapted SIN TR339. Furthermore, using target
liposomes without HepPE, we observed indistinguishable fusion kinetics for HS-
adapted SIN viruses and non-adapted SIN TR339 (Figure 4C). Clearly, all of the
SIN viruses used fuse with  liposomes in a strictly low-pH-dependent manner,
exhibiting similar fusion kinetics irrespective of the presence of HepPE in the
target membrane.
The decrease of pyrene excimer fluorescence intensity by approx. 50%, seen in
the above measurements, corresponds to 50% fusion under the assumption that
when a virus particle fuses with a liposome the pyrene probe is diluted infinitely.
However, upon fusion of a virus particle with a comparatively small liposome, a
residual excimer fluorescence intensity will remain, implying that in this case the
actual extent of fusion may be underestimated in the pyrene assay. In this respect it
is important to note that the liposomes produced by the OGP dialysis method, as
used in our present experiments, tend to be smaller than the liposomes we use
routinely (5, 46, 48). Moreover, inclusion of increasing concentrations of HepPE
(> 0.02 mol%) in the membrane results in a further reduction of the size of the
liposomes, as judged by a decreasing opalescence of the preparation. As a
consequence, it is likely that, using the pyrene excimer fusion assay under these
conditions, one in fact underestimates the extent of fusion due to incomplete
dilution of the fluorophore.
Recently, we have shown that a  photoactivatable analog of cholesterol, 6-
photocholesterol ( photoChol), has the capacity to reversibly quench  pyrene
excimer and monomer fluorescence intensity (37). With this compound we were
able to investigate directly whether the pyrene assay indeed does underestimate the
actual extent of fusion. Fusion of pyrene-labeled SIN with photoChol-containing
liposomes is not only monitored on the basis of dilution but also on the basis of
quenching of the pyrene probe in the target membrane. Figure 5 shows the results.
Clearly, at pH 5.0, fusion of SIN 3970 with  liposomes consisting of
PC/PE/SPM/photoChol with or without 0.01  mol%  HepPE (curves  a,b)Heparan sulfate interaction and membrane fusion of alphaviruses 65
appeared more rapid and more efficient than fusion with corresponding liposomes
containing regular cholesterol (curves c,d). With photoChol-containing liposomes,
the initial rate of fusion was extremely fast: 35-40% of the virus particles
underwent fusion with the liposomes within the first second after acidification.
Furthermore, the apparent extent of fusion was over 70%. Taken together, these
results indicate that the extent of fusion of SIN with comparatively small
liposomes, as assessed by the regular pyrene assay, represents an underestimation
of the actual extent of fusion.
Figure 5.  Fusion of  pyrene-labeled SIN 3970 with  liposomes, containing
photocholesterol, at pH 5.0. Fusion was measured on-line at 37 °C as described in the legend
to Fig. 4. Curves a, PC/PE/SPM/photoChol  liposomes supplemented with 0.01  mol%
HepPE; curves b, PC/PE/SPM/photoChol  liposomes; curves c, PC/PE/SPM/Chol
liposomes supplemented with 0.01 mol% HepPE; curves d, PC/PE/SPM/Chol liposomes. All
fusion measurements were repeated at least two times.
Contents mixing during fusion of SIN with  trypsin-containing
liposomes.  To further quantify the extent of SIN-liposome fusion under the
conditions of our experiments, we also applied an entirely different fusion assay
based on mixing of the interior of the virus with the liposomal lumen. Contents
mixing was measured as the degradation of the viral capsid protein by trypsin,
encapsulated in target  liposomes, in the presence of  trypsin inhibitor in the
medium (46, 47, 54). [35S]Methionine-labeled SIN, either HS-adapted SIN 3970 or
non-adapted SIN TR339, and trypsin-containing supplemented with 0.01 mol%
HepPE liposomes (100 µM phospholipid) were incubated for 1 min at 37 ºC, pH
7.4, to allow the virus to bind to the liposomes. Figure 6 shows that there was very
little capsid degradation under these conditions (lanes a). This, again, demonstrates
that virus-receptor interaction at neutral pH does not induce fusion of the virus
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Figure 6.  Transfer of the viral  capsid into the  liposomal lumen assayed as the
degradation of the viral capsid protein. [35S]methionine-labeled SIN (approx. 108-109 virus
particles) was incubated with trypsin-containing PC/PE/SPM/Chol liposomes supplemented
with 0.01 mol% HepPE (100 µM liposomal phospholipid) at 37 °C, and viral capsid protein
degradation was determined, as described in Materials and Methods. (A) and (B) show the
results for HS-adapted SIN 3970 and non-adapted SIN TR339, respectively. Lanes a and d,
trypsin-containing liposomes; lanes b and e, empty liposomes; lanes c and f, trypsin-containing
liposomes in presence of TX-100 and absence of trypsin inhibitor in the medium. Lanes a-c,
pH 7.4; lanes d-f, pH 5.0. (C) and (D) show the quantification of the extent of capsid protein
degradation. Solid bars, TR339; shaded bars, 3970; open bars, TRSB. (C), target liposomes
supplemented with 0.01  mol%  HepPE; (D), target  liposomes without  HepPE. All  capsid
degradation experiments were repeated at least two times.
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with target liposomes. On the other hand, when SIN 3970 or SIN TR339 were
incubated with the  liposomes at pH 5.0, almost all of the  capsid protein was
degraded (lanes d). In control experiments, in which SIN was incubated with
empty  HepPE-supplemented  liposomes at pH 7.4 or pH 5.0, no  capsid
degradation was observed (lanes b,e). The ratio of the radioactivity of the capsid
band relative to the total amount of radioactivity was close to 0.4, as expected on
the basis of the number of methionine residues in the structural proteins of SIN.
Complete capsid degradation was observed when Triton X-100 was added to the
reaction mixture, in absence of trypsin inhibitor in the medium (lanes c,f). The
extent of capsid degradation, as function of the pH, for HS-adapted SIN 3970 and
TRSB or non-adapted SIN TR339 after fusion with HepPE-containing liposomes
at different pHs is shown in panel 6C. For SIN TR339 (solid bars), little to no
capsid degradation was observed at pH 7.4, whereas at pH 5.0 82% of the capsid
protein was degraded. For HS-adapted SIN 3970 (shaded bars) and TRSB (open
bars), similar results were obtained. Furthermore, in all cases the extent of capsid
degradation after fusion of the viruses with liposomes without HepPE was similar
to that observed upon fusion with  HepPE-containing  liposomes (Figure 6D).
Interestingly, the extents of fusion measured with the  trypsin assay closely
correspond to those observed with the pyrene assay in the presence of photoChol
in the target membrane (confer Fig. 4). This underlines the above conclusion that
the regular  pyrene assay underestimates the actual extent of fusion due to
incomplete dilution of the probe into the comparatively small dialysis liposomes.
Clearly, upon exposure to low pH, under the conditions of our experiments the
large majority of the viruses fuse with the  liposomes whether or not these
liposomes contain the HepPE attachment receptor.
Interaction of SFV with  HepPE-containing  liposomes. Next, we
addressed the question whether SFV, another member of the genus Alphaviruses,
has the capacity to adapt to HS during passage in cell culture. To this end, we used
SFV derived from the infectious clone pSFV4 as well as a strain of virus passaged
many times on BHK-21 cells. The pSFV4 clone was generated from a laboratory
strain of SFV, which had also been passaged frequently on BHK-21 cells (31). HS
adaptation of SFV derived from the infectious clone pSFV4 was evaluated in
binding assays. Figure 7A shows that SFV from pSFV4 bound efficiently to
monolayers of BHK-21 cells. To assess the specificity of this interaction, we used
heparin- versus albumin-agarose beads as cell surrogates in suspension binding
assays (28). The results show that SFV bound efficiently to heparin-agarose beads,
whereas the virus did not bound to albumin-agarose beads (Figure 7A).
Figure 7B shows that pSFV4-derived virus bound efficiently to  HepPE-
containing liposomes at neutral pH. The extents of binding were very similar to
those obtained with HS-adapted SIN (confer Fig. 1A). With  liposomes
supplemented with 0.02 mol% HepPE, more than 90% of the virus bound, while
with 0.01  mol%  HepPE in the target  liposomes half-maximal binding wasChapter 3 68
observed. There was no binding to liposomes lacking HepPE in the membrane.
Very similar results were obtained with a plaque-purified laboratory-adapted strain
of SFV (results not shown). Taken together, these results demonstrate that SFV
passaged frequently on BHK-21 cells, is strongly adapted to interaction with HS.
Figure 7. Interaction of SFV with BHK-21 cells, heparin-agarose beads and HepPE-
containing  liposomes. (A) [ 35S]methionine-labeled SFV particles (approx. 108-109 virus
particles) were added to BHK-21 cell monolayers or heparin- or albumin-agarose beads, and
binding was measured after incubation for 1 h at 4 °C, as described in Materials and Methods.
Bar a, binding to BHK-21 cells; bar b, binding to heparin-agarose beads; bar c, binding to
albumin-agarose beads. (B) Binding of [ 35S]methionine-labeled SFV (approx. 108-109 virus
particles) to PC/PE/SPM/Chol liposomes supplemented with various concentrations HepPE
(100 µM liposomal phospholipid) at pH 7.4, for 1 h at 4 °C. Binding of SFV to liposomes was
assessed as  decribed in the legend to Fig. 1. Each bar represents the average of triplicate
binding assays.
Finally, we investigated the membrane fusion activity of SFV upon interaction
with  HepPE-containing  liposomes. Figure 8 shows the results. Interaction of
pyrene-labeled SFV with HepPE in the liposomal membrane did not result in
fusion at neutral pH (curve c). However, the virus fused rapidly and efficiently
with HepPE-containing liposomes at pH 5.5 (curve a). Moreover, similar fusion
kinetics were observed with or without HepPE in the target liposomes 5.5 (curve a
versus b). There was no fusion of SFV with liposomes lacking the HepPE receptor
analog at neutral pH (curve d).
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Figure 8. Low-pH-dependent fusion of pyrene-labeled SFV with liposomes. Fusion of
pyrene-labeled SFV with PC/PE/SPM/Chol liposomes with or without 0.01 mol% HepPE
(100 µM liposomal phospholipid) at 37 °C was determined as described in the legend to Fig. 4.
Curves a, PC/PE/SPM/Chol  liposomes supplemented with 0.01  mol%  HepPE; curves b,
PC/PE/SPM/Chol  liposomes; curves c, PC/PE/SPM/Chol  liposomes supplemented with
0.01 mol% HepPE; curves d, PC/PE/SPM/Chol liposomes. All fusion measurements were
repeated at least three times.
Discussion
The study presented in this paper evaluates a new liposomal model system in
which a lipid-conjugated heparin (HepPE)  is incorporated in the target membrane
as an attachment receptor for HS-adapted  alphaviruses. The sulfated
polysaccharide heparin is commonly used as an analog for HS in receptor-ligand
assays, since  ligand interaction with heparin and analogous HS have little
qualitative difference (27). It is demonstrated here that HS-adapted SIN 3970 and
TRSB, at neutral pH, interact efficiently with  liposomes supplemented with
remarkably low levels of HepPE in the membrane (Figures 1 and 2). Without
HepPE in the target membrane the HS-adapted SIN viruses were unable to bind
to the  liposomes, indicating that the viruses bind specifically to the heparin
molecule. Furthermore, SIN strain TR339, which is not adapted to HS, was unable
to bind to HepPE-containing liposomes under the same conditions. Moreover,
binding competition experiments showed that soluble heparin blocked binding of
HS-adapted SIN to HepPE liposomes, further underlining the notion these viruses
specifically interact with the lipid-conjugated heparin moiety on the  liposomal
membrane. Despite the efficient interaction of SIN with  HepPE-containing
liposomes at neutral pH, there was no fusion under these conditions, as measured
with the pyrene- and the trypsin-assay (Figures 4 and 6), as discussed in more detail
below.
The interaction of HS-adapted SIN with  HepPE-containing  liposomes is
extremely efficient. Half-maximal binding was observed with liposomes containing
as little as 0.01  mol% HepPE in the membrane, demonstrating that about 15
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HepPE molecules on the outer surface of a liposome are sufficient for efficient
binding of the virus to the liposomal membrane. Almost no binding was observed
when, on average, 1-2 HepPE molecules were incorporated in a single liposome.
Therefore, we hypothesize that a SIN virus particle, after initial binding to a single
HepPE molecule in the liposomal membrane, subsequently recruits more HepPE
molecules to the site of interaction, resulting in multiple interactions between the
virion and most if not all of the HepPE molecules at the liposome surface. This
hypothesis is substantiated by the observation that a high concentration of soluble
heparin was required for competition. This concentration was at least an order of a
magnitude greater than that required for complete competition of binding of HS-
adapted SIN to BHK-21 cells (28). An explanation for this difference could be that
binding of HS-adapted SIN to cells involves fewer interactions with HS per virus
particle than binding to HepPE-supplemented liposomes. This may be related to a
limited mobility of HS-carrying  core proteins on the cell surface, possibly
restricting recruitment of multiple HS moieties to the site of interaction (27).
There is convincing evidence to indicate that SIN, like SFV (22, 23, 34, 35),
infects its host cell by receptor-mediated endocytosis and subsequent fusion from
within acidic endosomes (15, 20, 46, 47). In this regard, it is intriguing to note that
recently Hernandez and coworkers (24) published a paper, supporting earlier data
(1, 6, 17), suggesting that exposure to an acidic compartment within cells may not
be an obligatory step in alphavirus infection. Accordingly, it has been proposed
that virus-receptor interaction triggers conformational changes in the viral spike
protein, inducing fusion of the viral membrane with the plasma membrane of the
cell. The results presented in this study clearly demonstrate that, despite the
efficient interaction of SIN with the HepPE receptor in target liposomes at neutral
pH, there is no fusion under these conditions. This indicates that the presence in
the liposomal membrane of HepPE, an analog of the HS attachment receptor used
by cell culture-adapted strains of SIN, has no functional role in triggering
membrane fusion activity of SIN at neutral pH. Therefore, it appears that the sole
requirement for SIN-liposome fusion, even after interaction with the HS receptor
analog, is exposure of the virus to low pH. This is in agreement with earlier data
demonstrating that not only SIN, but also SFV, and TBE, fuse efficiently at low
pH with  liposomes lacking a protein or carbohydrate receptor (5, 13, 46, 47).
Formally, it cannot be excluded that initial receptor interaction could influence the
detailed characteristics of the pH-dependent membrane fusion process of SIN.
However, similar fusion kinetics were observed for HS-adapted SIN versus non-
adapted SIN with or without  HepPE in the target membrane, indicating that
receptor interaction has no influence on the detailed pH dependence of virus
fusion in the  liposomal model system. Taken together, our present results
demonstrate that, even after attachment of SIN to HepPE, as an HS receptor
analog, fusion remains strictly dependent on exposure of the virus to a mildly
acidic pH. This finding strengthens the notion that SIN infects its host cells viaHeparan sulfate interaction and membrane fusion of alphaviruses 71
receptor-mediated endocytosis and low-pH-dependent fusion from within acidic
endosomes. It is however, important to note that our present study does not
address HS-independent virus-receptor interactions. It is likely that some, if not all
alphaviruses have cellular receptors in addition to or instead of HS (7, 8, 28).
  Newly isolated or  unpassaged strains of SIN, RRV and VEE viruses, all
members of the alphavirus genus, do not bind to heparin and attach poorly to cells
in culture relative to laboratory-adapted strains (2, 21, 28). Passage of non-HS-
adapted SIN TR339 on BHK-21 cells resulted in virus mutants which bind with
high affinity to BHK-21 cells and interact with HS (28). In vivo, these HS-adapted
viruses typically exhibit an attenuated phenotype (8, 28). Similar results were
obtained in  passaging of RRV and VEE on cells. In the present paper, we
demonstrate that SFV, derived from the infectious clone pSFV4 (31), efficiently
interacts with cell-surface HS. It was found that this virus efficiently binds to
BHK-21 cells. Evidence that the efficient binding of SFV to BHK-21 cells
involves cell-surface  HS, was obtained from heparin binding experiments. We
observed that SFV interacts with immobilized heparin-agarose beads.
Furthermore, it is shown that SFV binds to  HepPE in  liposomal membranes.
These results suggest that SFV utilizes HS for infection of cells. Thus, adaptation
to HS attachment receptors appears to represent a common cell culture-adaptive
mechanism among the alphavirus genus.
There is extensive evidence that viruses from different families and genera
have the capacity to interact with GAGs, in most cases with HS (2, 7, 10, 11, 12,
14, 26, 28, 30, 32, 33, 44, 56). In several instances, high-affinity binding to HS, as
with alphaviruses, has been found to be a cell culture adaptation for a number of
viruses, including  flaviviruses,  pestiviruses,  picornaviruses, and retroviruses. In
some cases, however, interaction with HS was not found to be a cell culture
adaptation. For example, herpes simplex virus type 1 interacts with HS carrying a
specific sulfation pattern, which serves as functional receptor or co-receptor for
the virus (45). Since numerous viruses interact with HS, the  liposomal model
system presented here may serve as a novel tool to study basic virus-receptor
interactions and membrane fusion properties of viruses from different families or
genera.
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Abstract
It has been reported that low-pH-induced fusion of influenza virus with liposomes
results in rapid and extensive release of both low- and high-molecular-weight
substances from the liposomes (Günther-Ausborn, S., A. Praetor, and T. Stegmann.
1995. J. Biol. Chem. 270:29279-29285; Shangguan, T., D. Alford, and J. Bentz. 1996.
Biochemistry 35: 4956-4965). Here, we demonstrate retention of encapsulated water-
soluble compounds during fusion of Semliki Forest virus (SFV) or Sindbis virus (SIN)
with  liposomes at low pH. Under conditions allowing complete fusion of the
liposomes, a limited fluorescence dequenching of liposome-encapsulated calcein was
observed, particularly for SFV. Also, radioactively labeled inulin or sucrose were
largely retained. Freezing and thawing of the virus in the absence of sucrose resulted
in an enhanced  leakiness of fusion. These results support the notion that the
alphavirus fusion event per se is non-leaky and may well involve a discrete hemifusion
intermediate.Membrane fusion of alphaviruses is non-leaky 77
Introduction
Alphaviruses, such as Semliki Forest virus (SFV) and Sindbis virus (SIN), belong
to the category of enveloped viruses that infect their host cells through receptor-
mediated endocytosis and subsequent low-pH-induced fusion from within acidic
endosomes (8, 12, 14, 16, 21). This fusion process is mediated by the E1 component
of the viral E2/E1 heterodimeric envelope glycoprotein (4, 9, 11, 18, 23, 28, 35). SFV
and SIN fuse efficiently with liposomes in a strictly low-pH-dependent manner (4, 27,
31, 32). Fusion requires the presence of cholesterol (4, 22, 29, 32, 35, 36) and
sphingolipids in the target membrane (7, 26, 27, 32). Cholesterol is involved in low-
pH-dependent irreversible binding of the virus to target  liposomes, while
sphingolipids appear to function as a specific cofactor, catalyzing the actual viral
membrane fusion process (27).
Fusion of SFV with liposomes has been first studied by White and Helenius (36),
who used fusion assays based on encapsulation of trypsin or RNase in the liposomes.
Efficient degradation of the viral capsid protein or RNA was demonstrated after
incubation of SFV with the liposomes at low pH. No RNA degradation was observed
when RNase was added to the external medium. Likewise, the presence of an excess
of trypsin inhibitor in the external medium did not interfere with degradation of the
capsid protein during fusion of SFV or SIN with trypsin-containing liposomes (26, 27,
32, 36). Although the trypsin and RNase assays do not unequivocally prove the non-
leakiness of the fusion process, the results of these studies are consistent with the idea
that SFV-liposome fusion is not very leaky to large molecules, such as RNase or
trypsin inhibitor. Similar observations have been made for influenza virus. For
example, White et al. (37), using the above trypsin assay, and Young et al. (38),
studying virus interaction with planar bilayers, reported that the fusion process of
influenza virus is non-leaky. However, more recent investigations of influenza-
liposome fusion (13, 15, 30), strongly suggest that the fusion process is quite leaky.
Unlike the study of White et al. (37), these latter investigations are based on the release
of reporter molecules from the liposomes during the fusion process. For example,
Shangguan and coworkers (30) demonstrated that not only calcein (MW 623) but also
10kD dextran is rapidly released from liposomes upon fusion with influenza virus.
These observations prompted us to reinvestigate the leakiness of alphavirus-liposome
fusion, using similar reporter molecules encapsulated in the liposomes.
Materials and methods
Chemicals. Phosphatidylcholine (PC) from egg yolk, phosphatidylethanolamine (PE)
prepared from egg-PC, sphingomyelin (SPM) from bovine brain, and cholesterol (Chol) were
obtained from  Avanti Polar Lipids (Alabaster, AL).  Calcein and 1-hexadecanoyl-2-(1-
pyrenedecanoyl)-sn-glycero-3-phosphocholine (pyrPC) were from Molecular Probes (Leiden,
The Netherlands).3H-sucrose and  3H-inulin were from  Amersham  Pharmacia BiotechChapter 4 78
(Buckinghamshire, UK).
Viruses. SFV and SIN were produced from baby hamster kidney cells (BHK-21), as
described before (4, 32). Virus was purified from cell-culture medium by ultracentrifugation
and sucrose-density gradient centrifugation in 5.0 mM HEPES, pH 7.4, containing 0.15 M
NaCl and 0.10 mM EDTA (HNE). Unless stated otherwise, fresh virus preparations, that had
not been frozen and thawed but just stored in the cold, were used. Storage never exceeded 3
days. Viral phospholipid was determined by phosphate analysis (3) after extraction of the lipids
according to Bligh & Dyer (2).
Liposomes.  Liposomes (large  unilamellar vesicles) were prepared by freeze/thaw-
extrusion in HNE, as described before (17, 32). The extrusion step was done in a LiposoFast
mini-extruder ( Avestin, Ottawa, ON, Canada), using first two stacked  Nucleopore
polycarbonate filters with a pore size of 200 nm and then two stacked filters with a pore size
of 50 nm (filters were from Costar Co., Cambridge, MA). The latter extrusion was done 81
times. The mean diameter of vesicles prepared in this fashion was determined by quasi-elastic
light scattering in a Model 370 Submicron Particle Sizer (Nicomp, Santa Barbara, CA), and
found to be 70 nm with a narrow size distribution.
Liposomes consisted of either PC/PE/SPM/Chol/pyrPC (molar ratio,
0.85:1.0:1.0:1.5:0.15), PC/PE/SPM/Chol (1.0:1.0:1.0:1.5), PC/PE/Chol/pyrPC
(0.85:1.0:1.0:0.15) or PC/PE/Chol (1.0:1.0:1.0). For encapsulation of calcein, liposomes were
prepared in 60 mM calcein (sodium salt), 5.0 mM HEPES, 0.1 mM EDTA, pH 7.4. Non-
encapsulated calcein was removed by gel filtration on Sephadex G-50 (Pharmacia, Uppsala,
Sweden) in HNE. For encapsulation of 3H-sucrose or 3H-inulin, liposomes were prepared in
HNE containing 225 µCi/ml 3H-sucrose (13 Ci/mmol) and 1 mM unlabeled sucrose, or 200
µCi/ml 3H-inulin (0.39 Ci/mmol), respectively. Non-encapsulated sucrose or inulin were
removed by gel filtration. Phospholipid contents of the liposome preparations were determined
by phosphate analysis (3).
Fusion assay. Lipid mixing during virus-liposome fusion was monitored as a decrease of
pyrene excimer fluorescence following acidification of mixtures of SFV or SIN with pyrPC-
containing liposomes, as described before (32). Virus (10 µM phospholipid) and liposomes (2
µM phospholipid) were mixed in 0.66 ml HNE in a quartz microcuvette. Subsequently, the pH
of medium was adjusted to 5.5 (for SFV) or 5.0 (for SIN) by addition of 0.040 ml 0.30 M
MES,  pretritated to achieve the desired final pH. The time course of  pyrene  excimer
fluorescence was measured at excitation and emission wavelengths of 345 nm and 480 nm,
respectively, in the presence of a 475-nm cutoff filter in the emission beam, in an AB2
fluorometer (SLM-Aminco, Urbana, IL). The cuvette holder of the fluorometer was equipped
with a magnetic stirring device and maintained at 37 ºC. The fusion scale was set such that the
initial excimer fluorescence intensity represented 0% fusion, and the fluorescence intensity at
33% dilution of the probe represented the 100% value. Complete dilution of the probe was
induced by addition of 0.035 ml of 0.20 M octaethyleneglycol monododecyl ether (C12E8;
Fluka Chemie AG, Buchs, Switzerland).
Release of liposome contents during fusion. Release of calcein from the liposomes
during fusion with SFV or SIN was determined under conditions as in the fusion assay.
Calcein is a water-soluble fluorophore (MW 623) exhibiting fluorescence self-quenching at high
concentrations. Thus, leakage of calcein from liposomes containing 60 mM of the probe results
in fluorescence dequenching (1). Calcein fluorescence was measured, in the AB2 fluorometer
as above, at excitation and emission wavelengths of 460 nm and 520 nm, respectively, in theMembrane fusion of alphaviruses is non-leaky 79
presence of a 495-nm cutoff filter in the emission beam. The fluorescence of completely
released calcein was determined after the addition of 0.070 ml of 10% (v/v) Triton X-100
(Fluka) to the cuvette.
Leakage of 3H-sucrose was assessed by gel filtration chromatography. Liposomes (10 µM
phospholipid) containing 3H-sucrose were mixed with SFV (50 µM phospholipid) in 0.50 ml
HNE and acidified as above. After 1 min at pH 5.5 the medium was adjusted to pH 7.8 with
0.018 ml of 0.5 M Tris (pH 9.5). The mixture was loaded on a 24 x 1 cm Sepharose CL-4B
column. The column was eluted with HNE, containing 1 mg/ml BSA and 0.1 mM unlabeled
liposomes to avoid binding of fusion complexes to the column material. The radioactivity in
0.5 ml fractions was assessed by liquid scintillation counting. Leakage of 3H-inulin during SIN-
liposome fusion was determined in a similar manner.
Results
Fusion of SFV or SIN with liposomes assessed by lipid mixing. To determine
leakage of liposomal contents during virus-liposome fusion, we used conditions
allowing fusion of essentially all of the liposomes in a virus-liposome mixture. This
condition is achieved with an excess of virus over liposomes, as shown previously for
fusion of SIN with liposomes (32). In this latter study, using 70-nm liposomes, we
demonstrated that, at liposome and SIN concentrations of 2 and 2.5 µM phospholipid
(corresponding to 4*1010 liposomes and 1011 virions per ml), a liposome fuses on
average once with a single virus particle. Given the diameter of the liposomes of 70
nm and that of an alphavirus particle, excluding the external glycoprotein layer, of 50
nm (9), fusion of a liposome with a virion results in a reduction of pyrPC surface
density by 33% and thus in a decrease of pyrene excimer fluorescence by 33%, the
excimer intensity being proportional to the surface density of the probe (10). Likewise,
100% fusion of the liposomes corresponds to a 33% decrease of the total pyrene
excimer fluorescence. This value has indeed been observed previously (32).
Now, using pyrPC-labeled PC/PE/SPM/Chol liposomes, again with a diameter
of 70 nm, and unlabeled virus at concentrations of 2 and 10 µM, respectively,
(corresponding to a liposome:virus particle ratio of 1:10), we observed a decrease of
pyrene excimer  fluorescence intensity in 1 min of 42% for SFV at pH 5.5 (Figure 1A,
curve a) and 37% at pH 5.0 for SIN (Figure 1B, curve a). These values correspond to
127% and 112% fusion, respectively. Therefore, under the condition of these
experiments, on average all of the liposomes fuse at least once with a virus particle.
The initial rate of SIN-liposome was approx. 2-fold lower than that of SFV-liposome
fusion under the condition of the experiment (Figure 1A vs. 1B).
Release of calcein from liposomes during fusion with SFV or SIN. Fig. 1A
(curve b) shows the result of a calcein dequenching experiment. PC/PE/SPM/Chol
liposomes, loaded with 60 mM calcein, were incubated with SFV at pH 5.5, 37 ºC, at
a liposome-to-virus particle ratio of 1:10. Clearly, an only limited dequenching of
calcein fluorescence occurred, reaching about 15% after 1 min. Virtually no
dequenching was observed at pH 7.4 (not shown), or at pH 5.5 with liposomes lackingChapter 4 80
SPM (Figure 1A, curve c). We have shown that fusion of SFV requires the presence
of SPM in target liposomes (27). Therefore, the limited fluorescence dequenching
observed with SPM-containing liposomes at pH 5.5 was due to the fusion process.
  This dequenching, however, may not be due to release but can possibly be
accounted for by redistribution of calcein within the liposome-virus fusion products.
When a 70-nm liposome fuses with a 50-nm virion and the fusion product assumes
a spherical shape, the internal volume of the fusion product increases almost 2-fold
relative to the internal volume of the original liposome. Thus, we compared the
fluorescence of 30 mM calcein to that of 60 mM calcein, both encapsulated in
liposomes. The residual relative fluorescence intensities were 30% and 17%,
respectively. This implies that a 2-fold dilution of the calcein within liposome-virus
fusion products would result in an increase of fluorescence intensity of 100x(30-
17)/(100-17)= 16%. The observed dequenching of 15% is similar to this value.
Therefore, even though virus-liposome fusion products may not be perfectly spherical,
the above argument shows that the observed calcein dequenching is likely to be due,
at least in part, to dilution of the probe within virus-liposome fusion products.
Figure 1.  Fusion of SFV (A) or SIN (B) with  pyrPC-labeled or  calcein-containing
liposomes. Fusion was measured on the basis of pyrene excimer fluorescence decrease, and
release calcein on the basis of fluorescence dequenching, both at virus and liposome concentrations
of 10 µM and 2.0 µM phospholipid, respectively. The fusion scale is calibrated such that 33%
decrease of pyrPC excimer fluorescence intensity represents 100% fusion (see text). The calcein
dequenching scale is calibrated such that the initial residual fluorescence of the  liposomes
represents 0% and the fluorescence intensity in the presence of TX-100, inducing lysis of the
liposome, 100%. Curves a, fusion of PC/PE/SPM/Chol/pyrPC liposomes with SFV at pH 5.5
or with SIN at pH 5.0; curves b, calcein release from PC/PE/SPM/Chol liposomes upon fusion
with SFV at pH 5.5 or SIN at pH 5.0; curves c, calcein release from PC/PE/Chol liposomes at pH
5.5 in the presence of SFV (A) or from PC/PE/SPM/Chol liposomes at pH 5.0 in the absence of
SIN (B).
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Fusion of SIN with calcein-loaded liposomes (Figure 1B) was more leaky than
SFV-liposome fusion. With SIN we observed approx. 50% dequenching of calcein
under conditions where all of the liposomes fuse at least once with a virion (curve b).
This implies that, while SFV-liposome fusion appears to be essentially non-leaky, SIN-
liposome fusion results in partial release of calcein to the external medium.
Retention of radiolabeled sucrose or inulin within virus-liposome fusion
products. Final proof for SFV-liposome fusion being essentially non-leaky came from
the evaluation of 3H-sucrose release from the liposomes. Liposomes containing 3H-
sucrose (MW 344) were incubated with SFV for 1 min at pH 5.5, 37 ºC, at liposome
and virus concentrations of 10 µM and 50 µM phospholipid (liposome-to-virus
particle ratio of 1:10). Fig. 2A shows the elution profile of 3H-sucrose obtained after
gel filtration analysis of the liposome-SFV fusion. It is evident that only a small
fraction (approx. 9%) of the 3H-sucrose had leaked out (closed circles). The controls
show that unfused liposomes also retained the  3H-sucrose (open circles), while
TX100-treated liposomes completely released the probe (triangles).
Similar experiments were done with SIN and liposomes containing 3H-inulin. Since
from the calcein dequenching experiments (Figure 1B) it was evident that SIN-
liposome fusion results in partial release of the probe, we decided to use, rather than
sucrose (MW 344) which is smaller than calcein (MW 632), the larger marker inulin
(MW 5200). Fig. 2B demonstrates that inulin was largely retained during SIN-liposome
fusion, only 11% being released (closed circles).
Figure 2. Release of 3H-sucrose or 3H-inulin from liposomes upon fusion with SFV (A) or
SIN (B), respectively. A mixture of SFV or SIN (50 µM) and PC/PE/SPM/Chol liposomes (10
µM) containing 3H-sucrose or 3H-inulin, respectively, was incubated at pH 5.5 (SFV) or pH 5.0
(SIN), 37 ºC, for 1 min and subsequently neutralized. The incubation mixtures were then eluted
on a Sepharose CL-4B column, and the fractions were analyzed for radioactivity. Open circles,
untreated virus-liposome mixtures at neutral pH; closed circles, liposomes after low-pH-induced
fusion with SFV or SIN; triangles, virus-liposome mixtures after addition of TX-100.
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Effects of freeze-thawing of the virus on calcein retention. Previous studies
(37, 38) have indicated that fusion of SFV or influenza virus with planar bilayers or
liposomes becomes increasingly leaky when the virus is damaged by freeze-thawing.
In the above experiments, we used fresh virus preparations which had been stored in
the cold for no longer than 3 days. In order to assess the effect of freeze-thawing,
aliquots of SFV or SIN, in HNE containing 35-40% sucrose, were subjected to freeze-
thawing 5 times, subsequently fused to calcein- or pyrPC-containing liposomes. The
treatment had no detectable effect on the extents of calcein dequenching (Figures 3A
and B, curves b) or fusion in the pyrene assay (results not shown).
However, when SFV or SIN were frozen and thawed in HNE in the absence of
sucrose as a cryopreservative, the fusion process with liposomes did become leaky,
resulting in 55% calcein dequenching with SFV (Figure 3A, curve a). For SIN, similar
results were obtained (Figure 3B, curve a), but the effect of freeze-thaw treatment was
much less prominent than with SFV. This indicates that freezing and thawing in the
absence of a cryopreservative may induce structural defects in the virus membrane,
resulting in leakage of liposome contents after fusion of such a damaged virus with
liposomes.
Figure 3: Effect of freezing and thawing on calcein release from liposomes upon fusion
with SFV (A) or SIN ( B). Calcein dequenching was measured as in the experiment of Fig. 1, with
virus preparations subjected to freezing (in liquid nitrogen) and thawing (in a waterbath of 37 ºC).
Curves a, virus frozen and thawed once in HNE; curves b, virus frozen and thawed 5 times in
HNE containing 35-40% (w/v) sucrose; curves c, unfrozen virus. 
Discussion
The results of this study indicate that fusion of alphaviruses with liposomes,
particularly fusion of SFV, is a relatively non-leaky process. Early studies on SFV-
liposome fusion, employing an assay based on trypsin or RNase encapsulated in the
liposomes, had provided circumstantial evidence for the fusion event to be non-leaky
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to large molecules (36). Our present observations, based on direct evaluation of the
release of marker molecules from the liposomes, extend this notion by demonstrating
that even small molecules, such as calcein and sucrose, are largely retained during the
fusion process. The initial integrity of the viral membrane appears to be crucial, as
prior freeze-thaw treatment of the viruses in the absence of sucrose resulted in an
increased leakiness. This suggests that, when release of marker molecules from target
liposomes is observed during alphavirus-liposome fusion, it may not be due to the
fusion process per se, but rather the result of the presence of structural defects in the
viral membrane. It is interesting that Young et al. (38), studying fusion of SFV with
planar lipid bilayers, also concluded that fusion of SFV is a non-leaky process
provided that the virus is fresh and the viral envelope undamaged. Furthermore, SFV
or SIN have been observed to become hemolytic only when the viruses are subjected
a freeze-thaw treatment prior to incubation with the erythrocytes (34).
There appeared to be a difference between the degrees of leakiness of SFV- and
SIN-liposome fusion, the latter resulting in a more extensive release of calcein (Figure
1). At the same time, freeze-thaw treatment of SIN had a comparatively small effect
(Figure 3B). This suggests that the SIN virus preparation, although freshly and
carefully isolated, may have acquired more structural defects during the purification
process than SFV. Yet, SIN-liposome fusion was essentially non-leaky to the marker
molecule inulin (MW 5200).
Our results are in apparent disagreement with observations by Spyr et al. (33) and
Käsermann et al. (19), indicating that, at low pH, isolated SFV particles become
permeable to small molecules, such as propidium iodide. The authors propose that the
viral E1 protein forms non-specific pores in the viral membrane under acidic
conditions. Accordingly, one would expect that, upon virus-liposome fusion, small
molecules initially encapsulated in the liposomes would be released to the external
medium through these pores. However, since we did not observe such release, it
would appear that the pores are either not or only transiently formed under the
conditions of our experiments or that they are not accessible, possibly due to blocking
by the viral nucleocapsid.
It is remarkable that, while  alphavirus-liposome fusion is essentially tight,
influenza-liposome fusion has been found to be leaky not only to calcein but also to
10kD dextran (13, 15, 30). It is unclear what the basis for this difference is. However,
the following points can be made. There is convincing evidence to indicate that fusion
mediated by the influenza hemagglutinin (HA) involves a hemifusion intermediate, a
so-called stalk (5, 6, 20, 25). Conceptually, a distinct hemifusion intermediate, in which
the outer leaflets of the interacting membranes have merged while the inner leaflets
are still separate, would provide a very plausible explanation for a fusion process being
non-leaky. Therefore, the observed leakiness of influenza-liposome fusion (15, 30)
may in fact not be due to leakiness of the fusion process  per se, but rather to
preexisting structural defects in the viral membrane, as discussed above, or to a
secondary effect of virus-liposome fusion. It is interesting that influenza virus fusionChapter 4 84
is strongly hemolytic (24) whereas the fusion event with erythrocytes per se, involving
a hemifusion intermediate, may well be non-leaky. 
At the same time, the relative non-leakiness of alphavirus-liposome fusion supports
the notion that this fusion involves a distinct hemifusion intermediate. In this regard,
we have characterized the effects of lysophosphatidylcholine and free fatty acids on
SFV-liposome fusion and observed that these effects indeed strongly suggest that the
fusion reaction proceeds via a stalk mechanism (Ortiz et al., to be submitted).
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Abstract
The amino acid at position 55 of the E2 glycoprotein (E2:55) of Sindbis virus
(SIN) is a critical determinant of SIN neurovirulence in mice. Recombinant virus
strain TE (E2:55= histidine) differs only at this position from virus strain 633
(E2:55=  glutamine), yet TE is considerably more  neurovirulent than 633. TE
replicates better than 633 in a neuroblastoma cell line (N18), but similarly in BHK-
21 cells. Immunofluorescence staining showed that most N18 cells were infected
by TE at a multiplicity of infection (MOI) of 50-500 and by 633 only at an MOI of
5,000 while both viruses infected essentially 100% of BHK-21 cells at an MOI of
5. When exposed to pH 5, TE and 633 viruses fused to similar extents with
liposomes derived from BHK-21 or N18 cell lipids, but fusion with N18-derived
liposomes was less extensive (15-20%) than fusion with BHK-21-derived
liposomes (~50%). Binding of TE and 633 to N18, but not BHK-21, cells was
dependent on the medium used for virus binding. Differences between TE and
633 binding to N18 cells were evident in  Dulbecco’s modified Eagle medium
(DMEM), but not in RPMI. In DMEM, the binding efficiency of 633 decreased
significantly as the pH was raised from 6.5 to 8.0 while that of TE did not change.
The same pattern was observed in RPMI when the ionic strength of RPMI was
increased to that of DMEM. TE bound better to heparin-Sepharose than 633, but
this difference was not pH-dependent. Growth of N18 and BHK-21 cells in
sodium chlorate to eliminate all sulfation decreased virus-cell binding, suggesting
the involvement of sulfated molecules on the cell surface. Taken together, the
presence of  glutamine at E2:55 impairs SIN binding to neural cells under
conditions characteristic of interstitial fluid. We conclude that mutation to
histidine participates in or stabilizes the interaction between the virus and the
surface of neural cells contributing to greater neurovirulence.Cell binding and neurovirulence of Sindbis virus 89
Introduction
Sindbis virus (SIN), the prototype member of the genus  Alphavirus in the
family Togaviridae, causes age-dependent mortality in mice (23). In newborn mice,
the AR339 strain of SIN causes acute fatal encephalomyelitis while in older mice
the disease is mild and nonfatal. A neuroadapted strain of Sindbis virus (NSIN)
isolated after serial intracerebral passages of SIN causes high mortality in older
mice associated with severe encephalomyelitis resulting in  kyphoscoliosis and
hindlimb paralysis (24). Fatal infection correlates with the induction of neuronal
death, the primary target cells of SIN infection in the nervous system (34).
SIN is a plus-strand RNA virus with a cell-derived lipid bilayer membrane
containing heterodimers of the two viral envelope glycoproteins E2 and E1 (51).
Entry of SIN into host cells involves association of the virus with the cell surface,
interaction with specific receptors,  clathrin-mediated  endocytosis, and acid-
induced fusion of SIN with the endosomal membrane to release the nucleocapsid
into the cytoplasm (29). Coordinated association and dissociation of the E2 and
E1 glycoproteins during interaction with the cellular membrane and exposure to
acidic pH are required for  alphaviruses to deliver  genomic RNA into the
cytoplasm (19). The E2 glycoprotein is the major mediator of attachment while the
E1 glycoprotein carries membrane fusion activity (5, 46, 51, 57). Many studies
suggest that the attachment of SIN to the cell surface is mediated by a cell surface
protein (51). Tissue culture-adapted SIN strains become highly dependent on the
proteoglycan heparan sulfate (HS) for initial virus attachment (7, 32) and it is likely
that multiple cellular and viral factors influence SIN attachment and entry into
cells in vivo and in vitro.
RNA viruses often adapt quickly to new environments due to the generation
and selection of mutants facilitated by the lack of proofreading of the viral RNA-
dependent RNA polymerase. Alterations at the viral entry steps, which include
receptor recognition, virus attachment/penetration and membrane fusion, could
influence the rate of virus growth and tissue tropism, two major determinants in
viral pathogenesis.  Studies of SIN, Venezuelan equine encephalitis (VEE), Semliki
Forest (SFV) and Ross River (RRV) viruses have demonstrated that mutations in
the envelope proteins are important determinants of virus virulence (12, 21, 55,
56) and the mechanisms of virulence have begun to be elucidated. For instance,
rapid penetration of BHK-21 cells is negatively correlated with virus virulence for
SIN and VEE (11, 12, 39) and binding to HS contributes to the attenuation of
SIN infection in mice (8, 32). Major determinants of the neurovirulence of the
neuroadapted strain of SIN have been mapped to the glycoprotein regions of the
genome and, in particular, the change from  glutamine to  histidine at position
E2:55 is rapidly acquired during replication in the nervous system and plays a
critical role in the acquisition of neurovirulence (35, 54). Recombinant viruses TE
and 633 were constructed on the same genomic background and differ only at theChapter 5 90
E2:55 position, where TE has a histidine and 633 has a glutamine. In 2-week old
mice inoculated intracerebrally, TE causes close to 100% mortality, whereas 633
causes no mortality (54).  Neuronal death occurs more often in TE-infected than
633-infected mice (34). In tissue culture, both TE and 633 replicate equally well in
non-neural cell lines, such as BHK-21 cells. However, in mouse brain and in N18
mouse neuroblastoma cells, replication is markedly different (14). TE replicates
more rapidly and grows to higher titer than 633. Therefore, replication of SIN in
N18 cells may reflect the molecular and cellular basis of neurovirulence in vivo.
Results of infectious-center assays indicate that more N18 cells are infected with
TE than with 633 at the same multiplicity of infection (MOI) (14), but differences
in the initial interactions between these viruses and the N18 cell surface did not
appear to account for the profound differences in infection (53).
Knowledge of the interactions between the viral envelope and cellular
receptor(s) could substantially facilitate the understanding of the process of cell
entry. In this study, we have extended the studies of infection of N18 cells to
identify determinants of the differential infection by TE and 633. We show that
the lipids of N18 cells are much less conducive to SIN fusion than the lipids of
BHK-21 cells and that the ionic strength of the virus diluent alters binding of 633
to the N18 cell surface in a pH-dependent fashion, while binding of TE is
unaffected.
Materials and Methods
Cell culture, virus stocks, and plaque assays.  BHK-21 cells and the N18 clone of
the C1300  neuroblastoma cell line  (1) were maintained in  Dulbecco's modified Eagle
medium (DMEM) (Gibco BRL, Gaithersburg, MD) supplemented with 10% fetal bovine
serum (FBS), 50 µg/ml gentamicin and 2 mM glutamine (GIBCO). Plaque forming units
(PFU) were determined on BHK-21 monolayers and MOIs were calculated based on
these data.
To prepare [35S]-labeled TE and 633, BHK-21 cells were grown to confluence and
infected at an MOI of 1. At 5 h after infection, the medium was replaced with
methionine/cysteine-free DMEM containing 2% FBS and 33 µCi/ml TRANS35S-LABEL
(~1,000 Ci/mmol; ICN, Irvine, Calif.). After overnight incubation, the culture supernatant
fluid was clarified and virus was concentrated by polyethylene glycol precipitation, purified
by centrifugation through a 15 to 45% (wt/vol) sucrose gradient, and concentrated
through a 15% sucrose cushion  (15). The final pellet was  resuspended in DMEM
containing 1% FBS and stored in aliquots at –80 °C.
To prepare virus stocks for infection, BHK-21 cells were infected at an MOI of 0.1
and incubated overnight. The supernatant fluid was clarified and virus concentrated either
by PEG precipitation or by centrifugation at 32,000 rpm in a Beckman SW-41 rotor at 4
°C for 90 minutes. Pellets were resuspended in DMEM containing 1% FBS and stored in
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Pyrene-labeled TE and 633 viruses were produced on BHK-21 cells, essentially as
described before for SFV and SIN (5, 38, 46, 57). Briefly, BHK-21 cells were cultured in
medium containing  15 µg/ml 16-(1-pyrenyl)-hexadecanoic (Molecular Probes, Eugene
OR). At sub-confluence, viral infection was initiated with an MOI of 4. At 24 h post-
infection, the  pyrene-labeled TE or 633 viruses were harvested from the medium by
ultracentrifugation in a Beckman type 19 rotor for 2.5 h at 100,000 x g, 4 °C, and further
purified on a sucrose density gradient (20-50% w/v) by ultracentrifugation in a Beckman
SW41 rotor for 16 h at 100,000 x g, 4 °C. The phospholipid content of the viruses was
determined, after lipid extraction according to Bligh and Dyer (3), by phosphate analysis
(4).
Immunofluorescence staining and microscopy.  BHK-21 and N18 cells were
seeded at 3-4 x 104 cells/well in 8-well Permanox chamber slides (Nalge Nunc, Naperville,
Ill.) and allowed to grow for 24 h. Cells were washed once in the specified binding
medium and infected with 200 µl of virus diluted in the same binding medium. After 1 h
at 37 °C, the virus inoculum was replaced with 200 µl of DMEM/2% FBS and 2 h later
200 µl of DMEM/2% FBS containing 20 mM ammonium chloride was added to each
well. After an additional 3 h of incubation, the cells were fixed in 4% paraformaldehyde in
phosphate-buffered saline (PBS) for 5 min, washed and incubated at room temperature
overnight with mouse anti-E2c monoclonal antibody (MAb) 209 (36, 49) diluted 2,000 in
PBS/2% FBS. After 3 washes in PBS, Alexa 488-conjugated goat-anti-mouse IgG (H+L)
(Molecular Probes) diluted 1/200 in PBS/2% FBS was added for 30 min, followed by 3
washes in PBS. To stain the nuclei, 1 µg/ml propidium iodide (Sigma, St. Louis, MO) in
PBS containing 0.1% Triton X-100 was added to the cells for 1 min. After 5 washes in
PBS and 1 wash in H 2O, the slides were mounted in PermaFluor aqueous mounting
medium ( Immunon, Pittsburgh, PA), and examined with a Nikon Eclipse E800
microscope.
RNA synthesis. N18 cells were seeded in 12-well plates at 3 x 105 cells per well and
cultured overnight. TE and 633 were diluted either in DMEM/1% FBS or in RPMI
containing 20 mM HEPES (pH 7.55) and 0.5% bovine serum albumin (BSA). After 1 h of
incubation at 37 °C in the presence of 5% CO2, the virus inoculum was aspirated, the cells
were overlayed with DMEM/2% FBS containing 1 µg/ml actinomycin D (Calbiochem,
San Diego, Calif.) and incubated at 37 °C. To label newly synthesized viral RNA,
DMEM/2% FBS with 20 µg/ml actinomycin D and 150 µCi/ml 3H uridine (50 Ci/mmol;
ICN, Boston, Mass.) was added to the cells and incubated for 1 h. Cell  lysates were
prepared in 1% SDS with 200 µg/ml proteinase K and precipitated in 10% trichloroacetic
acid (TCA) at  4 °C. The precipitates were harvested onto GF/C  glassfiber filters
(Whatmann, Maidstone, Kent, UK) which were washed 2 times with 5% TCA (4 °C) and
once in cold 95% ethanol. The filters were counted in BetaMax (ICN) in a Beckman LS
6500 scintillation counter.
Virus-cell binding assays. A variety of binding buffers were used and were based
either on DMEM, RPMI-1640 or Dulbecco’s PBS (8.5 mM Na2HPO4, 1.8 mM KH2PO4 ,
2.7 mM KCl, 137 mM NaCl, pH7.5) as the basic salt solution. DMEM with sodium
bicarbonate (3.7 mg/ml) (DMEM+SB), DMEM without sodium bicarbonate (DMEM-
SB), and DMEM+ SB without glucose ( Gibco BRL) were supplemented with
combinations of 1% FBS, 20 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid, pH
7.55 (HEPES; Gibco BRL). RPMI without sodium bicarbonate (RPMI-SB) (Gibco BRL)Chapter 5 92
was supplemented with 0.5 % bovine serum albumin (BSA) and 20 mM HEPES (20).
PBS was supplemented with 1mM MgCl2, 1mM CaCl2, and 0.5%BSA. To make binding
buffers of different pH values,  20  mM phosphate buffers (diluted from 1M sodium
phosphate made with appropriate ratios of 1M NaH2P04 and 1M Na2HP04) with different
pH values were used to replace HEPES. For the compositions of binding buffers used for
specific experiments, see figure legends.
The virus-cell binding assays were carried out essentially as previously described (7,
52). For chlorate treatment, the cells were dissociated in trypsin and incubated in F-12
HAM medium (Sigma) supplemented with 10 mM sodium chlorate, 2% dialysed FBS, 50
µg/ml glutamine, and 10,000 U/ml penicillin for one additional day. Cells were washed
once and detached by incubation in PBS containing 1 mM EDTA for 15 min. Cells were
washed in the specified binding buffer (4 °C), and resuspended at 4-7 x 105 cells per ml.
Subsequently, 290 µl of the cell suspension was mixed with 10 µl of diluted virus (10,000
cpm) in a 1.7-ml microfuge tube. The tubes were rocked at 4 °C for 30 to 180 min and
centrifuged for 5 min at 4,500 rpm at 4°C. The cells were washed twice in 600 µl of the
binding buffer and lysed in 100 µl 1% SDS. The tubes were rinsed once with 100 µl water.
The lysate and the rinse were combined and mixed with Liquiscint (National Diagnostics,
Atlanta, GA) and counted.
Binding of virus to BHK-21 cells was carried out under similar conditions with cell
monolayers in 12-well tissue culture plates. At 95-100% confluence, cells were washed
twice with 300 µl of the binding buffer (4 °C). [ 35S]-labeled TE or 633 was diluted to
10,000 cpm in 300-µl of the appropriate binding buffer and added to each well. The plates
were rocked at 4 °C for 30-180 min, washed twice with 600 µl binding buffer and lysed in
300 µl of 1% SDS. Cell lysates were transferred to scintillation vials together with 300 µl
of H2O used to rinse the well and counted. All of the binding assays were carried out in
triplicate. Three separate aliquots of the viruses used were counted to determine total cpm
and calculate % bound.
Binding to HS was determined by heparin-Sepharose chromatography as previously
described (7).
Preparation of  liposomes.  Phosphatidylcholine (PC) from egg yolk,
phosphatidylethanolamine (PE) prepared by transphosphatidylation of egg PC and egg
sphingomyelin (SPM) were obtained from  Avanti Polar Lipids (Alabaster, AL). High-
grade cholesterol ( Chol) was from  Solvay Pharmaceuticals ( Weesp, The Netherlands).
Alternatively, lipids were extracted from N18 and BHK-21 cells according to Bligh and
Dyer  (3). Large  unilamellar vesicles (LUV) were prepared by a freeze/thaw-extrusion
procedure. Briefly, lipid mixtures were dried from a chloroform/methanol (2:1) solution
under a stream of nitrogen and further dried under vacuum for at least 1 h. The lipids
were hydrated in 5 mM HEPES, 150 mM NaC1, 0.1 mM EDTA, pH 7.4 (HNE), and
subjected to five cycles of freezing and thawing. The vesicles were then extruded through
a Unipore polycarbonate filter with a pore size of 0.2 µm (Nucleopore, Pleasanton, CA) in
a LiposoFast mini-extruder (Avestin, Ottawa, Canada). Liposomes consisted of N18 cell
lipids, BHK-21 cell lipids, or a PC/PE/SPM/Chol mixture (molar ratio, 1:1:1:1.5).
Phospholipid content of the liposomes was determined by phosphate analysis (4).
Fusion assay. Fusion of  pyrene-labeled TE or 633 viruses with  liposomes was
monitored continuously as a decrease of pyrene-excimer fluorescence intensity due to
dilution of pyrene-labeled lipids from the viral envelope into the target liposomes (5, 38,Cell binding and neurovirulence of Sindbis virus 93
46, 57). Briefly, pyrene-labeled virus (0.5 µM viral phospholipid) and liposomes (200 µM
phospholipid) were mixed in a cuvette of an AB2 fluorometer (SLM/Aminco, Urbana,
IL) in a volume of 0.665 ml HNE. The content of the cuvette was magnetically stirred
and maintained at 37 °C. Fusion was initiated by injection of 35 µl 0.1 M MES, 0.2 M
acetic acid,  pretitrated with  NaOH to achieve the final desired pH.  Pyrene  excimer
fluorescence intensity was monitored at excitation and emission wavelengths of 345 and
480 nm, respectively. The fusion scale was calibrated such that 0% fusion corresponded to
the initial excimer fluorescence intensity and 100% fusion to the fluorescence intensity at
infinite probe dilution obtained by addition of  35 µl 0.2 M  octaethyleneglycol
monododecyl ether (C12E8; Fluka Chemie AG, Buchs, Switzerland).
Results
Susceptibility of N18 cells to infection by TE and 633. As demonstrated
by infectious center assays, TE infects more N18 cells than 633 at an MOI of 10
to 50 (14). There are at least two possible explanations for this observation. A
subpopulation of N18 cells (such as cells at a particular stage of the cell cycle) may
be resistant to infection by 633, but not TE, or all of the N18 cells may be
susceptible to infection by both viruses, but infection with 633 is much less
efficient than infection with TE. To test these hypotheses, N18 cells were infected
with TE and 633 at MOI of 50, 500, and 5,000, and incubated for 2 h to allow
virus entry before adding ammonium chloride to block secondary virus infection.
Cells were fixed 5 h after infection and stained with an anti-E2 MAb to detect the
expression of E2 on the cell surface. Individual cells were identified by propidium
iodide staining of the nuclei (Figure 1). At an MOI of 50, TE infected more N18
cells than did 633 (70 % vs 7 %) (Figures 1A and D). At an MOI of 500, 80% of
the N18 cells were infected with TE, but only 39% were infected with 633 (Figures
1B and E). However, at an MOI of 5,000, almost all N18 cells were infected with
633 (91%) as well as with TE (97%) (Figures 1C and F). Therefore, the whole
population of N18 cells was susceptible to infection by 633, but 633 was less
efficient at establishing infection than TE. However, N18 cells were much less
susceptible than BHK-21 cells to infection with either virus. At an MOI of 5
essentially 100% of BHK-21 cells were infected by either TE or 633 (Figures 1J
and K).
To be sure that the SIN glycoprotein on the N18 cell surface reflected virus
replication at these high MOIs, viral RNA synthesis was examined (Figure 2). At
an MOI of 5,000, similar levels of  3H-uridine were incorporated into a TCA-
precipitable form in TE- and 633-infected N18 cells at 5 to 6 h after infection.
There was less viral RNA synthesis in 633- than in TE-infected N18 cells at MOIs
of 50 (P = 0.03) and 500 (P = 0.02). These results imply that as long as 633 and
TE can enter the N18 cells to initiate virus infection, viral RNA synthesis does not
differ.Chapter 5 94
Figure 1. Susceptibility of N18 and BHK-21 cells to TE and 633 infection. N18 (A-I) and
BHK-21 (J-L) cells were infected with TE or 633 at BHK-21 MOIs of 5, 50, 500 or 5000. The
virus inoculum was diluted in either DMEM+SB supplemented with 1% FBS or RPMI-SB
supplemented with 20 mM HEPES and 0.5% BSA. At 2.5 h after infection, 20 mM ammonium
chloride was added and incubation continued for an additional 3 h. Cells were fixed in
paraformaldehyde and stained with an E2-specific monoclonal antibody (209).  Alexa 488-
conjugated goat anti-mouse antibody (green) was used as the secondary antibody. Visualization
of individual cells was facilitated by a  propidium iodine nuclear stain (red). Cells, viruses,
medium and MOI are as follows: N18 plus 633 in DMEM at MOI = 50 (A), 500 (B) or 5000
(C); N18 plus TE in DMEM at MOI = 50 (D), 500 (E) or 5000 (F). N18 plus 633 (G) or
TE(H) in RPMI at MOI = 50; N18 plus TE in DMEM, control without primary Ab (I). BHK-
21 + TE(J) or 633(K) in DMEM at MOI = 5. BHK-21 + TE in DMEM, control without
primary Ab (L).
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Figure 2. Viral RNA synthesis in N18 cells infected with TE and 633. N18 cells were
incubated for 1 h at 37 °C in the presence of 5% CO2  with TE and 633 diluted in
DMEM+SB/1% FBS to contain BHK-21  MOIs of 0, 50, 500 or 5,000. The cells were
maintained in DMEM+SB/2% FBS for 5 h before the addition of 150 mCi/ml of [3H]-uridine,
20 mg/ml actinomycin D. After 1 h TCA-precipitable counts in the cells were determined. *, P
< 0.005, Student’s t test.
Fusion of 633 and TE to N18 and BHK-21 cell-derived liposomes. Since a
substitution of threonine for isoleucine at E2:12 of SFV, a related alphavirus, leads
to decreased virus-cell fusion by lowering the pH required for the initial E1-E2
dimer dissociation (22), the effects of the mutation at E2:55 on fusion were
examined. Liposomes were prepared using lipid extracts from N18 or BHK-21
cells and used as target membranes for fusion of  pyrene-labeled TE and 633
(Figure 3). At pH 7.4, there was no fusion between the viruses and liposomes. On
the other hand, at pH 5.0, TE and 633 fused with BHK-21- or N18-derived
liposomes with similar kinetics and to similar levels. Also, the detailed pH
dependences of fusion of TE and 633 were very similar (results not shown).
Although TE and 633 did not differ in fusion, both viruses fused more extensively
with BHK-21-derived liposomes (~ 50% fusion) than with N18-derived liposomes
(17-20% fusion). Fusion of the viruses with BHK-21-derived liposomes was very
similar to fusion with PC/PE/SPM/Chol liposomes in terms of both kinetics and
final extent (results not shown).
Effect of buffer composition on binding of TE and 633 to N18 cells. TE
and 633 were previously demonstrated to bind to N18 cells to similar extents.
However, the conditions for testing binding were different (RPMI-SB/0.5%
BSA/20 mM HEPES at 4 °C without CO2) than those used routinely for infection
(DMEM+SB/1% FBS at 37 °C in 5% CO2) (7, 53). Therefore, binding of [35S]-
labeled TE and 633 to N18 cells at 4 °C was compared with viruses diluted in
RPMI-SB, PBS or DMEM+SB (Figure 4A). TE and 633 bound to N18 cells with
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Figure 3. Fusion of TE and 633 with liposomes prepared from N18 or BHK-21 cell
lipids.  Lipids were extracted from N18 (A) and BHK-21 (B) cells and used to prepare
liposomes. Pyrene-labeled TE or 633 viruses were mixed with liposomes at 37 °C.  At = 0 sec,
the buffer pH was adjusted to 5.0 or maintained at 7.4, after which the change in  pyrene
excimer fluorescence intensity at 480 nm, due to dilution of the pyrene-labeled viral lipids into
the liposome membrane, was monitored continuously.
similar kinetics and to similar extents when diluted in RPMI-SB-based buffer. TE
showed somewhat improved binding in PBS and DMEM compared to RPMI
while 633 showed lower binding than TE when diluted in PBS (P < 0.03 at all time
points) and almost no binding when diluted in DMEM+SB (P < 0.0005 at all time
points). Under the same conditions, no consistent diluent-dependent differences
were detected in TE and 633 binding to BHK-21 cells (Figure 4B). Consistent with
previous observations (53) both viruses were able to bind to BHK-21 cells more
efficiently than to N18 cells when diluted either in RPMI (P = 0.0004 for TE; P =
0.0054 for 633) or in DMEM (P < 0.0001 for TE and 633).
Since in our previous studies (14) and in the above experiments (Figures 1 and
2) comparing TE and 633 entry, and replication in N18 cells, virus was diluted in
DMEM+SB, it was important to determine whether TE and 633 would replicate
similarly in N18 cells if virus was diluted in RPMI rather than DMEM. N18 cells
were infected with TE or 633 diluted in RPMI-SB at an MOI of 50. Infection of
N18 cells with TE and 633 in RPMI led to similar high proportions (47% and
68%) of infected cells at 5 h (Figures 1G and H).
Sensitivity to pH of TE and 633, binding to N18 cells in DMEM. To
investigate whether binding of TE and 633 diluted in DMEM to N18 or BHK-21
cells is sensitive to pH, DMEM-SB supplemented with 1% FBS was adjusted to
pHs between 6.5 and 8.5 with 20 mM phosphate (Figure  5A). Binding to BHK-21
cells did not change over this pH-range, while binding of 633 to N18 cells
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Figure 4. Effects of binding buffer on binding of 633 and TE to N18 and BHK-21 cells.
N18 (A) and BHK-21 (B) cells were incubated with [ 35S]-labeled TE or 633 diluted in
DMEM+SB supplemented with 20  mM HEPES, pH 7.3 and 1% FBS (circle).  RPMI-SB
supplemented with 20  mM HEPES (pH 7.3) and 0.5% BSA (square) or PBS (pH 7.3)
containing 1 mM MgCl2, 1 mM CaCl2, and 0.5% FBS (triangle) at 4 °C. Virus binding was
assessed after rocking the virus-cell mixture for 10, 30, 90 and 180 min at 4 °C. Binding of 633
to N18 cells was significantly lower than that of TE when viruses were diluted in PBS (P =
0.0036, 0.005, 0.004 and 0.025 at 10, 30, 90 and 180 min respectively) or DMEM (P < 0.0005 at
all time points).
decreased at pHs above 7.0. Binding of TE to N18 cells decreased only above pH
8.0. Binding of 633 was significantly lower than that of TE at pHs of 6.95 and
above ( P < 0.005). pH-dependent binding differences to N18 cells were not
observed when these viruses were diluted in RPMI (results not shown).
Effects of glucose concentration and ionic strength on binding of TE
and 633 to N18 cells. The composition of RPMI and DMEM differ in a number
of ways including glucose concentration (11  mM and 25  mM), ionic strength
(10,800 µS and 11,970 µS) and Ca2+ concentration (0.4 mM and 1.8 mM). To
determine the relevance of these differences each parameter was adjusted
independently and binding assessed. DMEM+SB without glucose was
supplemented with 11 or 25 mM glucose and 1% FBS. TE bound to N18 cells
better than 633 at both concentrations of glucose (Figure 5C) so lowering the
glucose concentration of DMEM to that RPMI did not improve 633 binding. The
ionic strength of RPMI (pH 7.5) was systematically increased by addition of NaCl
(Figure 5B), resulting in a steady decline in virus binding to N18 cells that was
greater for 633 than TE. Binding to BHK-21 cells was not affected. The
conductivity of RPMI was adjusted to that of DMEM, requiring the addition of
about 14 mM NaCl and binding assessed at different pHs (Figure 5D). Binding to
N18 cells, but not to BHK-21 cells of TE and 633 diluted in RPMI of increased
ionic strength differed significantly in a pH-dependent manner (Figure 5D) and
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Figure 5. Binding of 633 in DMEM to N18, but not BHK-21, cells is more sensitive to
pH changes than binding of TE. (A) BHK-21 and N18 cells were mixed with [35S]-labeled
TE and 633 in DMEM-SB supplemented with 1% FBS and 20 mM phosphate buffer at pH
6.5, 6.95, 7.4, 7.85, and 8.5 for 90 min at 4 °C. Binding of 633 was lower than binding of TE to
N18 cells at pHs of 6.95 (P = 0.0013) and above (pHs 7.4 and 8.5, P < 0.0001; pH 7.85, P =
0.0037). (B) The glucose concentration of DMEM without glucose was adjusted to 11 mM and
25 mM. N18 cells were mixed with [35S]-labeled TE and 633 for 120 min at 4 °C. (C) The ionic
strength of RPMI-SB containing 0.5% BSA (conductivity = 10,800 µS) was adjusted to that of
DMEM-SB containing 1% FBS (conductivity = 11,970 µS) by raising the NaCl concentration
approximately 14 mM. Phosphate (20 mM) was used to adjust the pH to 6.6, 7.15, 7.5, 7.85,
and 8.10. N18 and BHK-21 cells were incubated with [35S]-labeled TE and 633 for 150 min at 4
°C. (D) The  NaCl concentration of RPMI-SB supplemented with 0.5% BSA and 20  mM
phosphate (pH 7.5) was raised by 0, 5, 10, 15, 17.5, 25, 35 mM (final conductivities were
12,500, 12970, 13380, 13730, 14550, 15340 µS, respectively) and binding of TE and 633
assessed as above.
the pattern was similar to that observed for virus diluted in DMEM (Figure 5A).
Lastly, increasing the Ca2+  concentration of RPMI to that of DMEM did not
decrease binding of either virus to N18 cells, but did enhance the difference
between TE and 633 possibly due to the concomitant increase in ionic strength.
There was no effect on binding to BHK-21 cells (results not shown).
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The role of sulfated molecules in TE and 633 binding to N18 and BHK-
21 cells. HS, a highly negatively charged molecule, is a determinant of SIN binding
to the cell surface. HS binding increases the efficiency of infection of CHO and
BHK-21 cells (7, 32). To determine if the differences in binding of TE and 633 to
N18 cells and the effect of pH on that binding could be explained by the relative
strength of binding to HS we examined binding to heparin-Sepharose and to cells
differing in the levels of sulfated molecules on the cell surface. Each virus was
bound to a heparin-Sepharose column at a NaCl concentration of 50mM and then
eluted with a 50-500 mM NaCl gradient prepared at either pH 6.5 or 7.5 (5 mM
phosphate). The results show that 633 bound less tightly to HS than TE at both
pH values, TE required 403 and 320 mM NaCl, respectively; 633 required 346 and
302 mM NaCl, respectively.
To investigate whether HS or other sulfated molecules participated in the SIN-
N18 cell binding that is ionic strength- and pH-sensitive, N18 and BHK-21 cells
were grown in low sulfate medium in the presence of 10 mM sodium chlorate, a
potent inhibitor of ATP-sulfurylase, the first enzyme in the biosynthesis of the
cosubstrate for sulfation (2, 28). Binding assays were carried out in DMEM-SB
containing 1% FBS and 20 mM phosphate, pH 6.5 or 7.5, conditions at which TE
and 633 showed the least and the most significant differences in binding to N18
cells (Figure 5A). At pH 6.5, binding of TE and 633 to N18 cells was decreased
similarly by the chlorate treatment, indicating that binding of both viruses to N18
cells is affected by the desulfation of the cells (Figure 6A). At pH 7.5, TE reacted
well with sulfated molecules on the surface of N18 cells, but 633 did not. Binding
of TE (P = 0.0045) and 633 (P = 0.0025) to the chlorate-treated N18 cells was
lower than to untreated N18 cells (Figure 6A), but differences between TE and
633 were still observed. Chlorate treatment decreased binding of TE and 633 to
BHK-21 cells at pH 7.5 from >70 % to approximately 10% (Figure 6B), similar to
the binding of both viruses to CHO cells lacking HS (results not shown).
Discussion
The substitution of the amino acid histidine for glutamine at residue 55 of the
E2  glycoprotein has a profound effect on the  neurovirulence of SIN. This is
reflected in the relative abilities of recombinant viruses containing either histidine
(TE) or glutamine (633) to replicate in mouse brain and in N18 neuroblastoma
cells (34, 54). In the current studies we have shown that all N18 cells can be
infected by both viruses, but infection is 10- to 100-fold less efficient for 633 than
TE. Both viruses infect N18 cells less efficiently than BHK-21 cells, presumably as
a result of decreased binding to the cell surface combined with a limited ability ofChapter 5 100
Figure 6. Sulfated molecules appear to be involved in the ionic strength- and pH-
sensitive binding of TE and 633 to N18 cells. N18 (A) and BHK-21 (B) cells were grown in
Ham’s medium containing a low concentration of sulfate with (+) or without (-) 10 mM sodium
chlorate overnight. Binding was performed in DMEM-SB containing 1% FBS and 20 mM
phosphate at pH 6.5 or 7.5.
the lipids in the plasma membrane of N18 cells to support SIN fusion. Both TE
and 633 bound to HS, a major determinant of binding to BHK-21 and CHO cells
(32). Binding of the viruses to N18 cells differed in that 633, but not TE, was
exquisitely sensitive to the composition of the diluent used in the binding assay
and decreased substantially as ionic strength and pH increased to physiologic
levels. Treatment of N18 cells with sodium chlorate to inhibit sulfation decreased
the binding of TE at pH 7.5 to approximately the binding of 633 to N18 cells not
treated with chlorate. The limited binding of 633 was further decreased by chlorate
treatment. The data suggest that BHK-21 cells have a sulfated molecule to which
TE and 633 bind efficiently to initiate infection and that this molecule is either not
present on N18 cells or present in an altered form. The interaction of SIN with the
primary receptor on N18 cells is affected by a glutamine at E2:55 in a way that
impairs binding at physiologic conditions of salt concentration and pH.
Different types of cells exhibit different degrees of susceptibility to SIN
infection. Clearly, both TE and 633 infect N18 cells much less efficiently than
BHK-21 cells. An MOI of 50-500 (determined on BHK-21 cells) was required to
establish synchronous infection in N18 cells with TE, while 633 required an MOI
of 5,000 (Figure 1). Both viruses bind less efficiently to N18 cells than to BHK-21
cells (Figure 4). Furthermore, the viruses fuse less extensively with N18-derived
liposomes than with BHK-21-derived liposomes (Figure 3).
It is well established that the lipid composition of the target membrane has a
profound effect on the membrane fusion characteristics of enveloped viruses (41,
44, 50). For alphaviruses, studies in both liposomal model systems as well as in
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cells have shown that membrane interaction and fusion are dependent on
cholesterol  (5, 30, 40, 57, 59). Furthermore, fusion requires the presence of
sphingolipid in the target membrane  (10, 37,  38). Cholesterol appears to be
primarily involved in the initial low-pH-dependent binding of the virus to the
target membrane lipids, while spingolipids presumably play a catalytic role in the
subsequent fusion event itself  (38). There is no reason to suspect that in our
present study the N18  liposomes were deficient in either cholesterol or
sphingolipid: the plasma membrane of N18 cells has a high cholesterol-to-
phospholipid ratio, and sphingomyelin is a major component of the phospholipid
fraction (9). The detailed fusion characteristics of TE or 633 in the liposomal
model system (Figure 3) indicate that with N18-derived  liposomes a smaller
fraction of the virus fuses than with BHK-21-derived  liposomes or  liposomes
consisting of an artificial PC/PE/SPM/Chol mixture. Yet, the fraction of virus
that does fuse exhibits very similar fusion kinetics in either case. In view of the
high cholesterol content of the liposomes, it is unlikely that the low extent of
fusion is due to a low degree of binding. It thus appears that with N18-derived
liposomes part of the liposome-bound virus remains unfused. This is suggestive of
a degree of heterogeneity at the surface of the  liposomes, such that sites or
domains that do support efficient fusion coexist with other areas that do not.
Although recent experiments have shown that the presence of
cholesterol/sphingolipid domains in target  liposomes is neither required nor
inhibitory to  alphavirus membrane fusion (B. L.  Waarts and J.  Wilschut,
unpublished observations), the fusion of TE and 633 with N18-liposomes is
reminiscent of SIN fusion with liposomes containing domains with a relatively
high degree of fatty acid saturation resulting in tight lipid packing. Cultured
neuroblastoma cells generally contain low concentrations of polyunsaturated fatty
acids, unless specific fatty acid-supplemented medium is used (42). In addition,
N18 cell membranes contain N-acylphosphatidylethanolamine and N-
acylethanolamine  (25) which may contribute to a tighter lipid packing and a
decreased susceptibility to SIN fusion.
While there was a distinct difference between N18-derived and BHK-21-
derived liposomes in terms of fusion with TE or 633, paired comparison showed
that both viruses fused equally well. Apparently, substitution of His for Gln at
E2:55 has little effect on the viral fusion process, suggesting that an improved
interaction of the TE virus with target cell membrane lipids does not account for
the increased neurovirulence of TE relative to that of 633. Fusion of alphaviruses
is mediated by the E1 glycoprotein, presumably in a homotrimeric configuration
(5, 46, 57) while receptor interaction is a function of E2 (47). Therefore, it is likely
that amino acid changes in E1 primarily affect fusion with the neuronal cell
membrane, while changes in E2 are expected to have their principal effects on
virus binding.Chapter 5 102
Significant differences in binding to N18 cells were observed between TE and
633 diluted in DMEM, but not in RPMI, while binding to BHK-21 cells was
similar. These differences were explained primarily by the higher ionic strength of
DMEM, which was associated with a loss of 633 binding to N18 cells at
physiologic pH. Binding of both TE and 633 to N18 and BHK-21 cells was
diminished after treatment with chlorate, suggesting that the binding of SIN to
N18 cells is mediated primarily by sulfated molecules which are highly negatively
charged with ligand interactions that are often sensitive to ionic strength and pH
(6).
Binding of 633 to BHK-21 cells was not sensitive to changes in pH and ionic
strength, implying that the sulfated groups on the surface of BHK-21 and N18
cells with which SIN is interacting are different. The sulfated molecules on BHK-
21 cells could provide more stable interactions to the SIN glycoproteins than those
on N18 cells and therefore would be less sensitive to the interference by high salt
concentration. Alternately, the density of sulfated molecules on BHK-21 cells
could be more abundant than on N18 cells, providing stronger binding
interactions. Therefore, increased efficiency of SIN infection of BHK-21 cells
compared to N18 cells is likely to represent a combination of better initial binding
to sulfated molecules including HS on the cell surface and the fusogenicity of the
lipids present in the plasma membrane. Both of these parameters are suboptimal
in N18 cells so that selection of viral variants with improved attachment and/or
fusion would be predicted to increase neurovirulence.
Binding of proteins to glycoaminoglycans (GAG) has been considered to be
primarily electrostatic, but recent studies indicate that this interaction is both more
complicated and more specific than solely charge-determined interactions would
imply. Proteoglycan expression is regulated in both developmental and in tissue-
specific ways (18, 27, 31). Proteoglycans vary in core proteins, the types, locations
and numbers of GAG chains attached, and in the degree of  sulfation. This
variability allows relatively specific binding of a wide range of ligands (27). Of the
HS proteoglycans, syndecan-2 is most abundant in liver and kidney and syndecan-
3 is highly expressed in neonatal, but not adult brain (45). Little is known about
the proteoglycans expressed on neurons and the sulfated molecule on N18 cells
involved in SIN binding to the cell surface is not clear. Tyrosine sulfation is a
relatively common posttranslational modification of proteins (26) and sulfation of
CCR5 at an N-terminal tyrosine residue has been implicated as an important factor
in cytokine-CCR5 binding and in HIV entry into cells (17).
The region of the E2  glycoprotein we investigated in the present study is
important for virulence in other alphaviruses as well. A mutant with a deletion of
amino acid 55-61 of E2 of RRV generates small plaques and is less virulent in mice
(55). Whether E2:55 is involved in binding to the sulfated molecules directly or
indirectly is not known. Glutamine is not charged at neutral pHs, while histidine is
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which would be predicted to decrease the affinity of E2 for negatively charged
sulfate groups. When histidine has been implicated directly in HS binding this
interaction is improved at pH 6.5 (6). However, in DMEM, binding of TE to N18
cells remained unaffected when the pH was raised between 7 and 8, suggesting
that E2:55 is not directly involved in the charge interactions between E2 and the
cell surface.
It is possible that additional receptors are present on N18 and BHK-21 cells
that are cell-specific and their interactions are facilitated by the virus-sulfate
molecule interactions. Other viruses use different cell receptors on different cells.
Mouse hepatitis virus uses isoforms of the murine carcinoembryonic antigen gene
family  (16) and herpes simplex viruses are able to use a number of different
receptors alone or in combination to infect various cell types such as epithelial and
neuronal cells (48, 58).
From the results of the binding assays, the attachment of 633 virus to N18
cells appears more susceptible to changes in the environment than TE. The
association between the change from glutamine to histidine at E2:55 and SIN
isolates with higher degrees of neurovirulence has been repeatedly detected in our
laboratory (33), suggesting that virus with a histidine at E2:55 has a strong selective
advantage in mouse brain. Altered kinetics of virus entry into the cell could affect
virus growth rate and virulence by influencing the establishment or spread of the
virus. Efficiency of virus spread is a critical determinant for neurovirulence of
polytropic murine retroviruses, rabies virus and mouse hepatitis virus (13, 43).
Considering the ionic strength and pH of extracellular fluid, histidine at E2:55
would facilitate virus spread in mouse brain. Therefore, we hypothesize that TE
has an envelope that interacts  stably with the neuronal receptor in the
microenvironment of the CNS and is able to initiate more rounds of replication
before the onset of the immune response, thus increasing virulence.
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Abstract
The  ectodomains of  Sindbis virus (SIN)  glycoproteins E2 and E1 are
glycosylated at aspargine residues in a consensus sequence Asn-X-Ser/Thr. Here,
we studied the biological role of the N-linked oligosaccharides at positions E2:196
and E1:139, using SIN mutants with an asparagine-to-glutamine substitution at
either one of these positions. It was observed that the removal of a single
glycosylation site dramatically affects the infectivity of the virus on baby hamster
kidney cells (BHK-21). Moreover, deglycosylated SIN mutants were impaired in
their ability to fuse with liposomes under mildly acidic conditions, indicating that
the reduced infectivity of the virus mutants on BHK-21 cells lies at the level of the
fusion process. We suggest that the membrane fusion process of deglycosylated
SIN mutants is affected by subtle changes in the conformation of the viral spike
proteins, influencing the stability of the E2/E1 heterodimer.Membrane fusion of Sindbis virus glycosylation mutants 109
Introduction
Sindbis virus, the prototype member of the  alphavirus genus, has a highly
structured envelope composed of a host-cell derived lipid  bilayer in which 80
hetero-oligomeric spikes are assembled (42). A single spike consists of a trimer of
E2/E1 heterodimers. The E2 and E1 glycoproteins, which mediate the infectious
entry of the virus into its host cell, are type I transmembrane proteins with the
amino-terminus facing the external surface of the virus particle. The  carboxy-
terminal domain of E2 interacts with the viral nucleocapsid, which contains the
positive-strand genomic RNA associated with 240 copies of the capsid protein.
  The structural proteins of alphaviruses are translated as a single polypeptide in
the order NH2-capsid-PE2-6K-E1-COOH from the 26S subgenomic RNA (42).
Upon folding of the  capsid protein, it cleaves itself off in an  autoproteolytic
fashion, and the remainder of the polypeptide is  translocated to the rough
endoplasmatic  reticulum (ER). As soon as the nascent polypeptide enters the
lumen of the ER, it is cleaved in three distinct polypeptides (PE2, 6K, and E1) by
ER resident signal peptidases. The PE2 (PE2 is the precursor protein of E2) and
E1 polypeptides start to fold immediately, disulfide bonds are formed and the
proteins become  glycosylated. The polypeptides contain  oligosaccharide chains
linked to the asparagine residues at positions E2:196, E2:318, E1:139, and E1:245
(40). It is believed that N-linked glycosylation, at this stage, increases the solubility
of the folding intermediates and prevents the formation of protein aggregates (5,
8). In addition, molecular chaperones such as calnexin and calreticulin (16) bind to
the oligosaccharide chains of PE2 and E1, and assist the folding of the proteins
(31, 32). During the folding of the spike proteins in the ER, the PE2 and E1
subunits associate to form a PE2/E1 heterodimer. Then, the PE2/E1 heterodimer
continues its folding and maturation while passing through the Golgi-apparatus. If
the folding of the protein renders the oligosaccharide chains accessible to cellular
processing enzymes, the  mannosidic side chains are further modified to a
complex-type oligosaccharide (48). Complex N-linked glycans were observed at
position E2:318, and E1:245, an mannosidic side chain at position E2:196, and a
mixture of both types at position E1:139. However, the modification of
oligosaccharide chains to a complex-type was found to be dependent on the host
cell (17, 18, 28).
Not only the spike proteins of SIN, but in fact many viral envelope proteins
have been found to be glycosylated. These include the envelope glycoproteins of
HIV-1, hepatitis C virus, dengue virus, influenza virus, and respiratory syncytial
virus (14, 21, 24, 30, 50). A variety of functions have been ascribed to the N-
glycans of viral glycoproteins, including the folding and transport of the proteins
(5, 7, 12), the stability of the protein conformation (11, 14, 35), the activity or the
immunological properties of the protein (9, 12, 36, 44), and host cell tropism (2, 3).
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influenza hemaglutinin (HA) has been found to stabilize the metastable form of
HA required for fusion activity (35). On the other hand, the N-linked
oligosaccharide chains attached to the HA ectodomain in close proximity to the
receptor-binding site appear to control the receptor binding specificity and affinity
(13, 15, 36). Furthermore,  glycosylation of HA at antigenic  epitopes has been
shown to interfere with the access of antibodies (33, 44), and may therefore
contribute to the antigenic drift of influenza virus (43).
In contrast, little is known about the function of N-linked glycosylation of the
spike proteins of alphaviruses. Moreover, the oligosaccharide chains show large
variation in location, structure, and number among the alphavirus genus. Earlier
studies showed that removal of a single glycosylation site in the ectodomain of
SIN  glycoproteins E2 or E1, resulted in virus mutants with reduced growth
properties on baby hamster kidney cells (BHK-21), when compared to wild-type
virus (38). A further decrease of the growth rate was observed with SIN mutants in
which more than one glycosylation site were eliminated.
In this study, we examined the role of the oligosaccharide chains, linked to
asparagine residues E2:196 and E1:139 of the spike proteins of SIN, in the
infectious cell entry and membrane fusion activity of the virus. To this end, we
used the infectious SIN clone TE12, and two single deglycosylated mutants, in
which the  asparagine residues at position E2:196 or at position E1:139 were
substituted by glutamines. It is demonstrated that the removal of either one of
these glycosylation sites dramatically affects the infectivity of the virus on BHK-21
cells. Furthermore, the fusogenic properties of the mutant viruses were evaluated
in a  liposomal model system, as described previously (45, 46). There was no
detectable fusion of the single deglycosylated SIN mutants in a pH range from 4.5
to 7.4, indicating that the reduced infectivity of these viruses lies at the level of the
fusion process.
Materials and Methods
Viruses. All viruses were generated from cDNA clones. The construction of SIN
clone TE12, and the single deglycosylated SIN virus clones E2:196 and E1:139 has been
described previously (27, 38).
The viruses were produced by high-efficiency electroporation of BHK-21 cells with in
vitro transcripts of linearized cDNA clones, as described before (26). Viruses released from
the cells at 20 h post-transfection were harvested, and these stocks were used directly for
the production of  pyrene-labeled SIN particles, as previously described (6, 45, 46).
Labeling of SIN with the pyrene-probe does not affect the infectivity of the virus (45, 46).
The viruses were characterized by plaque assay on BHK-21 cells (22), phosphate analysis
(4), and protein determination (37). The purity of the viruses was confirmed by SDS-
PAGE. The pyrene concentration of the labeled virus preparations was determined by
measuring the emission spectrum of the  pyrene probe in an AB2  fluorometer
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Liposomes. Large  unilamellar vesicles (LUV) were prepared by a freeze/thaw-
extrusion procedure, as previously described (6, 45). Liposomes were prepared with an
average size of 200 nm. Liposomes consisted of phosphatidylcholine (PC) from egg yolk,
phosphatidylethanolamine (PE) prepared by  transphosphatidylation of egg PC,
sphingomyelin (SPM) from egg yolk, and cholesterol (Chol) in a molar ratio of 1:1:1:1.5.
The lipids were obtained from Avanti Polar Lipids (Alabaster, AL). The phospholipid
concentration of liposome preparations was determined by phosphate analysis (4).
Fusion assay.  Fusion of  pyrene-labeled SIN with  liposomes was monitored
continuously in an AB2 fluorometer, at excitation and emission wavelengths of resp. 345
and 480  nm (6, 45,  49). Briefly,  pyrene-labeled SIN (1.0  µM viral  phospholipid) and
liposomes (100 µM phospholipid) were mixed in a magnetically stirred and thermostatted
(37 ￿C) quartz cuvette of the fluorometer in a final volume of 0.665 ml in HNE. At t= 0
sec, fusion was initiated through the addition of 35 µl 0.1 M MES, 0.2 M acetic acid,
pretitrated with NaOH to achieve the final desired pH. The fusion scale was calibrated
such that 0% fusion corresponded to the initial excimer fluorescence value and 100%
fusion to infinite dilution of the probe (6, 45, 49). The initial rate of fusion was determined
from the tangent to the first part of the curve. The extent of fusion was determined 60 s
after acidification.
Results
Characterization of  pyrene-labeled  deglycosylated SIN viruses. To
directly evaluate the potential role of spike protein glycosylation in the infectivity
and cell entry of SIN, virus mutants derived from the clone TE12 were used in
which the  asparagine residue at E2:196 or E1:139 had been substituted for a
glutamine (Table 1). Pyrene-labeled stocks of the parental virus and both mutants
were generated to allow fusion measurements, as described below. However, first,
the purified pyrene-labeled virus preparations were characterized by plaque assay
on BHK-21 cells. It was observed that the plaque titer of the single deglycosylated
SIN viruses was at least 3 logs reduced, compared to the parental TE12 virus
Virus           E2:196 E1:139
TE12 Asn Asn
E2:196 Gln Asn
E1:139             Asn Gln
TABLE 1. Amino acid differences of  
deglycosylated Sindbis virusesChapter 6 112
(Table 2). On the other hand, analysis of the protein and phosphate contents of
the virus preparations demonstrated that the total amounts of virus produced were
similar for the parental TE12 virus, and the E2:196 and E1:139 mutants (data not
shown). Calculation of the number of virus particles showed that about 1.0*1012
particles per ml were present in all three purified virus preparations (data not
shown). For the calculation, a theoretical amount of 5.45 *10-17 g of protein or 4.6
*10-20  mol of phosphate per viral particle was used (see also corresponding
numbers for SFV; 23). Determination of the PFU-to-particle ratio revealed that
almost all of the produced SIN TE12 particles were infectious on BHK-21 cells,
the PFU-to-particle ratio being less than 1:10 under the conditions of the
experiment (Table 2). By contrast, the PFU-to-particle ratios of both single
deglycosylated SIN mutants were found to be greater than 1 to 40.000 (Table 2).
Thus, it appears that elimination of a glycosylation site in the ectodomain of SIN
glycoprotein E2 or E1 dramatically affects the infectivity of these viruses. Next, we
investigated whether the high PFU-to-particle ratio of the single deglycosylated
SIN mutants was related to the membrane fusion activity of these viruses.
Low-pH-dependent fusion of pyrene-labeled deglycosylated SIN viruses
with liposomes. Fusion was evaluated in a liposomal model system on the basis
of lipid mixing, using pyrene-labeled SIN, as described previously (45, 46). Pyrene-
labeled SIN (1 µM  phospholipid) and PC/PE/SPM/Chol  liposomes (100 µM
phospholipid) were mixed, with continuous stirring, and incubated for 1 min at 37
ºC. Then, fusion was triggered by acidification of the medium to pH 5.0. Figure 1
shows the results. At pH 5.0, SIN TE12 fused rapidly and efficiently with
liposomes (curve  a). At 60 s after acidification, an extent of fusion of
approximately 52% was observed. However, under the same conditions, there was
no detectable fusion observed with SIN mutants E2:196 and E1:139 (curve b, c).
         Viral infectivity          PFU to particle          PFU to particle
Virus          on BHK-21 cells         ratio based on            ratio based on
  (PFU/ml)    protein           phosphate
TE12      6*1011                 1:8              1:4
sM139 1*108 1:82.000              1:41.000
sM196      5*107                 1:164.000              1:64.000
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Figure 1. Fusion of pyrene-labeled deglycosylated SIN viruses with PC/PE/SPM/Chol
liposomes at pH 5.0. Fusion was measured on-line at 37 ￿C, as described in Materials and
Methods. Final viral and  liposome concentrations were 1.0 and  100 µM membrane
phospholipid, respectively. All fusion measurements were repeated at least three times. Curves:
a, TE12; b, E2:196; c, E1:139.
To investigate whether  deglycosylation of SIN influences the detailed pH-
dependent fusion properties, fusion was evaluated in a pH range from pH 4.5 to
7.4. Figure 2A presents the initial rate of fusion of SIN TE12 (circles), E2:196
(triangles), and E1:139 (squares) as function of the pH. At pH 5.0, 22% of the SIN
TE12 virus particles fused with the  liposomes within the first second after
acidification. Higher or lower pH values than pH 5.0, resulted in a slower rate of
fusion. The pH threshold of fusion was 6.5, similar to that of other SIN strains
(45, 46). The initial rates of fusion for the single glycosylated SIN mutants were
undetectably low, in the entire pH range from 4.5 to 7.4. Figure 2B shows the
extent of fusion, determined 60 sec after acidification. Again, throughout the entire
pH range no fusion was observed for the single  deglycosylated SIN mutants
E2:196 (triangles) and E1:139 (squares), whereas the parental SIN TE12 virus
(circles) showed high extents of fusion with an optimum at pH 5.0.
Discussion
The present analysis of the SIN clone TE12 and two SIN  glycosylation
mutants revealed that  oligosaccharide chains coupled to the E2 and E1 viral
envelope proteins strongly facilitate the membrane fusion activity of the virus. It is
demonstrated that the removal of a glycosylation site within the ectodomain of
either E2 or E1 dramatically affects both  infectivity and low-pH-dependent
membrane fusion activity of the virus, indicating that the reduced infectivity of the
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Figure 2. Detailed pH-dependent fusion of pyrene-labeled deglycosylated SIN viruses
with liposomes. Fusion of SIN TE12 (circles), E2:196 (triangles), and E1:139 (squares) virus
with liposomes was determined at different pH values, as described in the legend to Figure 1.
All fusion measurements were repeated at least two times. (A) The initial rates of fusion were
determined from the tangents to the first part of the curve. (B) The extents of fusion were
determined 60 s after acidification.
mutant viruses lies at the level of the membrane fusion process occurring in acidic
endosomes.
How can N-linked glycans influence the membrane fusion process of SIN?
One possibility is that the oligosaccharide chains are directly involved in the fusion
reaction. However, it seems unlikely that an oligosaccharide chain in E2 plays a
direct role in the fusion process of SIN, since alphavirus fusion is mediated by the
E1 glycoprotein (6, 20, 45, 49). Moreover, preliminary characterization of a double
deglycosylated SIN mutant carrying a second-site resuscitating mutation in E2
revealed that membrane fusion is partially restored, despite a sustained lack of
glycosylation (unpublished results). Another possibility is that the N-linked glycans
are required for the proper folding of the viral glycoproteins. Elimination of a
glycosylation site could induce a conformational change within the viral spike that
may not be tolerated in the stringent lattice of the  icosahedral SIN particle.
However, detailed cryo-EM analysis demonstrated no detectable conformational
differences between the parental SIN TE12 virus and the SIN  glycosylation
mutants, other than those directly associated with the lack of  oligosaccharide
chains (38). This indicates that deglycosylation of E2 or E1 does not result in
major conformational alterations of the viral spike. Therefore, we suggest that the
elimination of a single glycosylation site in either E2 of E1 induces an only subtle
change in the conformation of the viral spike protein, as discussed in more detail
below. This conformational change could affect the stability of the E2/E1
heterodimer, and therefore influence the structural rearrangements of the viral
glycoproteins during the membrane fusion reaction.
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Inhibition of  glycosylation by  glucosidase inhibitors or  mutagenesis of the
glycosylation sites has been shown to cause misfolding and aggregation of several
viral glycoproteins, resulting in the retention of these proteins within the ER (7,
29). Although, it has been observed that individual N-linked oligosaccharides differ
in terms of their importance for folding of the glycoprotein in the ER, some N-
glycans can be eliminated with little or no consequence while others appear to be
essential (1, 19, 34, 35, 41). For SFV, the glucosidase inhibitor castanospermine
blocked binding of p62 (corresponding to PE2 in SIN) and E1 to calnexin and
calreticulin, and as a result, 80% of the folding intermediates ended up in protein
aggregates and were retained within ER (32). Apparently, the removal of a single
glycosylation site in E2 or E1 does not dramatically affect the folding of the
protein. This may suggest that calnexin and/or calreticulin still assist the folding of
the protein, albeit perhaps to lesser extents. On the other hand, the reduced
binding capacity of the molecular chaperones might allow subtle changes in the
folding intermediate of the protein, which could result in a slightly different
conformation of the spike heterodimer.
A role for N-glycans in the stability of the viral glycoproteins has also been
proposed for a number of other enveloped viruses, including influenza virus,
dengue virus, HIV-1, and human respiratory syncytial virus (9, 10, 11, 14, 35, 50).
For example, treatment of HIV-1 infected cells with N-butyldeoxynojirimycin
(NB-DNJ), a  a-glucosidase inhibitor,  blocks  syncytium formation and the
formation of infectious virus (9). Although binding to CD4 occurs, the
conformational shift and cleavage of gp120 that results in the exposure of gp41
does not (11). Thus, viral entry is blocked by the increased stability of gp120 in the
viral envelope. Moreover, it has been observed that in the presence of NB-DNJ
there is a regional misfolding in the V1/V2 loops of gp120 (10). On the other
hand, deglycosylation of the stem region of influenza HA resulted in a higher pH
threshold for fusion, indicating that the oligosaccharides preserve the metastable
form of HA required for triggering fusion (35). Also, the removal of the
glycosylation site in the dengue virus E protein resulted in virus mutants with a
higher pH threshold for fusion (14). In a later study, it was shown that this
oligosaccharide chain protects the fusion peptide of the virus, which suggests that
the N-linked glycan stabilizes the E dimer contacts within the viral envelope (39).
Although the overall fold of alphavirus E1 is similar to that of flavivirus E, the
alphavirus E1 protein is not glycosylated at this position (25, 38, 39).
Recently, the three-dimensional localization of the oligosaccharide moieties on
SIN have been revealed by cryo-EM image difference map analysis of a panel of
deglycosylated SIN mutants (38). It was shown that the  asparagine residue at
position E2:196 lies at the external side of the spike trimer that forms the receptor
binding motif of  alphaviruses (47). The  glycosylation site at E2:318 lies
immediately downstream of the conserved  Trp-Ile-Val region, a region that is
assumed to interact with the fusion peptide of E1. Residues E1:139 and E1:245 lieChapter 6 116
within the viral “skirt” around the base of each spike. A crystallographic dimer of
the ectodomain of SFV E1 shows that the E1:139 residue lies within the central
domain of the protein, whereas the E1:245 residue lies within the dimerization
domain of the protein (25). The location of the glycosylation sites would suggest
that the individual sites have different effects on the stability of the E2/E1
heterodimer. For example, one could argue that the  oligosaccharide chain at
E2:318 is involved in E2-E1 dimer interactions. Deglycosylation of the protein at
this position could thus destabilize the E2/E1 heterodimer, which might result in a
higher pH threshold for fusion. On the other hand, the removal of the
glycosylation sites in E1 could induce a subtle change in the protein conformation,
such that it cannot rearrange to a fusion competent complex at mildly acidic pH.
We are currently investigating the influence of N-linked glycans on the stability of
the E2/E1 heterodimer.
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Abstract
The envelope glycoproteins E1 and E2 of Sindbis virus are palmitoylated at
cysteine residues within their transmembrane domains (E1 at position 430, and E2
at positions 388 and 390). Here, we investigated the  in vitro membrane fusion
activity of Sindbis virus variants (derived from the Toto1101 infectious clone), in
which the E1 C430 and/or E2 C388/390 residues had been substituted for
alanines. Both the E1 and E2 mutant viruses, as well as a triple mutant virus, fused
with liposomes in a strictly low-pH-dependent manner, the fusion characteristics
being indistinguishable from those of the parent Toto1101 virus. These results
demonstrate that acylation of the transmembrane domain, of Sindbis virus E1 and
E2 is not required for expression of viral membrane fusion activity.Membrane fusion of Sindbis virus deacylation mutants 123
Introduction
Sindbis virus (SIN), the prototype member of the genus Alphavirus of the family
Togaviridae, contains three major structural proteins: the capsid protein, C, and two
envelope glycoproteins, E2 and E2 (15, 27, 33). The E1 and E2 proteins, which
mediate the infectious host cell entry of the virus, are exposed on the viral surface
as 80 trimeric spikes each consisting of three E1/E2 heterodimers. E1 and E2 are
type-I integral membrane proteins with a single transmembrane anchor sequence
and a very small C-terminal domain located at the internal half of the viral
membrane. The transmembrane sequences of E1 and E2 contain a number of
cysteine residues, which are conserved among most of the members of the
alphavirus genus and represent potential sites for covalent attachment of long-
chain fatty acids. Indeed, in SIN, these cysteine residues, at E1 position 430 and
E2 positions 388 and 390, appear to be palmitoylated (26).
Not only the spike proteins of alphaviruses, but in fact many transmembrane
glycoproteins of animal viruses have been shown to be acylated (11, 28, 31). These
include the G protein of vesicular stomatitis virus (37), the hemagglutinin (HA) of
influenza virus (19, 20, 29, 32, 34) and the transmembrane subunit of the envelope
glycoproteins of human and simian  immunodeficiency viruses (39). Although
modification with long-chain fatty acids thus appears to be a common
phenomenon among viral transmembrane proteins, the biological function of this
acylation remains elusive. Several investigators have used site-directed mutagenesis
in order to selectively replace the cysteine residues that provide sites for acylation.
Such modified proteins have been studied after expression in cultured cells or in
systems generating recombinant viruses. However, conflicting results have been
obtained with regard to the role that spike protein acylation plays in the life cycle
of the viruses involved. Particularly, the potential function of fatty acids in the
membrane fusion activity of viral spikes, such as the influenza virus hemagglutinin,
has remained controversial (7, 14, 17, 19, 24, 29, 32, 40).
With regard to SIN, studies involving site-specific  mutagenesis have
demonstrated that deacylation of the transmembrane domains of the E1 and/or
E2 spike  glycoproteins slows down virus growth early in infection (26).
Furthermore, these  deacylation mutant viruses are more sensitive to treatment
with detergent as compared to wild-type SIN (26). Little is known about the
potential effect of spike protein deacylation on the membrane fusion activity of
SIN. However, the fact that the E1 and/or E2 deacylation SIN mutants do infect
a variety of cell types (26) suggests that the viral life cycle, including the membrane
fusion step, is unlikely to be grossly affected by lipid modification.
Here, we studied the effect of deacylation of the transmembrane domains of
SIN glycoproteins E1 and E2 on the viral membrane fusion capacity. Fusion of
SIN virus derived from the infections clone Toto1101 and several  acylation
mutants was evaluated in a liposomal model system on the basis of both lipidChapter 7 124
mixing and contents mixing. It is demonstrated that SIN fuses rapidly and
efficiently with  liposomes in a strictly low-pH-dependent manner. Moreover,
deacylation of the transmembrane domains of E1 and/or E2 had no effect on the
membrane fusion characteristics of the virus.
Materials and Methods
Acylation mutant SIN viruses. A cDNA, containing the Toto1101 infectious clone
of SIN virus (25), as well as three acylation mutant cDNAs, were generously provided by
Dr. Milton  Schlesinger (Washington University, St. Louis, MO,  USA). In the first
acylation mutant, the transmembranal cysteine at E1 position 430 had been substituted
for an alanine (E1:C430A), which results in an almost complete lack of palmitoylation of
E1 and a minor reduction in  palmitoylation of E2 (26). In the second mutant, the
cysteines at E2 positions 388 and 390 had been substituted for  alanines (E2:C388A-
C390A), resulting in a reduction of E2 palmitoylation by about 70% and a reduction in E1
palmitoylation by about 50% (26). The third mutant, with all three  transmembrane
cysteine mutations in E1 and E2 (E1:C430A/E2:C388A-C390A), lacks E1 palmitoylation
completely and has a residual 30%  palmitoylation of E2 (26). The residual fatty acid
binding to E2 in the presence of the C388A and C390A mutations is presumably due to
acylation at other cysteine residues in the cytoplasmic domain of the protein (12).
Production and characterization of virus particles. For the production of virus
particles, RNA was synthesized and transfected into baby hamster kidney cells (BHK-21)
by electroporation, as described previously (16). Viruses released from cells at 20 h post-
transfection were harvested, and these stocks were subsequently used directly for the
production of pyrene- and [35S]methionine-labeled viruses, essentially as described before
for  Semliki Forest Virus (SFV) or SIN (2, 21, 30). The concentration of the virus
preparations was determined by lipid phosphate (1) and protein (23) analysis. The purity
of the virus particles was confirmed by SDS-PAGE. Viral infectivity was determined by
titration on BHK-21 cells in 96-well plates.
Preparation of liposomes. Liposomes (large unilamellar vesicles) were prepared in 5
mM  Hepes, 150  mM  NaCl, 0.1  mM EDTA, pH 7.4 (HNE) by subjection of lipid
mixtures, dried from chloroform solution, to five cycles of freezing and thawing and
subsequent extrusion (10) through 0.2 µM filters (Nuclepore Inc., Pleasanton, CA, USA)
in a  LiposoFast mini-extruder ( Avestin, Ottawa, Canada).  Liposomes consisted of
phospholipids (Avanti Polar Lipids, Alabaster, AL, USA) and cholesterol (Sigma Chem.
Co., St Louis, MO, USA). The phospholipids were phosphatidylcholine (PC) derived from
egg yolk, phosphatidylethanolamine (PE) prepared by transphosphatidylation of egg-PC,
and sphingomyelin (SPM) from egg yolk, mixed with cholesterol (Chol) in a molar ratio of
1:1:1:1.5.  Trypsin-containing liposomes were prepared likewise, only in this case lipids
were dispersed in HNE containing  10 mg/ml  trypsin ( Fluka  Chemie  Ag,  Buchs,
Switzerland). The trypsin-containing liposomes were separated from free trypsin by gel
filtration on a Sephadex G-100 column in HNE. The phospholipid concentration of the
liposome preparations was determined by phosphate analysis (1).
Fusion assays. Fusion of pyrene-labeled SIN with liposomes was monitored on-line
in an AB2 fluorimeter (SLM/Aminco, Urbana, IL), as described previously (30). Briefly,Membrane fusion of Sindbis virus deacylation mutants 125
pyrene-labeled SIN (0.5 µM viral phospholipid) and liposomes (200 µM phospholipid)
were mixed in a volume of 0.665 ml in HNE, in a quartz cuvette, magnetically stirred and
maintained at 37 °C. At t=0 s, fusion was initiated by the addition of 0.035 ml 0.1 M
MES, 0.2 M acetic acid, pretitrated with NaOH to achieve the final desired pH. The
fusion scale was calibrated such that the initial pyrene excimer fluorescence at 480 nm
represented 0% fusion. The 100 % fusion value was set after addition of 0.035 ml 0.2 M
octaethyleneglycol monododecyl ether (Fluka Chemie AG). The initial rate of fusion was
determined from the tangent to the first part of the curve. The extent of fusion was
determined 60 s after acidification.
Fusion of SIN with liposomes was also assessed using a contents mixing assay based
on degradation of the viral  capsid protein by  trypsin, initially encapsulated in the
liposomes (18, 30, 36). Briefly, [35S]methionine-labeled virus (0.5 µM phospholipid) was
incubated with  trypsin-containing PC/PE/SPM/Chol  liposomes (200 µM  liposomal
phospholipid) in presence of 125 µg/ml  trypsin inhibitor ( Boehringer, Mannheim,
Germany) in the external medium, at 37 °C. The mixture was acidified, under continuous
stirring, to the desired pH with 0.1 M MES, 0.2 M acetic acid, as described above. After
30 s, samples were neutralized by the addition of a pretitrated volume of 0.1 M NaOH,
and further incubated for 1 h at 37 °C. Subsequently, samples were analyzed by SDS-
PAGE, the protein bands being visualized by autoradiography. Quantification of the viral
proteins was done by  phosphorimaging analysis using Image  Quant 3.3 software
(Molecular Dynamics, Sunnyvale, CA, USA).
Results
Low-pH-dependent fusion of pyrene-labeled SIN with liposomes. Fusion
of SIN was measured on-line in a liposomal model system, using a lipid mixing
assay based on pyrene excimer fluorescence (2, 21, 30). In order to exclude any
potential effects of the fluorescence labeling procedure on the biological
properties of the virus, we first evaluated the specific infectivities of pyrene-labeled
Toto1101 and  acylation mutant SIN virus preparations. Viral  infectivity was
determined by titration on BHK-21 cells and related to the number of virus
particles present based on biochemical analyses (30). In all cases a particle to
infectious unit ratio of 4-5 was found, similar to that seen in unlabeled virus (data
not shown). These results demonstrate that neither the fluorescence labeling
procedure nor the presence of the acylation mutations in E1 and/or E2 had any
significant effect on the specific infectivity of the viruses.
The pyrene fusion assay relies on a decrease of pyrene excimer fluorescence
owing to dilution of  pyrene-labeled  phospholipids from the viral into the
liposomal membrane. This decrease can be translated directly to the extent of
fusion, since each individual fusion event results in a large dilution of the probe
and, thus, in an essentially complete disappearance of the excimer fluorescence
intensity of the virus particle involved. Figure 1 presents the fusion kinetics of
pyrene-labeled Toto1101 SIN virus with PC/PE/SPM/Chol liposomes. At pHChapter 7 126
4.6, the virus fused rapidly and efficiently with the liposomes, the extent of fusion
being approximately 55% at 10 s after acidification of the virus-liposome mixture
(curve a). With increasing pH, fusion became slower and less extensive (curves b,
c). At pH 7.4 there was no detectable fusion (curve d). We also measured fusion of
pyrene-labeled Toto1101 SIN virus with liposomes lacking either SPM or Chol or
both, and observed that fusion was absent (data not shown). These results indicate
that the membrane fusion activity of SIN derived from the Toto1101 infectious
clone is triggered by a mildly acidic pH and exhibits a similar overall lipid
dependence as fusion of wild-type SIN (laboratory-adapted strain AR339) (30) or
SFV (4, 21).
Figure 1. Low-pH dependent fusion of pyrene-labeled SIN derived from cDNA clone
Toto1101 with liposomes. Fusion of pyrene-labeled SIN Toto1101 with PC/PE/SPM/Chol
liposomes was measured on-line at 37 °C as described in Materials and Methods. Final
concentrations of virus and liposomes corresponded to 0.5 µM and 200 µM phospholipid,
respectively. Curves: a, pH 4.6; b, pH 5.0; c, pH 5.75; d, pH 7.4.
Fusion characteristics of SIN  acylation mutants. Figure 2 presents the
fusion kinetics of the three  acylation mutant SIN viruses, E1:C430A, E2:
388A/C390A, and E1:C430A/E2:C388-C390A, in comparison with the original
Toto1101 virus. Clearly, the fusion kinetics of the  acylation mutants  were
indistinguishable from those of the unmodified virus. Importantly, none of the
viruses had any significant fusion activity at neutral pH.
Figure 3 compares the detailed pH dependence of Toto1101 (open triangles)
and the  acylation mutant virus E1:C430A/E2:C388A-C390A (closed triangles).
Panel A shows the initial rate of fusion as a function of the pH, determined from
the tangent to the first part of the fusion curves. Rates were very similar for
unmodified and acylation mutant viruses in the entire pH range from pH 4.0 to
pH 7.4. Figure 3B presents the extent of fusion as function of the pH, measured
60 s after acidification. Again, throughout the pH range from 4.0 to 7.4, no
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differences were observed between the unmodified and  acylation mutant SIN.
Under optimal conditions, 18-20% of the virus particles fused within the first
second after acidification, with an extent of fusion of 60% at 60 s post-
acidification. The pH threshold for fusion was 6.2 for both viruses. The acylation
mutant viruses E1:C430A and E2:C388A-C390A gave essentially identical results
in terms of initial rate and extent of fusion (data not shown).
Figure 2. Low-pH dependent fusion of pyrene-labeled acylation mutant SIN viruses
with  liposomes. Fusion of  pyrene-labeled  acylation mutant viruses with  liposomes was
measured at pH 4.6 and 7.4, as described in the legend to Figure 1. Curves: a, SIN; b,
E1:C430A; c, E2:C388A/C390A; d, E1:C430A/E2:C388A/C390A .
Figure 3.  Comparison of the pH-dependent of fusion of  pyrene-labeled  acylation
mutant and SIN Toto1101 viruses. Fusion of SIN Toto1101 (open triangles) and the
acylation mutant virus, E1:C430A/E2:C388A/C390A (closed triangles) was determined at
different pH values, as described in the legend to Figure 1. (A) The initial rates of fusion were
determined from the tangent to the first part of the curve.  (B) The extents of fusion were
determined 60 s after acidification.
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Contents mixing of [35S]methionine-labeled SIN with trypsin-containing
liposomes. In the above experiments fusion was evaluated on the basis of lipid
mixing. Another, very stringent, criterion for fusion involves the coalescence of
the interior of the virus with the liposomal lumen. Contents mixing was assayed as
the degradation of the viral capsid protein by trypsin, initially encapsulated in the
liposomes. Figure 4A shows the capsid degradation of SIN Toto1101 and the
acylation mutant virus E1:C430A/E2:C388A-C390A. In both cases,
incubation of the virus with trypsin-containing liposomes at pH 4.6 resulted in the
Figure 4. Degradation of the viral capsid protein by trypsin, initially incorporated in
liposomes. The trypsin assay was carried out as described in the Materials and Methods. Final
concentrations of [ 35S]methionine-labeled virus and ( trypsin-containing) PC/PE/SPM/Chol
liposomes corresponded to 0.5 µM and 200 µM phospholipid, respectively. (A) Viral structural
proteins of SIN Toto1101 (lanes a-c) and acylation mutant E1:C430A/E2:C388A/C390A (lane
d-f), visualized by autoradiography. Lanes: a and d, trypsin-containing liposomes at pH 4.6; b
and e,  trypsin-containing  liposomes at pH 7.4; c and f, empty  liposomes at pH 4.6. (B)
Quantification of the extent of  capsid protein degradation on the basis of the ratio
C/[C+E1+E2] by  phosphorimaging analysis. The ratios C/[C+E1+E2] of the controls, in
which empty liposomes were incubated with the viruses under otherwise identical conditions,
were taken as the 100% values. Bars: shaded, SIN; open, E1:C430A/E2:C388A/C390A.
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degradation of a substantial fraction of the capsid protein (lane a, d).  At pH 7.4 no
capsid degradation was observed (lane b, e). The controls, in which the viruses
were incubated with empty liposomes at pH 4.6, did not show degradation of the
capsid protein either (lane c, f). The ratio of the radioactivity of the capsid band
relative to the total radioactivity (C+E1/E2) of the samples incubated at pH 7.4
and the control samples with empty liposomes was close to 0.4, as expected on the
basis of the number of methionine residues in the SIN structural proteins (33).
Complete degradation of the capsid protein was observed when Triton X-100 was
added to the reaction mixture, in the absence of  trypsin inhibitor (results not
shown). Figure 4B shows the extent of capsid degradation as function of the pH,
quantified by  phosphorimaging. For SIN Toto1101, incubated at pH 4.6,
approximately 70% of the capsid protein was degraded, while at pH 5.0 and pH
5.5 the corresponding numbers were 41% and 19%, respectively. With the triple
acylation mutant virus, E1:C430A/E2:C388A-C390A, we detected an extent of
capsid degradation of 72% at pH 4.6, 45% at pH 5.0, and 25% at pH 5.5. Similar
results were obtained with the separate E1 or E2 acylation mutant viruses (results
not shown). The extents of capsid protein degradation seen in the pH range from
4.6 to 5.5 (Figure 4B) are very similar to the corresponding extents of lipid mixing
observed in the pyrene fluorescence assay (Figure 3B).
Discussion
The results presented in this paper demonstrate that SIN derived from the
infectious clone Toto1101 fuses rapidly and efficiently with receptor-free
cholesterol- and sphingolipid-containing liposomes in a strictly low-pH-dependent
manner. Fusion was evaluated on the basis of both membrane lipid mixing and
internal contents mixing between the virus and the  liposomes. The pH
dependence of fusion of the Toto1101 virus is very similar to that of the wild-type,
laboratory-adapted, SIN strain AR339 (30) and argues strongly for a cell entry
mechanism of SIN involving receptor-mediated  endocytosis and acid-induced
fusion of the viral envelope with the  endosomal membrane. This is entirely
consistent with recent observations of Glomb-Reinmund and Kielian (8). These
investigators showed that infection of BHK-21 cells by SIN is inhibited by agents
that interfere with  endosomal acidification, such as NH4Cl,  balifomycin or
concanamycin. Further support for a cell entry mechanism of SIN involving
receptor-mediated endocytosis has been provided by DeTulleo and Kirchhausen
(5), who observed that BHK-21 cell infection by SIN is affected by a mutated
form of  dynamin which inhibits the budding of  clathrin-coated vesicles.
In the light of this fairly convincing evidence, it is intriguing that quite recently
(9) Brown  and  coworkers  have presented data which support their previous
suggestion (3, 6) that exposure to an acidic pH may not be an obligatory step in
the infection of cells by  alphaviruses. These investigators observed that theChapter 7 130
infection of mosquito cells by SIN was not blocked by  choloroquine under
conditions such that the drug did raise the pH of the endosomal compartment of
the  cells (9).  Although it is possible that  alphaviruses use different routes of
infection in vertebrate and insect cells, our previous (2, 21, 30, 35) and present
studies in model systems, designed to specifically address the issue of alphavirus
fusion activation, strongly argue for exposure to a mildly acidic pH being an
essential step in the triggering of the fusion process.
The principal result of this study demonstrates that  acylation of the
transmembrane domains of the SIN glycoproteins E1 and E2 is not required for
expression of viral membrane fusion activity. Indeed, deacylation of E1 and/or E2
has no effect on the kinetics or the detailed pH dependence of the fusion process.
This conclusion is in agreement with similar results obtained for other enveloped
viruses, such as vesicular  stomatitis virus (37) and human and simian
immunodeficiency viruses (39). The potential role of acylation in the membrane
fusion activity of influenza HA however, remains controversial. HA-mediated
fusion has been studied extensively in cultured cells expressing the isolated HA,
with erythrocytes or erythrocyte ghosts serving as target membranes. In such
systems, deacylation of HA does not affect membrane lipid mixing, as measured
by fluorescence dequenching of the fluorophore R18 (7, 24). Likewise, deacylation
has been observed to have little effect on syncytia formation mediated by HA
expressed on the cell surface (32, 34). By contrast, other investigators have
reported distinct effects of deacylation of HA on various stages of the fusion
process, including initial fusion pore flickering (17) and late fusion pore dilation as
assessed by syncytia formation (7, 19). It is possible that this apparent discrepancy
is, at least in part, a consequence of the fusion process being primarily studied in
HA-expressing cells rather than with virus. In these cell systems the surface density
of HA may vary considerably and also its biological activity may be affected when
it is expressed in the absence of the M2 protein (22). It is a major advantage of our
present study that it involves the use of whole virus derived from a cDNA clone,
rather than SIN envelope glycoproteins expressed on the surface of cultured cells.
Similar approaches followed for influenza, involving reverse genetics and the
generation of mutant  virions however, have again resulted in conflicting
conclusions.  Zurcher et al. (40) reported that  deacylation of HA affects virus
assembly, whereas little effect on either assembly or infectivity was observed by
others (13, 14, 38).
With regard to alphaviruses, SIN in particular, the lack of effect of E1 and/or
E2 deacylation on viral membrane fusion activity, reported here, and the limited
effects on virus assembly and release (28) explain the observation made by us in
the present study and by others before (28) that deacylation mutant viruses are
fully infectious on cultured cells, exhibiting specific infectivity values. On the other
hand, the conserved nature of the cysteine residues in the transmembrane domains
of the E1 and E2 envelope glycoproteins suggests that fatty acid modification ofMembrane fusion of Sindbis virus deacylation mutants 131
these proteins has an important function in the life cycle of alphaviruses. Our
present results suggest that this biological function is not at the level of the low-
pH-induced virus membrane fusion process.
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Abstract
The spike glycoprotein E2 of Sindbis virus (SIN) is synthesized in the infected
cell as a PE2 precursor protein, which matures through cleavage by a cellular furin-
like protease. Previous work has shown that SIN mutants, impaired in PE2
cleavage, are non-infectious on BHK-21 cells, the block in infection being localized
at a step after virus-receptor interaction but prior to RNA replication. Here, we
studied the membrane fusion properties of SIN PE2 cleavage mutants and
observed that these viruses are impaired in their ability to form an E1 homotrimer
and to fuse with liposomes at a mildly acidic pH. The block in spike rearrangement
and fusion could be overridden by exposure of the mutant viruses to very low pH
values (pH < 4.5). Cleavage mutants with second-site resuscitating mutations in
PE2 were highly infectious for BHK-21 cells. The ability of these viruses to form
E1 homotrimers and to fuse at a mildly acidic pH was completely restored, despite
a sustained lack of PE2 cleavage.Membrane fusion of Sindbis virus PE2 cleavage mutants 137
Introduction
Alphaviruses, such as Sindbis virus (SIN) and Semliki Forest virus (SFV), are
enveloped viruses which contain three major structural proteins, the capsid protein,
C, and two envelope  glycoproteins, E2 and E1 (38). The  glycoproteins are
organized on the surface of the  virion in 80  hetero-oligomeric spikes, which
mediate the infectious entry of these viruses into cells. The E2 glycoprotein is
primarily involved in the interaction of a virus particle with cell surface attachment
receptors (37), whereas the E1  glycoprotein is necessary for the subsequent
membrane fusion process (8, 40). Very recent crystallographic and cryoelectron
microscopy studies have revealed that E1 in many respects resembles the flavivirus
E glycoprotein. The alphavirus E1 protein appears to lie flat on the viral surface
which drives lateral spike interactions, whereas E2 forms the spike protrusions (21,
30).
In the infected cell, the alphavirus structural proteins are translated as a large
polyprotein. Once the C protein is cleaved off, the NH2-terminus of PE2, the
precursor protein of E2 (PE2 is called p62 in SFV), serves to direct the
cotranslational translocation of the remaining  polyprotein to the endoplasmic
reticulum (ER) (38). This polyprotein is processed by signal peptidase within the
ER, and the two envelope proteins associate to form PE2/E1 heterodimers (38).
The PE2/E1 heterodimer matures further while passing through the Golgi and
trans-Golgi network (TGN). In the TGN or in a post-Golgi compartment PE2 is
cleaved close to its amino-terminus to form E2 and a residual peptide E3 (24). PE2
cleavage is mediated by a  furin-like host protease at a consensus recognition
sequence XBXBBX close to the amino-terminus, in which B is a basic and X a
hydrophobic amino acid (18). The peptide E3, which contains the XBXBBX
sequence, is retained on the SFV spike, but it is released in the case of SIN (24, 28).
Several investigators have shown that the efficiency of PE2 cleavage can be
influenced by amino-acid changes within the cleavage site (5, 13, 14, 19, 22, 34, 39).
Thus, a number of PE2 cleavage mutants of SIN, SFV, and Venezuelan Equine
Encephalitis virus (VEE) have been identified, and these viruses appear to have
defects in one or more biological functions due to the presence of uncleaved PE2.
For example, in SFV, cleavage of p62 was prevented by replacement of Arg by Leu
at position -1 of E2 (34). This p62 cleavage mutant virus (mL) was found to be
non-infectious on BHK-21 cells. The block in infection appeared to involve both
the virus-receptor interaction and fusion activity of the mutant virus. Viral
infectivity on BHK-21 cells was restored by in vitro cleavage of p62 with trypsin or
by exposure of the virus to very low pH values (22, 34, 40). Likewise, several SIN
PE2 cleavage mutants have been shown to be non-infectious.  For example,
replacement of the Arg or Ser residues at position 1 of E2 (the last amino acid of
the XBXBBX cleavage site) by an Asn residue within the context of the infectious
clones TRSB (corresponding to a laboratory-adapted strain of SIN) or TR339Chapter 8 138
(containing the consensus sequence of wild type SIN) almost completely blocked
viral infectivity (13, 14, 19, 25). SIN cleavage mutants in which part of the cleavage
site was deleted were also found to be essentially non-infectious for BHK-21 cells
(19).
Interestingly, it has been found that the lethality of PE2 cleavage mutation in
TRSB-N ( Arg-to-Asn substitution at position 1 of E2) could be reversed by
resuscitating second-site mutations in PE2 (14). These investigations showed that
after infection with TRSB-N  virions occasionally small plaques were formed.
Sequence analysis of the purified plaques revealed that some of these viruses
carried second-site mutations in PE2, but yet remained cleavage-deficient. While
these PE2 cleavage mutants with a resuscitating mutation in PE2 were found to be
infectious on BHK-21 cells, the viruses appeared to have an attenuated virulence in
CD-1 mice, as compared to the parental TRSB virus.
Recent data showed that the block in infection of PE2 cleavage-deficient SIN
viruses without second-site resuscitating mutations, is not at the level of the initial
virus-receptor interaction (19). By contrast, SIN PE2 cleavage mutants with an
intact cleavage site, bind very efficiently to BHK-21 cells, even better than the
parental TR339 virus. It has been shown that, the presence of the basic XBXBBX
sequence mediates an efficient interaction with  heparan sulfate (HS), which is
abundantly expressed on BHK-21 cells and thus acts as a receptor for the virus (4,
20). Furthermore, it has been shown that the presence of uncleaved PE2 in virions
does not influence RNA replication, or virus assembly and release (14, 19). Taken
together, these data indicate that the block in infection of these SIN PE2 cleavage
mutants lies downstream of the interaction of a virus particle with a cellular
receptor but prior to RNA replication, suggesting that these mutant viruses are
impaired in their membrane fusion properties.
Here, we studied the fusogenic properties of PE2 cleavage mutants, based on
the infectious clone TR339, using a liposomal model system. PE2 cleavage mutants
in which either the Ser residue at position 1 of E2 was replaced by Asn (E2:N1) or
from which the BXBB sequence within the PE2 cleavage site was deleted (FDF)
were used. The results show that PE2 cleavage mutants were unable to fuse with
liposomes at pH 5.0, indicating that the block in infection lies at the level of the
fusion process. Incubation of PE2 cleavage mutants at low pH demonstrated that
the viruses were impaired in their ability to form an E1 homotrimer, the fusion-
active conformation of the viral spike protein. The block in rearrangement and
fusion could be overridden by exposure of the virus to very low pH values (pH <
5.0). Furthermore, E2:N1 cleavage mutants with resuscitating mutations in PE2
were generated, analogous to those identified in TRSB-N, and found to be
infectious in BHK-21 cells. These PE2 resuscitated mutant viruses do form E1
homotrimers at a physiologically relevant acidic pH, despite the lack of PE2
cleavage. Accordingly, their membrane fusion activity appeared to be completely
restored.Membrane fusion of Sindbis virus PE2 cleavage mutants 139
Materials and Methods
Constructs. The construction of the cDNA clones pTR339, pE2:N1 (called p39N1 in
previous articles), and  pFDF has been described previously (19, 20). The “p” prefix
indicates the cDNA form of the virus clone. The cDNA pE2:N1/E3:R25 was constructed
by substitution into pE2:N1 of an AatII-to-StuI fragment from pTRSB-E3R25 (14). The
cDNA clones pE2:N1/T191 and pE2:N1/G216 were constructed by substitution into
pE2:N1 of an StuI-to-BssHII fragment from pTRSB-NE2T191 resp. pTRSB-NE2G216
(14). The introduced mutations were confirmed by DNA sequence analysis at the
University of North Carolina at Chapel Hill Automated Sequencing Facility with a 373A
DNA sequencer with the  Taq  DyeDeoxy terminator cycle sequencing kits (Applied
Biosystems).
Production and characterization of pyrene- and [ 35S]methionine-labeled virus
particles. Viruses were produced on BHK-21 cells. The cells were cultured in Glasgow’s
modification of Eagle’s minimal essential medium (Gibco/BRL, Breda, The Netherlands),
supplemented with 5% foetal calf serum (FCS), 10% tryptose phosphate broth, 200 mM
glutamine, 25 mM Hepes, and 7.5% sodium bicarbonate. For the production of pyrene-
labeled virus particles, BHK-21 cells, prior cultured for 48 h on medium containing 10
µg/ml 16-(1-pyrenyl)hexadecanoic acid (pyrene fatty acid; Molecular Probes, Eugene, OR,
USA), were transfected, by electroporation, with in vitro transcripts of linearized cDNA
clones. Pyrene-labeled SIN particles released from the cells at 20 h post-transfection were
harvested and purified from the medium, as described before (3, 27, 36). For the
production of [35S]methionine-labeled virus particles, BHK-21 cells were transfected with
in vitro transcribed viral RNA by electroporation, essentially as previously described (3, 27,
36). Briefly, at 3-4 h post-transfection, the culture medium was replaced by methionine-free
DMEM (Gibco/BRL) supplemented with 5% FCS and 200  mM  glutamine. After 2 h
starvation, 200 µCi/5 ml [ 35S]methionine was added to the medium and incubation was
continued overnight.  At 20 h post-transfection [35S]methionine-labeled viral particles were
harvested and purified from the medium, as described before (3, 27, 36, 43). The purity of
the produced virus particles was analyzed with SDS-PAGE. Visualization of the protein
bands and quantification of the PE2 content in virions were done by phosphorimaging
analysis using Image Quant 3.3 software (Molecular Dynamics, Sunnyvale, CA, USA). The
percentage PE2 in virions was determined, by relating the intensity of PE2 to the total
intensity of E1, PE2 and E2, corrected for the contribution of E1 on the basis of the
relative numbers of methionine residues in the E1, E2 and PE2 proteins (19, 32). The
specific  infectivity (PFU/cpm) was calculated for all batches [ 35S]methionine-labeled
viruses by plaque assay on BHK-21 cells (20).
Binding assays. Virus attachment to BHK-21 cells and heparin- and bovine serum
albumin (BSA)-agarose beads (both from Sigma Chemical Co, St. Louis, MO, USA) was
performed, essentially as described previously (19, 20). Briefly, BHK-21 cells (cultured in a
12-well plate; Costar, Cambridge, MA, USA) were washed two times with cold 5 mM
Hepes, 150 mM NaCl, 0.1 mM EDTA, pH 7.4 (HNE) + 1% fetal calf serum (HNE+).
Subsequently, 150 µl [35S]methionine-labeled virus particles were added to the cells (ranging
from 106 to 107 cpm ~ approx. 109 to 1010 virus particles) and incubation was continued at
4 °C for 2 h with gentle agitation. The cells were then washed twice with HNE+ and
trypsinized with 1*Trypsin/EDTA ( Gibco/BRL). For binding to heparin-agarose andChapter 8 140
BSA-agarose beads, 1 ml of beads was washed with HNE+ three times, and resuspended
in 1 ml HNE+. Fifty microliters of beads were added to 50 µl virus particles, similar to that
of the cell binding assay, and incubated for 2 h at 4 °C with gentle agitation. Subsequently,
the mixtures were washed three times with HNE+, and resuspended in 0.6% triton (Sigma)
in HNE. Viral radioactivity was quantified by liquid scintillation analysis. Control reactions
with no added virus were performed for each binding experiment, the cpm counted was
subtracted from total cpm bound.
Preparation of liposomes. Liposomes (large unilamellar vesicles) were prepared by
freeze/thaw extrusion as described before (3, 27, 36, 43). Briefly, lipid mixtures, dried from
chloroform/methanol, were hydrated in HNE and subjected to five cycles of freezing and
thawing. Subsequently, the suspension was extruded 21 times through two 0.2 µM filters
(Nucleopore, Inc., Pleasanton, CA, USA) in a LiposoFast mini-extruder (Avestin, Ottawa,
Canada).  Liposomes consisted of  phosphatidylcholine (PC)/phosphatidylethanolamine
(PE) / sphingomyelin (SPM)/Cholesterol ( Chol) with a molar ratio of 1:1:1:1.5. The
phospholipids were obtained from  Avanti Polar lipids (Alabaster, AL, USA) and
cholesterol from Sigma. The phospholipid concentration of the liposomes was determined
by phosphate analysis (2).
Fusion assay. Fusion of pyrene-labeled SIN with liposomes was monitored on-line in
an AB2 fluorimeter (SLM/Aminco, Urbana, IL, USA), at 37 ºC (3, 27, 36, 43). In the
fusion reaction, pyrene-labeled SIN (approx. 1010 particles) was continuously mixed with
an 5-fold excess of liposomes in a final volume of 0.665 ml in HNE. At t=0 s, fusion was
initiated by the addition of 35 µl 0.1 M MES (morpholinoethanesulfonic acid)-0.2 M acetic
acid,  pretitrated with  NaOH to achieve the final desired pH. The fusion scale was
calibrated such that 0% fusion corresponded to the initial pyrene-excimer fluorescence
level and 100% fusion to the fluorescence value obtained after the addition of 35 µl 0.2 M
octaethyleneglycol monododecyl ether (Fluka Chemie AG, Buchs, Switzerland) (3, 27, 36,
43). The extent of fusion was determined 60 s after acidification.
Analysis of the conformational changes in the viral spike protein.  The
conformational changes occurring in the viral spike protein were examined under the same
conditions as in the fusion experiments (3, 36). After the indicated pH treatment, samples
were neutralized by addition of a pretitrated volume NaOH, solubilized in SDS-PAGE
sample buffer, and analyzed by SDS-PAGE. Running gels were further incubated for 30
min in 1 M sodium salicylate and dried. Visualization and quantification of the E1 trimer
was done by phosphorimaging analysis, as mentioned above, by relating the intensity of the
E1  trimer to the total intensity of E1, PE2, E2 and E1  trimer, corrected for the
contribution of PE2 or E2 on the basis of the relative numbers of methionine residues in
the E1, E2 and PE2 proteins.
Results
Characterization of PE2 cleavage mutant SIN viruses. In this study we
investigated the membrane fusion activity of a number of SIN PE2 cleavage
mutant viruses. PE2 cleavage mutations were introduced into the background of
the infectious SIN clone TR339. Two mutants were chosen that have previously
been shown to affect PE2 cleavage efficiency (Table 1 ; 19). In the mutantMembrane fusion of Sindbis virus PE2 cleavage mutants 141
construct, designated E2:N1, the Ser residue at position 1 of E2 is replaced by an
Asn residue. This residue creates an N-linked  glycosylation signal, and the
glycosylation of the Asn residue at position 1 of E2 is proposed to interfere with
furin activity (19).  SDS-PAGE analysis of the E2:N1 mutant showed that indeed
PE2 cleavage was completely inhibited. Furthermore, the virus was poorly
infectious, as determined by plaque assay on BHK-21 cells. Likewise, the FDF
mutant, in which the BXBB sequence was deleted, incorporated 100% uncleaved
PE2 and also had a very low specific infectivity (Table 1).
The first step in viral entry is the interaction of a virus particle with a cellular
receptor.  Consistent with previous reports (20), we found that TR339 virus does
not bind very efficiently to BHK-21 cells (Figure 1A). The FDF mutant bound
equally poorly to BHK-21 cells. On the other hand, the E2:N1 virus did bind
efficiently to BHK-21 cells. Recent data have demonstrated that SIN viruses with
an intact cleavage site interact with HS, a cellular receptor which is abundantly
expressed on BHK-21 cells (19).  Accordingly, we found that the E2:N1 mutant
bound efficiently to heparin-agarose beads (Figure 1B). In a control, in which
albumin-agarose beads were used, none of the viruses bound to the beads (data not
shown). Since the two mutant viruses, as compared to TR339, bind similarly (FDF)
or much better (E2:N1) to BHK-21 cells, it is clear that the block in infection for
these mutants lies after binding of the virus particle to the cell surface, presumably
at the level of the viral membrane fusion process.
Fusion activity of pyrene-labeled PE2 cleavage mutant SIN viruses. To
study the fusogenic properties of the PE2 cleavage mutants, we used SIN variants
biosynthetically labeled with the fluorescent probe  pyrene. Because the mutant
viruses are almost non-infectious, RNA transcripts derived from the cDNA were
transfected directly into BHK-21 cells, cultured beforehand in the presence of
pyrene fatty acid. At 20 h post-transfection the pyrene-labeled virus particles were
Virus    Amino acids at PE2 Furin cleavage   % PE2   BHK specific
                 cleavage site    site              infectivitya
TR339      G  R  S  K  R S  Intact 4  18
FDF         G  -    -   -    -   S Deleted  100    0.5
E2:N1      G  R  S  K  R N Intact 100    1.5
a (PFU/cpm)
TABLE 1. Characterization of PE2 cleavage mutant Sindbis virusesChapter 8 142
Figure 1. Binding of PE2 cleavage-deficient SIN viruses to BHK-21 cells or heparin-
agarose beads. Approx. 1010 [35S]methionine-labeled virus particles were added to the cells or
beads and binding was measured after 2 h incubation at 4 °C, as described in Materials and
Methods. Each bar represent the mean of triplicate binding assays. Each set of triplicates was
repeated three times. The error bars represent standard deviations. (A) Binding to BHK-21
cells. (B) Binding to heparin-agarose beads.
harvested and purified from the medium (3, 27, 36). With this procedure no
additional passage of the virus is involved, thereby minimizing the possibility of
generating  revertant viruses. Subsequently, fusion of  pyrene-labeled SIN was
measured in a liposomal model system (3, 27, 36). Upon fusion of pyrene-labeled
virus particles with target liposomes, the pyrene phospholipids are diluted into the
liposomal membrane, resulting in a decrease of  pyrene  excimer fluorescence
intensity. For this assay, liposomes were prepared with an average diameter of 200
nm. Figure 2 presents the results. SIN derived from the infectious clone TR339
fused rapidly and efficiently with the liposomes at pH 5.0 (curve a), 60% of the
virus fusing within 60 s after acidification. No fusion was seen at neutral pH (data
not shown). In contrast to TR339, PE2 cleavage mutant E2:N1 hardly fused with
the liposomes at pH 5.0 (curve b). At 60 s after acidification to pH 5.0, an extent of
fusion of only 7% was observed.  Like E2:N1, PE2 cleavage mutant FDF, was
unable to fuse at pH 5.0 (curve c).
Construction and characteristics of viable E2:N1 revertants. Using SIN
PE2 cleavage mutant TRSB-N, Heidner et al. (14) showed that after infection of
cells with TRSB-N virions occasionally small plaques were formed. These viruses
were found to be infectious  revertants either with a restored PE2 cleavage
phenotype or with second-site mutations in PE2 along with retention of the PE2
cleavage defect.
Some of the second-site resuscitating mutations, identified in TRSB-N, were
now introduced into the E2:N1 PE2 cleavage mutant virus, i.e. in the TR339
background. In the first mutant, E2:N1/T191, the Pro residue (CCG) at position
191 of E2 was replaced by a Thr (ACG). In the second mutant, E2:N1/G216, the
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Figure 2. Fusion of PE2 cleavage-deficient SIN viruses with liposomes at pH 5.0. On-
line fusion experiments, with pyrene-labeled viruses, were performed at 37 °C, as described in
Materials and Methods. All fusion measurements were repeated at least three times. Approx.
1010 virus particles were mixed with a 5-fold excess of  liposomes, consisting of
PC/PE/SPM/Chol (molar ratio 1:1:1:1.5). Curve a, TR339; curve b, E2:N1; curve c, FDF.
Glu residue (GAA) at position 216 of E2 was replaced by a Gly (GGA). In the
third mutant, E2:N1/E3:R25, the Cys residue (TGT) at a position corresponding
to position 25 of E3 was replaced by an Arg (CGT). We were interested in whether
the introduced mutations promoted viral viability and membrane fusion capacity,
with retention of the PE2 cleavage-defective phenotype.
First, PE2 cleavage of each of the mutants was determined by SDS-PAGE
analysis of [ 35S]methionine-labeled protein from purified particles (Table 2). In
agreement with earlier observations on the corresponding TRSB-N revertants (14),
all of the second-site mutant viruses maintained the defect in PE2 cleavage. On the
other hand, the specific infectivities of the mutants were increased by a factor of
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Virus                  Substitution                               % PE2          BHK specific
mutation                    infectivitya
E2:N1                                           100                  1.5
E2:N1/T191 E2 position 191 Pro ﬁ Thr       100               230
E2:N1/G216 E2 position 216 Glu ﬁ Gly       100               136
E2:N1 E3:R25 E3 position   25 Cys ﬁ Arg       100               160
a (PFU/cpm)
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approx. 150-200, compared to the parental E2:N1 virus (Table 2). Thus, all three
resuscitating mutations restored virus viability while retaining the PE2 cleavage-
deficient phenotype. It is noteworthy, that the specific  infectivities of the
resuscitated mutants (Table 2) were significantly higher than the specific infectivity
of the TR339 virus (Table 1).
To determine whether the high specific infectivity of the resuscitated mutants
was due to an improved binding of these viruses to BHK-21 cells, cell-binding
assays were performed. Figure 3A shows the results. As indicated above (Figure 1),
the E2:N1 virus binds efficiently to BHK-21 cells. Likewise, the resuscitated
mutants E2:N1/T191, E2:N1/G216, and E2:N1/E3:R25 also bound very
efficiently to BHK-21 cells. Clearly, all PE2 cleavage-deficient mutants, retaining
the XBXBBX sequence, bind better to BHK-21 cells than TR339, explaining the
higher specific  infectivity of the resuscitated mutants.  Since the resuscitated
mutants are still PE2 cleavage-deficient, retaining the XBXBBX furin cleavage site,
it is likely that these viruses bind to HS on BHK-21 cells (19). To investigate this
Figure 3.  Binding of PE2 cleavage-deficient second-site resuscitated SIN viruses to
BHK-21 cells or heparin-agarose beads. Binding was measured after 2 h incubation at 4 °C,
as described in the legend to Figure 1. Bars: a, E2:N1; bars b, E2:N1/T191; bars c,
E2:N1/G216; bars d, E2:N1/E3:R25. (A) Binding to BHK-21 cells. (B) Binding to heparin-
agarose beads.
directly, we determined the binding capacity of the resuscitated mutants for
heparin- versus albumin-agarose beads. All viruses appeared to bind efficiently to
the heparin-beads (Figure 3B). None of the viruses bound to albumin-beads (data
not shown). Taken together, PE2 cleavage-deficient resuscitated viruses are
infectious, and have a high specific infectivity on BHK-21 cells, presumably due to
an interaction of the  uncleaved PE2 with HS on the cell surface. The high
infectivity of the resuscitated mutant viruses, as compared to the low infectivity of
the parent E2:N1 virus, suggests that the second-site mutations somehow restore
the fusion capacity of these viruses. This question was addressed subsequently.
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Fusion activity of  pyrene-labeled PE2 cleavage mutant SIN viruses
carrying a resuscitating mutation in PE2. Figure 4 presents the fusion kinetics
of pyrene-labeled PE2 resuscitated cleavage mutant SIN viruses with liposomes at
pH 5.0. The E2:N1/T191 mutant fused efficiently with liposomes, the extent of
fusion being about 55% within 60 s (curve a). The E2:N1/G216 and
E2:N1/E3:R25 mutants also fused efficiently with liposomes at pH 5.0 (curves b,
c). Again, the E2:N1 virus was unable to fuse at pH 5.0 (curve d). Thus, it appears
that, as a result of a single amino-acid substitution, the non-infectious PE2
cleavage-deficient E2:N1 virus regains  infectivity due to restoration of its
membrane fusion competence, despite retention of the uncleaved PE2 phenotype.
Figure 4. Fusion of PE2 cleavage-deficient SIN viruses with liposomes. On-line fusion
experiments were performed at 37 °C, as described in the legend to Figure 2. Curve a,
E2:N1/T191; curve b, E2:N1/G216; curve c, E2:N1/E3:R25; curve d, E2:N1.
PE2 cleavage mutant SIN viruses show an acidic pH-shift in the
activation of membrane fusion. Previous work, based on SFV, showed that the
block in infection of the p62 cleavage mutant  mL ( Arg-to-Leu substitution at
position –1 of E2) could be overridden by exposure of the virus to a very low pH
(34). Therefore, we were interested in whether incubation at a very low pH could
activate fusion activity of PE2 cleavage mutant SIN.
Figure 5A presents the fusion kinetics of several pyrene-labeled PE2 cleavage
mutants at pH 4.0 in the liposomal model system. As expected, the resuscitated
mutant E2:N1/T191 (curve a) fused efficiently, with fusion kinetics identical to
those of the TR339 virus (curve b). Importantly, however, under these extreme pH
conditions the non-infectious E2:N1 and FDF mutants were able to fuse as well
(curve c, d). As a control, the different pyrene-labeled SIN viruses were incubated
at pH 4.0 in the absence of  liposomes. In all cases, the fluorescence intensity
remained constant, demonstrating that, also under these extreme pH conditions,
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the decrease in pyrene excimer fluorescence intensity observed in the presence of
liposomes was due to dilution of the fluorescent probe from the viral membrane
into the liposomal membrane (data not shown). These results demonstrate that the
PE2 cleavage mutants FDF and E2:N1 are fusion-competent, but only when the
viruses are exposed to an unphysiologically low pH.
Figure 5B shows the detailed pH dependence of fusion of SIN PE2 cleavage
mutants with  liposomes. For TR339, optimal fusion was observed at pH 5.0
(squares). The threshold for fusion was pH 6.25, similar to that of the laboratory-
adapted SIN strain AR339 (36). The PE2 cleavage mutants FDF (diamonds) and
E2:N1 (circles) showed a clear-cut downward shift in the pH dependence of
fusion, with a threshold at pH 5.0. Only at very low pH values fusion of these
viruses was fast and extensive. Interestingly, an intermediate pH dependence was
observed for the resuscitated mutant viruses E2:N1/T191 (upward triangles) and
E2:N1/G216 (downward triangles). The other resuscitated mutant virus,
E2:N1/E3:R25, showed a comparable pH dependence to that of the E2:N1/T191
and E2:N1/G216 mutants (data not shown). The threshold for fusion was very
close to pH 5.75 for all cleavage-deficient SIN viruses with a resuscitating mutation
in PE2. Taken together, SIN PE2 cleavage mutants exhibit an acidic pH-shift in
their ability to fuse with  liposomes, and resuscitating mutations in PE2 partly
reverse this pH-shift.
Figure 5.  Low-pH dependent fusion of PE2 cleavage-deficient SIN viruses with
liposomes. On-line fusion experiments were performed, as described in the legend to Figure 2.
(A) Curve a, E2:N1/T191; curve b, TR339; curve c, E2:N1; curve d, FDF. (B) The extent of
fusion was determined 60 s after acidification. Line (n) TR339; line (s) E2:N1/T191; line (t)
E2:N1/G216; line (l) E2:N1; line (u) FDF.
Time (s)
0 20 40 60
0
20
40
60
F
u
s
i
o
n
 
(
%
)
a
,
b
c
d
A
E
x
t
e
n
t
 
o
f
 
f
u
s
i
o
n
 
(
%
)
p
H
5.5 5.0 6.0 4.5 4.0 6.5 7.5
B
0
20
40
60Membrane fusion of Sindbis virus PE2 cleavage mutants 147
Rearrangement of the spike heterodimer is impaired in PE2 cleavage
mutants. Earlier studies on SFV and SIN have demonstrated that, under low-pH
conditions, the E2/E1  heterodimer dissociates and a  trypsin-resistant E1
homotrimer is formed. (3, 16, 29, 36, 40, 41). It is believed that the E1 homotrimer
is the fusion-active conformation of the viral spike protein (16, 40). To determine
whether the PE2 cleavage mutants were blocked in their ability to rearrange to the
fusion-active conformation, the conformational changes of the viral spike proteins
were studied.  [35S]Methionine-labeled virus was incubated at low pH in the
presence of liposomes. At 60 s after acidification the mixture was neutralized and
the appearance of the E1  homotrimer was analyzed on SDS-PAGE. Figure 6
shows the results. The spike protein of TR339 already rearranged to form an E1
homotrimer at pH 5.75. Under optimal conditions for fusion (pH 5.0), 76% of the
TR339 E1 protein was converted to the trimeric configuration. The PE2 cleavage
mutants FDF and E2:N1 showed a large pH shift in the formation of the E1
Figure 6.  E1  trimerization of PE2 cleavage-deficient SIN viruses at 37 °C and the
indicated pH values. Approx. 1010 [35S]methionine-labeled SIN particles were incubated with
an 5-fold excess of liposomes consisting of PC/PE/SPM/Chol (molar ratio 1:1:1:1.5). After 60
s, samples were neutralized and analyzed for the appearance of E1 trimers on SDS-PAGE, as
described in Materials and Methods.
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trimer. Clearly, with these viruses, at pH values of 5.0 or above no significant
trimer formation occurred. Only when these mutants were incubated at a very low
pH, the E1 spike protein rearranged to its trimeric configuration. By contrast, the
resuscitated cleavage mutant E2:N1/T191 did convert to an E1 homotrimer at pH
5.0. The extent of E1 trimerization increased by incubation at pH values lower
than pH 5.0. Similar results were obtained with the other resuscitated mutants,
E2:N1/G216 and E2:N1/E3:R25 (data not shown). These results suggest that the
PE2/E1 heterodimer of the PE2 cleavage mutants FDF and E2:N1 is stable at pH
5.0, rearranging to the fusion-active state only at very low, non-physiological, pH
values. On the other hand, the PE2/E1 heterodimer of the resuscitated viruses is
less stable than that of the parental E2:N1 virus and rearranges to a fusion-active
conformation at a physiological mildly acidic pH (pH 5.0).
Figure 7 presents a comparison of E1 trimerization and fusion for the PE2
cleavage mutant SIN viruses at different pH values. Clearly, there is a distinct
correlation between the appearance of the E1 homotrimer and the ability of the
virus to fuse with liposomes. Under optimal conditions for fusion, the extent of E1
trimerization and fusion of TR339 at 60 s after acidification were 76 and 59%,
respectively. At pH 5.75, already 64% of the E1 glycoprotein had rearranged to the
fusion-active conformation and half-maximal fusion was observed. On the other
hand, the PE2 cleavage mutant FDF, at pH 5.0, showed extents of E1
trimerization and fusion of only 5% and 3%, respectively. At pH 4.0, the FDF
mutant did become fusogenic, 70% of the E1 protein converting to a homotrimer,
and 40% of the virus particles fusing with  liposomes, under these conditions.
Likewise, the PE2 cleavage mutant E2:N1 showed little E1  trimerization and
fusion at pH 5.0 (6 and 8%, respectively), whereas at pH 4.0 the extents of E1
homotrimer formation and fusion for this virus were 70% and 43%, respectively.
At pH 5.0, the resuscitated mutant E2:N1/T191 showed extents of E1
trimerization and fusion of 38% and 49%, respectively. At a pH lower than 5.0, the
extent of E1 trimerization and fusion further increased. At pH 5.75, only a very
small amount (2%) of the E1 glycoprotein was converted to a homotrimer, and
accordingly fusion was negligible. Similar results were obtained for the other
resuscitated mutants, E2:N1/G216 and E2:N1/E3:R25 (data not shown). The pH-
threshold of fusion for TR339 is 6.2 (Figure 5B), which is 0.5 pH unit higher than
that of the resuscitated viruses. The resuscitated mutants clearly showed a pH shift
in the formation of an E1 homotrimer and fusion as compared to TR339. Taken
together, the lower stability of the PE2/E1  heterodimer of the resuscitated
mutants, as compared to the parental E2:N1 mutant, enables the virus to become
fusion-active under physiological pH conditions, consistent with the restored
infectivity of these viruses in BHK-21 cells.Membrane fusion of Sindbis virus PE2 cleavage mutants 149
Figure 7.  Relative pH-dependence of E1  trimerization and fusion for several PE2
cleavage-deficient SIN viruses. The extents of E1 trimerization (shaded bars) and fusion
(open bars)  are shown at 60 s post-acidification to the indicated pH values. To compare E1
trimerization and fusion, the final extents of these processes at pH 4.0, were set to 100%. (A)
TR339 (absolute extents: 76% E1 trimerization, 55% fusion). (B) FDF. (absolute extents: 70%
E1  trimerization, 40% fusion). (C) E2:N1. ( absolute extents: 70% E1  trimerization, 43%
fusion). (D) E2:N1/T191. ( absolute extents: 70% E1  trimerization, 56% fusion). E1
trimerization was determined as described in the legend to Figure 6. Fusion was measured as
described in the legend to Figure 2.
Discussion
In this paper, we provide evidence that the block in viral infectivity of SIN PE2
cleavage mutant viruses on BHK-21 cells lies at the level of the membrane fusion
activity of the viral envelope glycoprotein (Figures 2,6-7). Earlier studies on similar
SIN PE2 cleavage mutants had shown that viral infection in vertebrate cells was
not blocked at the level of virus-receptor interaction, RNA replication or virus
assembly (14, 19). Our present results show that SIN PE2 cleavage mutants are
impaired in their fusion activity because of the inability of the immature PE2/E1
heterodimer to rearrange to an E1 homotrimer, at a physiological acidic pH. The
E1  trimer has been shown to represent the fusion-active conformation of the
alphavirus spike (3, 11, 16, 36, 40). The lethality of SIN PE2 cleavage defect could
be overridden by second-site resuscitating mutations in PE2 (Table 2), which
destabilize the PE2/E1 heterodimer interaction. Thus, the spike regains the ability
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to form a fusion-competent E1  trimer at a physiologically relevant acidic pH
(Figures 4-7).
Among members of the alphavirus genus, PE2 cleavage has been associated
with different biological functions of the viruses involved. Recent work has shown
that SIN PE2 cleavage mutants with an intact cleavage site (XBXBBX) interact
electrostatically with HS, a glycosaminoglycan which is abundantly expressed on
BHK-21 cells (19). These findings are in agreement with our results, showing that
the E2:N1 mutant (with an intact cleavage site) binds efficiently to BHK-21 cells
and heparin-beads, as compared to the PE2 cleavage mutant FDF (with a deleted
cleavage site) (Figure 1). PE2 cleavage mutant E2:N1 binds much more efficiently
to BHK-21 cells than the parental SIN TR339, confirming that the TR339 virus
does not interact directly with HS (20). For SFV, p62 cleavage mutants have been
generated by mutation of the cleavage site from RHRR to RHRL (mL mutant) (22,
34) or SHQL (1, 39). In contrast to our PE2 cleavage-deficient SIN viruses, these
SFV mutants show a large reduction in binding capacity to BHK-21 cells, as
compared to wild-type SFV. However, in the case of SFV the cleavage site was
disrupted to create the p62 cleavage-deficient viruses. Therefore it is difficult to
interpret these results in the context of our present data on SIN mutants which are
known to bind to cells through the furin cleavage site. Despite the efficient binding
of the E2:N1 PE2 cleavage mutant to BHK-21 cells, the virus was still found to be
non-infectious,  due  to  its  inability  to  fuse ( Table 1;  Figure 2).  However,  after
introduction of resuscitating mutations in PE2 E2:N1 regained fusion competence
and infectivity on BHK-21 cells, as discussed in more detail below. Interestingly,
the specific infectivity of these viruses on BHK-21 cells was found to be very high,
even 10-fold higher than that of the parental TR339 (Table 2). Our results
demonstrate that the resuscitated PE2 cleavage mutants are more infectious than
TR339, very likely as a result of the more efficient interaction of these viruses with
HS (Figure 3).
The inability of cleavage mutants E2:N1 and FDF to fuse at a physiologically
relevant acidic pH appears to be caused by a downward shift in the pH dependence
of the viral membrane fusion reaction (Figure 5B). Within the overall process of
low-pH-dependent  alphavirus membrane fusion, the E2/E1  heterodimer first
dissociates, followed by formation of a trypsin-resistant E1 homotrimer (3, 11, 16,
36, 40). In the present study, it became clear that the PE2/E1 heterodimer of the
cleavage mutant viruses is too stable to rearrange to the fusion-active E1
homotrimeric conformation, at a physiologically relevant acidic pH (Figures 6-7).
However, when the viruses were incubated at pH 4.0, the spike did form an E1
homotrimer, resulting in expression of full membrane fusion activity (Figures 6-7).
In conclusion, the low specific infectivity of SIN PE2 cleavage mutants is the result
of an impairment of the viral spike to rearrange to the fusion-active conformation
at a mildly acidic pH, due to the high stability of the immature PE2/E1
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deficient mL mutant, showing that viral infectivity on BHK-21 cells was restored
by exposure of the virus to pH 4.5 (34).
Several investigators have identified second-site resuscitating mutations in the
E3, E2 or E1 glycoproteins which promote infectivity of PE2 cleavage-deficient
alphaviruses (5, 14, 39). Some of these resuscitating mutations, found with the
TRSB-N SIN clone (14), were now introduced in the E2:N1 virus to investigate
the role of these mutations in viral  infectivity versus the stability of the spike
heterodimer. These E2:N1 mutants with resuscitating mutations in PE2 were
indeed infectious on BHK-21 cells (Table 2), and at the same time exhibited a
restored membrane fusion capacity at a physiologically relevant acidic pH (Figures
4-5). In this respect it is important to note that viruses which do cleave PE2 and
interact efficiently with the cell attachment receptor HS are more infectious on
BHK-21 cells than the resuscitated PE2 cleavage-deficient viruses (20). This
indicates that SIN cleavage mutants with resuscitating mutations in PE2 have an
intermediate infectivity on BHK-21 cells, which in fact correlates precisely with the
intermediate pH dependence of their membrane fusion activity with  liposomes
(Figure 5B). For example, the TR339 virus with a PE2 cleavage-deficient
phenotype, is already fully fusion-competent at pH 5.5, whereas the resuscitated
PE2 cleavage mutant viruses express full membrane fusion activity only at pH
values of 5.0 or below. Analysis of the conformational changes occurring in the
viral spike protein showed that the PE2/E1 spikes of the resuscitated mutants
were able to form an E1 homotrimer at a physiological acidic pH, in contrast to the
heterodimer of the E2:N1 virus (Figure 6). In conclusion, the presence of the
resuscitating mutations in PE2 destabilizes the PE2/E1 heterodimer such that the
viral spike protein regains the ability to undergo conformational changes with
formation of a fusion-active E1  trimer at a physiological relevant pH, despite
retention of the uncleaved PE2 phenotype.
The maturation of the alphavirus spike heterodimer through cleavage of the
PE2 precursor of E2 has a distinct function in the viral life cycle. During transport
of the heterodimer from the ER to the surface of the infected cell, the uncleaved
PE2 protein is presumed to function as a chaperone, protecting the spike from
premature destabilization within the acidic TGN (9). Subsequently, after cleavage
of PE2 in a post-TGN compartment by a furin-like protease, the mature viral spike
protein is primed for expression of membrane fusion activity when exposed to a
mildly acidic pH within the endosomal compartment of a new target cell. The
results of this study indicate that, while cleavage maturation is a common
phenomenon in viral assembly, it is not absolutely required for viral infection. SIN
PE2 cleavage mutants with resuscitating mutations in PE2 were found to be
infectious on BHK-21 cells, despite retention of the uncleaved PE2 phenotype.
Apparently, the resuscitating mutations in PE2 destabilize the PE2/E1
heterodimer to such an extent that the spike has the capacity to rearrange to the
fusion-active conformation at the lumenal pH of endosomes, while at the sameChapter 8 152
time the heterodimer is stable enough to survive the mildly acidic lumen of the
TGN (pH ~6.0 (35)) during transport to the cell surface.
Interestingly, another alphavirus PE2 cleavage mutant called S12 (Ser-to-Asn
substitution at position 1 of E2), derived from SAAR86, was found to be fully
infectious on BHK-21 cells (31, 33). In the light of our present results, we would
argue that the PE2/E1 heterodimer of the S12 mutant is less stable than that of the
E2:N1 virus, despite the fact that both viruses carry the same amino-acid
substitution at E2 position 1. Differences in the genetic background of S12 and
E2:N1, outside the PE2 cleavage region, could account for the different spike
stability, in agreement with our present observation that distant mutations in the
E2:N1 mutant have the capacity to restore viral infectivity by destabilization of the
spike heterodimer. We postulate that the S12 spike heterodimer has a very precise
pH dependence, so that it survives the TGN during maturation, but that it does
become fusion competent at acidic pH in endosomes. The stability of the spike
heterodimer and its fusion competence at low pH values of SAAR86 or S12 remain
to be determined.
The results in Figures 6 and 7 show that there is a clear correlation between
expression of low-pH-dependent membrane fusion activity of SIN and formation
of the E1 homotrimeric conformation. However, close scrutiny of the data reveals
that mutant SIN viruses with a relatively low pH threshold for fusion require a
lower extent of trimer formation to reach a certain level of fusion than the TR339
virus with a high pH threshold for fusion. This suggests that there are different
levels of pH control of viral fusion activation and that, besides E1 trimerization,
other pH-dependent conformational alterations are involved. In previous studies
on SFV (3) and SIN (36), we have shown that, kinetically, fusion in the liposomal
model system occurs with a distinct delay after virus-liposome binding and E1
trimerization. This lag phase prior to the onset of fusion may well involve the
rearrangement of several E1  trimers into a fusion complex. Interestingly, the
duration of the lag phase decreases with decreasing pH (3, 36). Thus, our present
observation suggesting that, at a relatively high pH, a relatively high extent of E1
trimerization is required for fusion, may well reflect the comparatively long lag
phase between E1 trimerization and the onset of fusion under these conditions.
The present results suggest that there is a direct correlation between the
infectivity of SIN on BHK-21 cells and low-pH-dependent membrane fusion
activity of the virus with  liposomes. Not only is SIN-liposome fusion clearly
dependent on low pH, it also appears that subtle shifts in the pH dependence of
fusion have a profound effect on viral infectivity. This result provides additional
support for the notion that exposure to a mildly acidic pH is an obligatory step in
the infectious entry of SIN into its host cell. This conclusion is in agreement with
recent observations of  Glomb-Reinmund and  Kielian (12) and  DeTulleo and
Kirchausen (6), indicating that SIN enters cells by receptor-mediated endocytosis
and fusion from within acidic  endosomes. On the other hand, very recentlyMembrane fusion of Sindbis virus PE2 cleavage mutants 153
Hernandez et al. (15) provided evidence, based on investigation of mosquito cell
infection by SIN, suggesting that exposure to an acidic pH may not be an obligatory
step in alphavirus cell entry. Clearly, it can not be excluded that alphaviruses use
different routes of cell entry in mosquito and vertebrate cells. Also, our
observations do not rule out the possibility that interaction of SIN with cell-surface
components induces conformational alterations priming the spike to subsequently
rearrange to its fusion-active structure (7, 26). Nevertheless, from our present
results it would appear that low pH is a very important factor in alphavirus spike
heterodimer destabilization and thus in the activation of viral membrane fusion
activity. This conclusion is completely consisted with recent structural data on the
SIN spike (30). Furthermore, SIN closely resembles SFV in terms of both spike
organization (21, 30) and membrane fusion characteristics (3, 27, 36). For SFV it
has been clearly demonstrated that it infects cells via receptor-mediated
endocytosis and fusion from within acidic endosomes (6, 10, 12, 17, 23, 42).
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Summary
The studies presented in this thesis address the molecular mechanisms
involved in the membrane fusion process of  Sindbis virus (SIN). There is
considerable controversy regarding the route of cell entry of SIN (see Chapter 1).
Several lines of evidence suggest that SIN enters cells via receptor-mediated
endocytosis and fusion from within acidic endosomes. However, in other reports
evidence is presented indicating that SIN infection is mediated by virus-receptor
interaction at the cell surface. Therefore, the first objective of the present study
was to elucidate the role of receptor interaction and/or low pH in triggering or
influencing membrane fusion of SIN (Chapter 2 and 3). We decided to use a
liposomal model system because such a system allows highly sensitive fusion
measurements, thus providing qualitative and quantitative insight in the membrane
fusion process of the virus involved. In Chapter 2, we demonstrate that SIN fuses
efficiently with receptor-free  liposomes in a pH-dependent manner, consistent
with fusion from within acidic  endosomes. The fusion process of SIN with
liposomes can be subdivided in several stages, including dissociation of the E2/E1
heterodimer, binding of the virus to the liposomal membrane, and the formation
of a trypsin-resistant E1 homotrimer. It is demonstrated that low-pH-dependent
fusion of SIN, similar to that of SFV, requires the presence of sphingolipid and
cholesterol in the target membrane. Cholesterol is primarily involved in low-pH-
dependent binding of the virus to the target membrane, whereas sphingolipid is
required for the subsequent fusion process. The liposomes that were used in this
study consisted of just lipids, which suggests that virus-receptor interaction is not a
mechanistic requirement for fusion.
To investigate the role of virus-receptor interaction more directly, we used
liposomes supplemented with heparin-conjugated  phosphatidylethanolamine
(HepPE), as a functional attachment receptor for the virus (Chapter 3). It had
been shown previously that cell-culture-adapted SIN binds efficiently to BHK-21
cells through interaction with heparan sulfate (HS), and that adapted viruses also
bind to heparin (44). In Chapter 3, it is demonstrated that cell-culture-adapted
SIN efficiently interacts with  liposomes supplemented with  HepPE in the
membrane at neutral pH, whereas non-adapted SIN does not bind to these
liposomes. Despite the efficient binding of HS-adapted SIN to these liposomes,
there was no fusion at neutral pH. These results demonstrate that virus-receptor
interaction does not support fusion of the viral membrane with the  liposomal
membrane. Fusion of SIN with  HepPE-containing  liposomes was observed,
however, when the virus-liposome mixture was acidified. This indicates that the
exposure of the virus to low pH is the sole requirement for triggering membrane
fusion of SIN, consistent with cellular entry via receptor-mediated endocytosis and
fusion from within acidic endosomes.Summarizing discussion 159
In Chapter 4, it is shown that fusion of alphaviruses with liposomes is a non-
leaky process. Fusion of SFV was non-leaky to molecules as small as calcein (MW
623) or sucrose (MW 342) initially encapsulated in the liposomes. SIN fusion was
found to be more leaky than that of SFV. Yet, during SIN-liposome fusion inulin,
with an average molecular weight of 5.2 kD, was retained. These results indicate
that membrane fusion of  alphaviruses is a tight process, and suggest the
involvement of a hemifusion intermediate.
In Chapter 5, the binding and fusion characteristics of SIN mutants TE and
633 were investigated. SIN mutant TE differs at only one amino acid position,
E2:55, from 633. Yet, TE is considerably more virulent in mice, and replicates
better in neuroblastoma (N18) cells (18, 77, 78). The data presented in Chapter 5
demonstrate that the TE virus is 10- to 100-fold more infectious on N18 cells than
SIN mutant 633. The enhanced infection efficiency of TE in N18 cells was found
to be related to an increased ability of TE to bind to these cells. Treatment of N18
cells with a sulfation inhibitor decreased the binding of TE to approximately that
of 633, indicating that TE interacts with a sulfated molecule expressed on the cell
surface of N18 cells. Moreover, it was observed that both TE and 633 bind
efficiently to BHK-21 cells, through interaction with HS. Taken together, the
results suggest that the sulfated receptor molecule, to which TE and 633 bind on
BHK-21 cells, is not present or exposed in an altered form on N18 cells. Both TE
and 633 fused equally well with liposomes derived from BHK-21 cell or N18 cell
lipids. However, the viruses fused significantly better with liposomes derived from
BHK-21 cell lipids. In conclusion, it appears that the increased infection efficiency
of TE in N18 cells is related to the binding properties of the virus to these cells,
rather than the membrane fusion process.
In  Chapter 6 , we demonstrate that N-linked  oligosaccharides located at
position E2:196 and E1:139, support membrane fusion of SIN. Removal of one of
these glycosylation sites was found to strongly affect the infectivity of the mutant
virus on BHK-21 cells. Moreover, evaluation of the fusion properties in a
liposomal model system revealed that the single deglycosylated SIN mutants were
impaired in their capacity to induce membrane fusion. This indicates that the
reduced infectivity of the mutant viruses on cells lies at the level of the fusion
process.
In  Chapter 7 , it is shown that fatty acid  acylation of the  transmembrane
regions of SIN glycoproteins E2 and E1 is not required for membrane fusion. The
fusion characteristics of SIN derived from the infectious clone Toto1101 and three
deacylated SIN mutants were determined in a liposomal model system using both
lipid and content mixing assays. Very similar fusion kinetics were observed for the
parental virus and the three deacylated SIN mutants in a pH range from 4.0 to 7.4.
In Chapter 8, we investigated the fusogenic properties of PE2 cleavage mutant
SIN viruses. It is demonstrated that PE2 cleavage mutants are non-infectious on
BHK-21 cells, because these mutants are impaired in membrane fusion. AnalysesChapter 9 160
of the spike conformational changes revealed that the block in membrane fusion
was caused by the inability of the PE2/E1 heterodimer to rearrange to an E1
homotrimer. Rearrangement of the viral spike glycoprotein, with formation of an
E1 homotrimer, and membrane fusion activity were observed, however, upon the
exposure of the virus to non-physiological pH conditions (pH < 4.5). Second-site
resuscitating mutations were identified that destabilize the PE2/E1 heterodimer
through which these viruses regain the ability to rearrange to a fusion-competent
E1 homotrimer at a physiological relevant acidic pH.
Cell entry of alphaviruses
Numerous studies have been conducted to unravel the cell entry properties of
alphaviruses, SFV and SIN in particular. More than two decades ago, it was
demonstrated that SFV infects cells via receptor-mediated endocytosis and fusion
from within acidic endosomes (34). This result has been confirmed by a number of
other studies (33, 38, 40, 53, 54). Furthermore, SFV fusion studies in model
systems have revealed that the virus fuses rapidly and efficiently with receptor-free
liposomes at a mildly acidic pH (5, 39, 58, 83, 86). Although SIN is an alphavirus
similar to SFV, several lines of evidence suggest that SIN infects its host cell by a
mechanism independent of low pH (1, 6, 9, 13, 19, 22, 36). Instead, fusion would
be triggered by virus-receptor interaction at neutral pH, resulting in fusion of the
viral membrane with the plasma membrane of the cell. In Chapter 2 and 3 we
investigated, in a direct manner, the role of low pH and receptor interaction in
triggering the membrane fusion process of SIN. It was found that SIN, like SFV,
fuses rapidly and efficiently with receptor-free liposomes in a low-pH-dependent
manner. This indicates that receptor interaction is not a mechanistic requirement
for fusion of SIN. Furthermore, as shown in Chapter 3, the interaction of SIN
with  liposomes supplemented with lipid-conjugated heparin, as a functional
attachment receptor for the virus, did not result in fusion of the viral membrane
with the liposomal membrane at neutral pH. Fusion of SIN with these liposomes
was observed, however, after exposure of the virus-liposome mixture to low pH.
Moreover, the data presented in  Chapter 8  indicate that there is a direct
correlation between the infectivity of SIN in BHK-21 cells and low-pH-dependent
fusion with liposomes. These results demonstrate that the sole requirement for
membrane fusion of SIN is exposure of the virus to low pH, consistent with
cellular entry from within acidic endosomes. This is entirely in agreement with
reports of Glomb-Reinmund and Kielian (27) and DeTulleo and Kirchhausen (17).
These studies showed that infection of BHK-21 cells by SIN is inhibited by agents
that interfere with  endosomal acidification or by inhibition of the budding of
clathrin-coated vesicles, respectively.
What then could be the explanation for the above discrepancy? It has been
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had been frozen in phosphate-buffered medium (17, 20). The pH of phosphate-
buffered medium decreases upon freezing, through which the viral spike proteins
would possibly rearrange to their fusion-active conformation. After thawing, the
virus would then be able to fuse directly with the plasma membrane of the cell at
neutral pH. This, however, does not seem to be a very plausible explanation. First,
in a recent paper Brown and coworkers have denied the use of virus prior frozen
in phosphate-buffered medium (36). Second, virus exposed to low pH in the
absence of target membranes becomes rapidly fusion-inactive and, moreover, does
not subsequently express fusion activity at neutral pH (5,  Chapter 2 ). As an
alternative explanation,  Glomb-Reinmund and  Kielian (27) suggested that the
types of cell-cell fusion assays, as used by Brown and coworkers, could be the basis
for the discrepancy. In cell-cell fusion assays, fusion is evaluated by morphological
changes of the cell that occur after the primary fusion event. Therefore, it would
be questionable whether the observations that were made are related to fusion or
are in fact caused by secondary effects on the morphological reorganization of the
cells. Yet, it remains difficult to explain positive observations of fusion under
conditions where endocytic entry is inhibited on the basis of such a reasoning.
Furthermore, quite recently, Brown and coworkers further examined the
effects of weak bases on the entry and replication of SIN in mosquito cells (36).
The authors showed that chloroquine inhibits the acidification of endosomes but
does not block the infection of mosquito cells by SIN. These data support their
previous results, suggesting that exposure of the virus to an acid environment
within the cell may not be required for viral infection of cells by SIN. Taken
together, it is not clear what the explanation is for the above discrepancy. It could
be possible that SIN uses different pathways for infection of vertebrate versus
insect cells.
To conclude, we believe, on the basis of our own studies (Chapters 2, 3 and
8) and those of Glomb-Reinmund and Kielian (27) and DeTulleo and Kirchhausen
(17), that alphaviruses infect their host cell by receptor-mediated endocytosis and
fusion from within acidic  endosomes. It would appear that the virus-receptor
interaction is primarily needed for the efficient binding of the virus to the host cell
and for the endocytic uptake of the virus by the cell. After the endocytic uptake,
the mildly acidic pH in the lumen of the endosomes triggers fusion of the viral
membrane with the endosomal membrane, and this membrane fusion reaction can
occur without involvement of the virus receptor.
The involvement of cholesterol and sphingolipid in membrane
fusion of alphaviruses
It has been shown that fusion of SFV and SIN requires the presence of
sphingolipid and cholesterol in the target membrane (5, 58, 86, 49, 64, Chapter 2
and 7). Cholesterol is primarily involved in low-pH-dependent binding of the virusChapter 9 162
to the liposomal membrane, whereas sphingolipid is important for the subsequent
fusion process (58, 87, Chapter 2).
Interestingly, detergent-resistant domains enriched in  sphingolipid and
cholesterol, known as rafts, have been identified in cellular membranes (7, 8, 66,
74). Rafts were found to be involved in a number of important cellular processes,
including trafficking of membrane proteins and signal transduction. Moreover, it
has been shown that budding of influenza virus, measles virus, and HIV occurs
selectively via sphingolipid-cholesterol domains (59, 69, 72, 81, 88). Also, for SV40
and HIV, a role for rafts in virus entry has been demonstrated (3, 30, 51, 60, 63).
It has been observed that sphingolipid-cholesterol domains exist in early and
recycling  endosomes (57). Since  alphavirus fusion occurs from within acidic
endosomes and is strictly dependent on the presence of cholesterol and
sphingolipid in the target membrane, one could argue that fusion may involve raft-
like domains in the target membrane. However, studies in our laboratory on fusion
of SFV or SIN have revealed that raft formation is not essential for fusion (82). In
these studies highly efficient fusion of SIN and SFV was observed with liposomes
containing a variety of sphingolipid analogs that do not interact with cholesterol to
form detergent-resistant domains. Furthermore, cholesterol-independent mutants
of SFV retain the requirement of  sphingolipid to support membrane fusion,
indicating that cholesterol and sphingolipid act independently (10). On the other
hand, when raft-like domains are present in the target membrane, fusion is not
inhibited (82). Therefore, during infection of cells, the virus could take advantage
of the presence of rafts in the endosomal membrane and therefore fuse at these
domains. Initial interaction of the virus with the attachment receptor HS could
bring the virus particles in close proximity to the raft domain. Upon exposure of
the virus to low pH in the endosomal lumen, the virus could interact and fuse with
these domains. Accordingly, it has been observed that a proteolytically truncated
ectodomain of E1, E1*, interacts efficiently with sphingolipid-cholesterol domains
in liposomal target membranes (2). It appears that this interaction is mediated by
the fusion peptide of E1. In contrast to this result, however, it was found that the
envelope glycoproteins of whole SFV virus particles do not associate with raft
domains.
Taken together, although the fusion peptide of E1* efficiently interacts with
sphingolipid-cholesterol domains in the  liposomal membrane, the presence of
these domains is not absolutely required for viral fusion. Fusion of the viral
membrane with a target membrane requires the presence of both sphingolipid and
cholesterol in the membrane, but these lipids do not have to be organized in rafts.
Model of alphavirus membrane fusion
Knowledge of the molecular mechanisms involved in the fusion process of
alphaviruses is far from complete. In this section we will try to compose a model.Summarizing discussion 163
A hypothetical schematic view of the low-pH-dependent membrane fusion
process of  alphaviruses is depicted in Figure 1. The course of events, with
emphasis on spike protein conformational changes and the hypothetical roles of
cholesterol and sphingolipid will be described in further detail below.
E2/E1 heterodimer dissociation. The first step in the fusion process of
alphaviruses involves low-pH-induced conformational changes in the E1 and
perhaps in the E2  glycoprotein that result in the dissociation of the E2/E1
heterodimer (5, 47, 84). Upon dissociation, the E2 glycoproteins move away from
the center of the spike, through an as yet unidentified mechanism. At the same
time, the E1 subunits would appear to move from their peripheral position in the
spike towards the center, thus preparing for the subsequent homotrimer formation
(see below). Recent structural data on the alphavirus spike strongly support this
idea (25, 46,  65). The E1 protein is composed of an amino-terminal  b-barrel
domain, which is flanked by a carboxy-terminal Ig-like domain and a finger-like
projection containing the fusion peptide. The molecule has an elongated shape
resembling in many respects the overall fold of the E protein of tick-borne
encephalitis virus, belonging to the family Flaviviridae. The alphavirus E1 protein,
like the  flavivirus E protein, lies almost flat on the virus membrane (46).
Interestingly, from the structure it would appear as though E1-E1 interactions
mediate the formation of a network stabilizing the virus, in agreement with the
observation that lateral spike-spike interactions suffice for building the virus
particle during assembly and budding (23). During fusion activation, these same
spike-spike interactions are weakened. E1-E1 interaction during assembly and
weakening of this interaction during cell entry thus provides a possible molecular
explanation for the assembly-disassembly paradox in the viral life cycle (25).
Binding to the target membrane. After E2/E1 heterodimer dissociation, the
E1 glycoprotein associates with the target membrane, presumably via membrane
insertion of the putative fusion peptide located between amino acids 79 and 97 of
E1 (2, 40, 42). This fusion peptide is located in the finger-like projection flanking
the central b-barrel domain. It is plausible that upon exposure to low pH the E1
protein not only moves from its position rather parallel to the viral membrane to a
more perpendicular position, so as to allow the fusion peptide to interact with the
target membrane. It has been found that efficient binding of SIN to liposomes
requires the presence of cholesterol in the target membrane (Chapter 2). It is likely
that virus-liposome binding does not require trimerization of E1, but rather that
E1  trimerization occurs  after binding of the virus to the target membrane, as
evidenced by Zn2+ inhibition experiments (15). Analysis of the spike
conformational changes in the presence of Zn2+ showed normal E2/E1
heterodimer dissociation and binding, whereas E1 trimerization was completely
inhibited. Moreover, characterization of a fusion peptide mutant of SFVChapter 9 164
Figure 1. Model of alphavirus fusion. Step 1: exposure of the virus to low pH results in
dissociation of the spike heterodimer. Step 2: binding of the E1 fusion peptide to cholesterol in
the target membrane. Step 3: cholesterol facilitates the formation of an E1 homotrimer. Step 4:
clustering of E1 homotrimers, mediated by sphingolipid in the target membrane. Step 5: the
clustered E1 homotrimers induce hemifusion. Step 6: formation and dilation of a fusion pore.
Step 7: end stage of the fusion process. (For further details, see text).
(Glu91Asp) revealed that this mutant was blocked in E1  trimerization, while
normal E2/E1 heterodimer dissociation and binding to liposomes was observed
(41).
E1  trimerization and formation of a fusion complex. We propose that
upon the interaction of the E1  glycoprotein with cholesterol in the target
membrane, cholesterol  facilitates the formation of an E1  homotrimer. This
hypothesis is substantiated by the observation that incubation of alphaviruses with
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PC/PE/Chol liposomes results in efficient formation of E1 homotrimers (14, own
unpublished results). The formation of E1 homotrimers is strongly reduced with
liposomes lacking cholesterol in the membrane. Despite the efficient formation of
E1 homotrimers with PC/PE/Chol liposomes, these E1 homotrimers are unable
to support membrane fusion. For the formation of fusion-competent E1
homotrimers, the presence of both cholesterol and  sphingolipid in the target
membrane is required.
Under suboptimal conditions for fusion in terms of pH and temperature, there
may be a considerable lag phase between the formation of E1 homotrimers and
the onset of the actual fusion reaction (5, Chapter 2). The occurrence of a lag
phase implies that additional rearrangements within or between the E1
homotrimers are required for the initiation of the fusion process. We hypothesize
that  sphingolipids play an important role in this rearrangement. Specific
interactions of the E1  homotrimer with  sphingolipid molecules in the target
membrane could mediate clustering of E1 homotrimers, thereby facilitating the
formation of a fusion-competent complex. The prediction that clustered E1
trimers represent the fusion-active state of the  virion is substantiated by the
observation that higher-order oligomers are formed upon acidification of a virus-
liposome mixture (own unpublished results, 26). Moreover, it has been observed
that membrane fusion mediated by the influenza virus hemaglutinin (HA) requires
the concerted action of at least three HA trimers (16).
Hemifusion, formation of a fusion pore, and membrane merging. Upon
the formation of a fusion complex a  hemifusion (“stalk”) intermediate is
presumably formed. This means that the monolayers of the interacting membranes
merge, while the inner monolayers remain separate. The formation of a hemifusion
intermediate in  alphavirus fusion has been studied using lipids such as
lysophosphatidylcholine or free fatty acids that, upon incorporation in the outer
monolayers of the interacting membranes, inhibit or promote stalk formation,
respectively (11, 12, 29). Indeed, it has been shown that SFV fusion is inhibited by
lysophosphatidylcholine at a stage after the formation of an E1 homotrimer (62).
On the other hand, SFV fused very efficiently with liposomes supplemented with
free fatty acids. These data support the notion that the membrane fusion process
of  alphaviruses proceeds via the formation of a  hemifusion intermediate.
Accordingly, the data presented in Chapter 4 demonstrate that the fusion process
of alphaviruses is essentially non-leaky. It is reasonable to assume that a membrane
fusion process, in which the merging of the outer membrane leaflets and that of
the inner ones are separated in time, remains tight throughout. We hypothesize
that at the end of the fusion process, the glycoproteins adopt a final conformation
that places the fusion peptide and the transmembrane domain at the same end of
the molecule. This conformation has been demonstrated for influenza virus HA
(85). At this moment, there is no data available that support this conformation in
fusion process of  alphaviruses. Finally, as a result of pore dilation, membraneChapter 9 166
merging is completed, which in the context of the host cell leads to the delivery of
the viral nucleocapsid to the cell cytosol.
Post-translational modifications of the spike proteins of
alphaviruses
Glycosylation. The E2 and E1 proteins undergo N-linked glycosylation within
the lumen of the ER. The oligosaccharide chains exposed on the outer surface of
the glycoprotein are further modified within the Golgi (see Chapter 1). The N-
linked  glycosylation sites, each characterized by an  Asn-X-Ser/Thr motif, are
located at residues Asn196 and Asn318 in E2, and at residues Asn139 and Asn245
in E1 (68). In  Chapter 6 , we evaluated the biological role of N-linked
oligosaccharides in the membrane fusion process of SIN, using SIN mutants
lacking a glycosylation site at residue E2:196 or at residue E1:139 (65). The results
show that the resulting deglycosylation reduces viral infectivity by 3-4 orders of a
magnitude, when compared to the parental SIN TE12 virus. It appears that the
block in infection lies at the level of the fusion process. At the same time there
does not appear to be any significant defect in the assembly of the glycosylation
mutant viruses. At this point it is not clear how N-linked oligosaccharide chains
may specifically affect the membrane fusion process of SIN. We hypothesize that
the addition of  oligosaccharide chains is required for the proper folding and
conformation of the spike proteins on the viral envelope (4, 21, 35). Specifically,
removal of a glycosylation site could induce a subtle conformational change within
the viral  glycoproteins that influences the stability of the E2/E1  heterodimer.
Indeed, it has been observed that  deglycosylation of the stem region of the
influenza HA or the ectodomain of the dengue virus E glycoprotein affects the
stability of the viral spike, such that a higher pH threshold for fusion is obtained
(28, 61). We are currently investigating the effects of N-linked glycosylation on the
stability and functional integrity of the SIN E2/E1 spike heterodimer.
Fatty acid  acylation. The  glycoproteins of SIN are  palmitoylated at the
cysteine residues within the  transmembrane and  cytoplasmic domains (see
Chapter 1). In Chapter 7, we investigated the role of fatty acid acylation of the
transmembrane domains of the glycoproteins E2 and E1 on the membrane fusion
activity of SIN with liposomes. To this end, deacylated SIN mutants were used, in
which the transmembranal cysteines at either E2 positions 388 and 390 or E1
position 430 or in both glycoproteins were replaced by alanine residues. The data
presented in Chapter 7 clearly demonstrate that deacylation of the transmembrane
domains of the SIN glycoproteins has no effect on the membrane fusion process
of the virus in a  liposomal model system. Very similar fusion kinetics and
characteristics were observed for the parental virus and the  deacylated SIN
mutants. These results indicate that acylation of the transmembrane regions of SINSummarizing discussion 167
glycoproteins E2 and E1 is not required for expression of viral membrane fusion
activity.
The conserved nature of the  cysteine residues in E2 or E1 among the
alphavirus genus would suggest that acylation of the viral glycoproteins has an
important function in the life cycle of  alphaviruses. What then could be the
physiological function of this acylation phenomenon? It has been proposed that
palmitoylation of proteins is one of the factors that target membrane proteins to
detergent-resistant raft domains (55). Accordingly, the  palmitoylated envelope
glycoproteins of influenza virus and HIV appear to be associated with rafts (55, 56,
69, 73). Targeting of influenza HA to rafts requires palmitoylation of all three
cysteine residues (55, 88). Moreover, it has been found that budding of influenza
virus and HIV occurs selectively via raft domains. Therefore, it appears that
palmitoylation of influenza HA and HIV gp160 targets these proteins to rafts to
mediate trafficking and targeting of the envelope  glycoproteins and selective
recruitment of raft domains into the budding virus particles.
With regard to SIN,  deacylation of the  cytoplasmic domain of the E2
glycoprotein has been shown to affect virus budding (24, 37). In contrast to
influenza virus and HIV, however, analysis of the presence of detergent-resistant
lipid domains within the SFV envelope revealed that the glycoproteins of SFV are
not associated with rafts (73). However,  deacylation of the  transmembrane
domains of SIN glycoproteins E2 and E1 showed that these mutants are more
sensitive to treatment with Triton X-100 than the parental virus (70). This suggests
that the lack of palmitoylation increases the solubility of the viral envelope in
detergent. In agreement with this view, DPH fluorescence polarization
experiments have shown that the membrane of SFV has a comparatively limited
fluidity (73). Therefore, we postulate that it is the  palmitoylation of the SIN
glycoproteins that causes the viral membrane to become less fluid. During budding
of a new virus particle, the saturated acyl chains of acylated glycoproteins might
alter the lipid composition in the surrounding regions and thereby facilitate a more
rigid membrane microenvironment. Indeed, analysis of the lipid composition of
the membrane of SFV cultured on BHK-21 cells, revealed that the cholesterol to
phospholipid ratio within the viral membrane is significantly increased, compared
to that of the plasma membrane of BHK-21 cells (45, 67, 79).
Perhaps, during virus assembly, the saturated palmitic acid chains coupled to
the viral spike proteins, recruit cholesterol resulting in a locally reduced membrane
fluidity. This may be beneficial for an ordered arrangement of the viral spike
proteins at the site of budding (23). In this respect, it is interesting to note that
cholesterol is required for efficient assembly of SFV and SIN (49, 50, 52, 80).
PE2 cleavage. In the infected cell, the E2 glycoprotein is synthesized as a
precursor protein, called PE2 in SIN or p62 in SFV (see  Chapter 1 ). PE2 is
presumed to act as a chaperone, protecting the spike from premature
destabilization during transport of the PE2/E1 heterodimer through the mildlyChapter 9 168
acidic  trans-Golgi network (TGN). Just before the appearance of the spike
proteins on the plasma membrane of the cell, PE2 is cleaved by a  furin host
protease to form the mature E2 and a small peptide E3 (48). It has been
demonstrated that this cleavage is necessary for the production of infectious virus
particles (31, 43,  71). Likewise, the PE2 cleavage mutants of SIN, studied in
Chapter 8, are non-infectious on BHK-21 cells. It is shown that these viruses are
impaired in membrane fusion capacity at a physiologically relevant acidic pH. The
reason appeared to be that the PE2 cleavage mutants exhibit a significantly more
acidic pH threshold for the formation of an E1 homotrimer and the initiation of
membrane fusion. These results are in agreement with observations of Salminen
and coworkers (71), who showed that the infectivity of a cleavage mutant of SFV
on BHK-21 cells was restored by exposure of the virus to pH 4.5. Clearly, the
presence of PE2 stabilizes the PE2/E1  heterodimer. More importantly, these
observations support the notion that PE2 acts as a chaperone to protect the spike
from premature destabilization within the slightly acidic TGN.
Yet, the data presented in Chapter 8 indicate that PE2 cleavage itself is not
absolutely required for viral infectivity. SIN mutants with second-site resuscitating
mutations in PE2 were found to be highly infectious on BHK-21 cells, despite a
sustained lack of PE2 cleavage. Apparently, the second-site resuscitating mutations
in PE2 destabilize the PE2/E1  heterodimer to such an extent that the spike
rearranges to a fusion-competent E1  homotrimer within the mildly acidic
endosomal compartment of the cell. At the same time the heterodimer remains
stable enough to survive the acidic pH in the TGN during the process of spike
maturation.
In conclusion, PE2 stabilizes the PE2/E1 heterodimer, during passage of the
spike through the TGN, by protein-protein interactions. These protein-protein
interactions are weakened by PE2 cleavage, through which the viruses are primed
to rearrange to a fusion-active conformation at a mildly acidic pH. Apparently, the
protein-protein interactions that stabilize the PE2/E1 heterodimer may also be
weakened by second-site resuscitating mutations in PE2. The second-site
mutations act to destabilize the PE2/E1  heterodimer enough for the spike to
rearrange to its fusion-competent conformation at a physiologically relevant acidic
pH, but not so much that the spike would presumably rearrange in the acidic TGN
during maturation in the infected cell.
Perspectives
In recent years there has been a revolutionary increase in our understanding of
the molecular mechanisms involved in viral membrane fusion. By far the best
understood membrane fusion protein is the HA of influenza virus (76). HA was
the first viral envelope glycoprotein for which the structure was resolved at the
atomic level. More recent crystallographic studies have revealed that the structuresSummarizing discussion 169
of several other viral membrane fusion proteins closely resemble that of influenza
HA. These include the envelope  glycoproteins of retroviruses,  filoviruses and
paramyxoviruses (75, 85). It is likely that these viruses all use a similar mechanism
of membrane fusion to penetrate their host cells, a key feature being the
conversion of a triple helix into a six-helical bundle. The identification of this
common structural conversion has led to the development of small peptides that
strongly interfere with the formation of the six-helical bundle.  These peptides
inhibit the membrane fusion process of these viruses. Interestingly some of these
molecules are currently in clinical evaluation as potential antiviral drugs, for
example in patients infected with human immunodeficiency virus.
Quite recently, as discussed in Chapter 1 and above, the structure of the E1
membrane fusion protein alphaviruses has been resolved at the atomic level (46).
Remarkably, this protein does not at all resemble the influenza HA. Rather, the
alphavirus E1 protein appears to be similar in many respects to the E fusion
protein of tick-borne encephalitis (TBE) virus, a member of the family Flaviviridae
(32). This family includes, besides TBE virus, several other major human
pathogens, such as hepatitis C virus, Dengue virus and yellow-fever virus. Based
on the similarity between their envelope glycoproteins, it is, again, quite plausible
that alphaviruses and flaviviruses utilize a similar membrane fusion mechanism. At
the same time, it is likely that this mechanism will be different from that used by
HA and HA-related fusion proteins. Based on this reasoning, membrane fusion
mediated by HA and HA-related proteins is being referred to as “class I” fusion
and fusion mediated by alphavirus or flavivirus membrane fusion proteins as “class
II” fusion (46). We hope that the present study on the membrane fusion properties
of Sindbis virus, which is by itself a minor human pathogen, will contribute to a
further understanding of “class II” viral membrane fusion in general and thus,
possibly, to the development of antiviral drugs interfering with cell entry of other,
highly pathogenic, viruses belonging to the “class II” category.
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BHK-21 baby hamster kidney cells
BSA bovine serum albumin
CHO Chinese hamster ovary
Chol cholesterol
Cryo-EM cryo-electron microscopy
DMEM Dulbecco’s modified Eagle medium
DTNB 5,5’-dithiobis(2-nitrobenzoic acid)
EEE Eastern equine encephalitis
ER endoplasmic reticulum
FBS fetal bovine serum
FCS fetal calf serum
GAG glycoaminoglycan
HA hemaglutinin
HepPE heparin-conjugated phosphatidylethanolamine
HNE 5 mM Hepes, 150 mM NaCl, 0.1 mM EDTA, pH 7.4
HS heparan sulfate
IU infectious unit
LUV large unilamellar vesicles
MAb monoclonal antibody
MES  morpholinoethanesulfonic acid
MOI multiplicity of infection
N18 neuroblastoma cell line
NB-DNJ N-butyldeoxynojirimycin
OGP n-octyl-ß-D-glucopyranoside
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PC phosphatidylcholine
PE phosphatidylethanol-amine
PFU plaque forming units
PhotoChol 6-photocholesterol
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SFV Semliki Forest virus
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srf  sterol requirement in function
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Inleiding
Sindbis virus (SIN) behoort tot de genus “Alphavirussen” binnen de familie
Togaviridae. Er zijn in totaal 25 verschillende alphavirussen geïdentificeerd.
Alphavirussen kunnen verschillende diersoorten infecteren, waaronder vogels,
knaagdieren en zoogdieren. Sommige alphavirussen veroorzaken een fatale
encefalitis (ontsteking van de hersenen) bij bijvoorbeeld paarden, terwijl andere
alphavirus-infecties veel mildere symptomen laten zien. Ook mensen kunnen
worden geïnfecteerd door alphavirussen, alhoewel dit echter relatief weinig
voorkomt. De symptomen van een alphavirus-infectie bij mensen variëren van
griepachtige verschijnselen tot een ernstige encefalitis. Alphavirussen behoren tot
de arbo (arthropod-borne) virussen; dat wil zeggen dat de infectie in de natuur
wordt overgedragen door insecten, zoals teken en muggen. Als een besmette mug
bloed zuigt bij een dier of mens, komt het virus in de bloedbaan terecht. Het SIN
virus is één van de minst gevaarlijke alphavirussen voor de mens en wordt daarom
vaak gebruikt als een modelvirus in wetenschappelijk onderzoek.
Alphavirussen zijn bolvormige deeltjes met een grootte van 70 nm (Hoofdstuk
1, figuur 1). In de kern bevindt zich het nucleocapside. Het nucleocapside bestaat
uit 240 kopieën van het capside-eiwit en één RNA molecuul met een grootte van
circa 11.000 basen (het virale genoom). Het nucleocapside wordt omgeven door
een laag van lipiden (membraan) waarin zich een tweetal zogenoemde spike-
eiwitten, het E2 en het E1, bevinden. In totaal zijn er 80 virale spikes aanwezig op
een virusdeeltje, waarbij iedere spike bestaat uit een trimeer (drieling) van E2/E1
heterodimeren. De E2 en E1 eiwitten steken door de virale membraan heen. Dit
houdt in dat het eiwit uit drie verschillende regio’s bestaat, het cytoplasmatische
domein (bevindt zich binnenin het virusdeeltje), het transmembraan-domein (dit
gedeelte zit in de membraan) en het ecto-domein (bevindt zich buiten de
membraan). Het E2 eiwit heeft een lengte van 423 aminozuren met een
cytoplasmatisch domein van 33 aminozuren. Het E1 eiwit is 439 aminozuren groot
en heeft een cytoplasmatische staart van slechts 2 aminozuren. Zowel het E2 als
het E1 eiwit zijn geglycosyleerd en geacyleerd; dat wil zeggen dat beide eiwitten
aminozuren bevatten waaraan respectievelijk suikergroepen en vetzuren gekoppeld
zijn.
Membraanvirussen kunnen in principe op twee verschillende manieren een cel
infecteren. Ze kunnen rechtstreeks fuseren met de plasmamembraan van de cel.
Daarnaast is het ook mogelijk dat de virusdeeltjes eerst worden opgenomen door
de cel via receptor-gemedieerde endocytose en pas daarna fuseren vanuit zure
blaasjes (endosomen) (Hoofdstuk 1, figuur 4). In het geval van plasmamembraan-
fusie bindt het virus aan een receptor op het celoppervlak waarbij deze interactie er
op zichzelf voor zorgt dat de virale membraan en de plasmamembraan van de cel
met elkaar versmelten (fusie). Virusdeeltjes die worden opgenomen door receptor-
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Vervolgens worden de virus-receptor complexen ingesloten door instulping en
afsnoering van een deel van de plasmamembraan; uiteindelijk komt het virus in
endosoom terecht. De inhoud van de endosomen verzuurt, waardoor het virus
verandert van structuur en zo het vermogen krijgt te fuseren met het endosomale
membraan.
Er bestaat in de literatuur grote onduidelijkheid over de route van infectie van
het SIN virus. Sommige studies laten zien dat SIN de cel infecteert via
plasmamembraan-fusie, terwijl andere onderzoekingen aangeven dat SIN fuseert
vanuit zure endosomen. Vast staat dat het E2 eiwit een belangrijke rol speelt bij
receptor-interactie en E1 verantwoordelijk is voor het fusieproces. Hoe dan ook,
na het samensmelten van de virale membraan met de plasmamembraan dan wel de
endosomale membraan komt het nucleocapside vrij in de cel. Het nucleocapside
wordt vervolgens ontmanteld waarna de synthese van nieuwe virusdeeltjes begint.
Het virale RNA wordt afgelezen in het cytoplasma van de cel, wat leidt tot de
vorming van nieuwe eiwitten en RNA moleculen. Uiteindelijk wordt er een groot
aantal nieuwe virusdeeltjes gevormd door een proces van “budding”
(knopvorming).
Resultaten en Conclusies
Het onderzoek beschreven in dit proefschrift richt zich op het ontrafelen van
het infectieproces van SIN.  Hoofdstuk 2, 3 en 4  beschrijven de basale
karakteristieken van SIN fusie in een modelsysteem. In Hoofdstuk 3 en 5 t/m 8
zijn aminozuur-veranderingen (mutaties) aangebracht op specifieke plaatsen in het
E2 en het E1 eiwit. Vervolgens is het effect van deze mutaties op de receptor-
interactie en membraanfusie-activiteit van SIN onderzocht.
In Hoofdstuk 2 is gekeken naar de invloed van lage pH op het fusieproces
van SIN. Het fusieproces van SIN is bestudeerd met behulp van een
modelsysteem. In dit systeem worden kunstmatige lipidemembranen (liposomen)
gebruikt als doelmembraan. Membraanfusie wordt gemeten met behulp van de
fluorescerende stof pyreen, die wordt ingebouwd in het virusmembraan. Fusie van
een pyreen-gemerkt virusmembraan met een liposomaal membraan resulteert in
een uitverdunning van de pyreen-moleculen in de liposomale membraan waardoor
de fluorescentie intensiteit van de merker daalt. Met deze methode kan het
fusieproces continu gevolgd worden.
De resultaten laten zien dat fusie strikt afhankelijk is van het blootstellen van
het virus aan lage pH. Optimale fusie wordt waargenomen bij pH 5.0. Onder
suboptimale condities kan er onderscheid worden gemaakt tussen verschillende
fasen in het fusieproces. Onder invloed van lage pH valt de virale E2/E1
heterodimeer uit elkaar en bindt het virus aan het liposomale membraan.
Vervolgens ondergaat het E1 eiwit allerlei veranderingen waarbij een trypsine-
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De aanwezigheid van deze “lag phase” zou kunnen betekenen dat er nog andere
veranderingen in het E1 trimeer plaatsvinden die nodig zijn voor fusie. Het is nog
niet bekend welke structuur het E1 eiwit heeft op het moment van fusie. Wel is het
duidelijk dat de aanwezigheid van cholesterol en sfingolipiden in het
doelmembraan noodzakelijk is voor de membraanfusie-activiteit van het virus. SIN
is niet in staat te fuseren met liposomen waarin één van deze lipiden ontbreekt.
Cholesterol speelt een belangrijke rol bij de binding van het virus aan het
liposoom, terwijl sfingolipiden verantwoordelijk zijn voor het fusieproces zelf. Uit
de bovengenoemde resultaten blijkt dat het blootstellen van het virus aan lage pH
essentieel is voor het initiëren van het fusieproces. Dit ondersteunt de gedachte dat
SIN de cel infecteert via receptor gemedieerde-endocytose en fusie vanuit zure
endosomen, en niet door directe fusie met de plasmamembraan.
In Hoofdstuk 3 is de rol van virus-receptor interactie in het membraanfusie-
proces van SIN nader onderzocht. Hierbij werden liposomen gebruikt waarin
lipide-gekoppeld heparine, als een specifieke receptor voor aangepast SIN, is
ingebouwd. Uit een eerdere studie was gebleken dat het SIN virus na
vermenigvuldiging op cellen is aangepast aan de receptor heparan-sulfaat en bindt
aan heparine. De resultaten beschreven in dit hoofdstuk laten zien dat het
aangepaste SIN virus goed bindt aan de heparine-lipide receptor, ingebouwd in
liposomen, bij neutrale pH. Desondanks treedt er geen fusie op onder deze
condities. Fusie wordt alleen waargenomen na aanzuring van het medium.
Samenvattend kan er geconcludeerd worden dat de virus-receptor interactie geen
belangrijke rol speelt in het fusieproces van SIN met liposomen. Het blootstellen
van het virus aan lage pH daarentegen is essentieel voor membraanfusie, opnieuw
suggererend dat fusie van SIN in cellen plaatsvindt vanuit zure endosomen.
In  Hoofdstuk 4  is gekeken of het fusieproces van alphavirussen met
liposomen gepaard gaat met lekkage van ingesloten moleculen. Hiertoe werden
kleine water-oplosbare moleculen (sucrose en inuline) ingesloten in liposomen. Uit
de resultaten blijkt dat tijdens membraanfusie deze stoffen nauwelijks weglekken.
Dit geeft aan dat de fusiereactie nauwkeurig georganiseerd is en ondersteunt de
gedachte dat het proces plaatsvindt via een zogenoemd hemifusie-intermediair. Dit
betekent dat de buitenste monolagen van de beide membranen eerst met elkaar
versmelten, pas in een wat later stadium gevolgd door de binnenste monolagen.
In Hoofdstuk 5  zijn de bindingskarakteristieken en membraanfusie-
eigenschappen van twee SIN varianten (SIN TE virus en SIN 633 virus) met
elkaar vergeleken. Deze virussen verschillen in slechts één aminozuur in het E2
eiwit. Desondanks is het TE virus veel meer pathogeen in muizen en vormt meer
virusdeeltjes in zenuwcellen dan het 633 virus. De resultaten laten zien dat de
infectiviteit van het TE virus hoger is in zenuwcellen omdat het virus beter bindt
aan deze cellen dan het 633 virus. Daarnaast is er gekeken naar de membraanfusie-
activiteit van beide virussen met liposomale membranen. De liposomen werden
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verschillen waargenomen tussen de fusiekarakteristieken van het TE en het 633
virus. Echter, beide virussen fuseren beter met liposomen afkomstig van niercellen
dan van zenuwcellen. Samenvattend kan er gezegd worden dat de verhoogde
infectiviteit van het TE virus voor zenuwcellen is gerelateerd aan de
bindingskarakteristieken van het virus en niet aan de membraanfusie-activiteit.
In Hoofdstuk 6 is de invloed van glycosylering van de virale spike eiwitten op
infectie van cellen door SIN bestudeerd. In SIN zijn twee suikergroepen
gekoppeld aan zowel het ecto-domein van het E2 als het E1 eiwit. Het is in het
algemeen bekend dat suikergroepen een belangrijke rol kunnen spelen bij de
vouwing van membraaneiwitten. In dit hoofdstuk wordt aangetoond dat het
verwijderen van een suikergroep in het E2 of in het E1 eiwit tot gevolg heeft dat
het virus nauwelijks infectieus is voor cellen. Daarentegen heeft de afwezigheid van
een enkele suikergroep in E2 of E1 geen grote gevolgen op de vouwing van de
spike eiwitten en op de vorming van virusdeeltjes. De blokkade in infectie lijkt dus
te liggen in de eerste stappen van het infectieproces. Uit de resultaten blijkt dat de
mutante virusdeeltjes niet in staat zijn te fuseren met liposomen onder lage pH
condities, wat suggereert dat het infectieproces is geblokkeerd op het niveau van
de fusiereactie. Onze hypothese is dat de afwezigheid van suikergroepen subtiele
veranderingen in de spike eiwitten teweeg brengt waardoor het virus niet de
conformationele veranderingen kan ondergaan, die nodig zijn voor
membraanfusie.
In  Hoofdstuk 7  wordt gekeken naar het effect van acylering van de
transmembraan-domeinen van de spike eiwitten op het fusieproces van SIN. De
transmembraan-domeinen van het E2 en het E1 eiwit bevatten respectievelijk twee
en één vetzuurketens. De aanwezigheid van vetzuurketens is sterk geconserveerd
bij verschillende alphavirussen, wat impliceert dat vetzuurketens een belangrijke rol
vervullen in de levencyclus van deze virussen. Er wordt in dit hoofdstuk
aangetoond dat de aanwezigheid van vetzuurketens niet belangrijk is voor
membraanfusie. Dezelfde fusiekarakteristieken werden waargenomen voor het
wild-type virus en drie virusmutanten waarbij de vetzuurketens in het E2 en/of het
E1 eiwit waren verwijderd.
In  Hoofdstuk 8  zijn de fusogene eigenschappen van immature SIN
virusdeeltjes bepaald. In een geïnfecteerde cel wordt het E2 eiwit gevormd als een
voorloper eiwit, het zogenoemde PE2. In een van de laatste stappen van de
vorming van het virusdeeltje wordt het PE2 eiwit gemodificeerd tot het mature
E2. In deze studie zijn SIN virussen gebruikt waarbij het PE2 niet meer wordt
omgezet naar E2. Dit betekent dat de virale spike bestaat uit een trimeer van
PE2/E1 heterodimeren. Eerdere studies hebben aangetoond dat deze virussen niet
infectieus zijn en dat de blokkade in infectie na receptor-interactie, maar vòòr
RNA replicatie ligt. Inderdaad, de resultaten laten zien dat het infectieproces
stagneert op het niveau van de fusiereactie. Er is gevonden dat PE2-bevattende
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Vervolgens zijn de verschillende fasen in het virus-liposoom fusieproces
onderzocht. Uit de resultaten blijkt dat PE2-bevattende virussen niet in staat zijn
een E1 trimeer te vormen. Kortom, PE2-bevattende virussen zijn niet infectieus in
cellen omdat de spike te stabiel is om conformationele veranderingen te ondergaan
en fusie-actief te worden. Vermenigvuldiging van PE2-bevattende virusdeeltjes op
cellen leidt tot de generatie van virusmutanten die wel infectieus zijn in cellen. Na
het karakteriseren van deze mutanten bleek dat de virussen nog steeds PE2
bevatten in de spike. Echter, de mutanten blijken een enkele mutatie in het PE2
eiwit te hebben. Deze mutatie destabiliseert de virale spike waardoor het virus
onder mild-zure condities in staat is een E1 trimeer te vormen en te fuseren met
liposomen.
In Hoofdstuk 9 worden de resultaten samengevat en in een algemene context
bediscussieerd.
Slotopmerkingen
De laatste jaren is er veel bekend geworden over de moleculaire mechanismen
van virale membraanfusie. Vooral onderzoek naar de fusie van het influenza virus
(griepvirus) heeft sterk bijgedragen aan dit verbeterde inzicht. Recent is gebleken
dat het membraanfusie-eiwit van het influenza virus, het hemagglutinine (HA), in
structureel opzicht sterke overeenkomsten vertoont met de fusie-eiwitten van een
aantal andere membraanvirussen, waaronder het humane immunodeficientie-virus
(HIV). En het lijkt erop dat al deze virussen in principe gebruik maken van een
overeenkomstig membraanfusiemechanisme om hun onderscheiden doelwitcellen
te infecteren. Deze nieuwe inzichten, die -nogmaals- vooral zijn gebaseerd op
onderzoek aan het griepvirus, hebben geleid tot de ontwikkeling van specifieke
moleculen die interfereren met dit fusieproces. Een aantal van deze fusieremmers
wordt momenteel geëvalueerd in klinische studies bij HIV-patienten.
Ook de structuur van de fusie-eiwitten van alphavirussen is recentelijk in detail
in kaart gebracht. Het blijkt dat deze eiwitten in het geheel niet lijken op het HA
van het influenza virus, maar wel op de fusie-eiwitten van membraanvirussen
binnen de familie van de Flaviviridae. Tot deze familie behoort een aantal zeer
belangrijke pathogenen, zoals het hepatitis C virus, het dengue-virus, het gele
koorts virus en het teken-encefalitisvirus. De overeenkomst tussen de alphavirus
en flavivirus fusie-eiwitten heeft ertoe geleid dat het fusieproces dat deze eiwitten
mediëren nu wordt geklassificeerd als klasse II membraanfusie (tegenover klasse I
fusie gemedieerd door het HA en aanverwante virale membraanfusie-eiwitten). Het
is waarschijnlijk dat klasse II virale membraanfusie in alle gevallen in principe op
dezelfde wijze verloopt. Hopelijk draagt het onderzoek aan een relatief
onbelangrijk humaan pathogeen als  het SIN virus, zoals beschreven in dit
proefschrift, uiteindelijk bij aan een beter inzicht in klasse II virale membraanfusie
in het algemeen en, op die wijze, aan de ontwikkeling van antivirale middelen tegen
zeer belangrijke humaan-pathogenen.Curriculum Vitae 189
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Nawoord
Het is alweer bijna zes jaar geleden dat ik voor het eerst bij de –toen nog-
vakgroep Fysiologische Chemie kwam binnen lopen. Het eerste jaar was ik aan het
werk als stagiaire van de hogere laboratorium opleiding. Ik raakte al snel
enthousiast voor het vak en toen de mogelijkheid zich voordeed om te blijven als
aio twijfelde ik dan ook geen moment. De daarop volgende jaren zijn voorbij
gevlogen! Ik kan het daarom nog haast niet geloven maar ik kan nu met recht
zeggen: “Ik ben …bijna klaar!!” Zoals de meeste mensen in mijn familie zeggen:
“Jolanda gaat nu echt bijna afstuderen.” Nu ben ik het niet helemaal eens met deze
woordkeuze maar vooruit dan maar. Het feit dat ik zover ben gekomen heb ik aan
een aantal mensen te danken.
Als allereerste wil ik mijn promotor Jan Wilschut bedanken. Er zijn zoveel
dingen waarvoor ik jouw moet bedanken dat ik vast de helft vergeet. Ten eerste wil
ik je bedanken voor de kans die je mij gegeven hebt om gelijk na mijn Hbo-
opleiding aio te worden. We wisten allebei niet precies hoe het zou gaan lopen,
maar ik ben blij dat we de gok gewaagd hebben. Natuurlijk hebben we allemaal wel
eens iets aan te merken op de “directe baas”, maar ik vind (met alle lof) dat je de
beste begeleider bent die een aio zich kan wensen. Je was altijd erg enthousiast
over ons werk en hoe druk je het ook had ik kon altijd bij je terecht. Door jouw
perfectionisme in het schrijven van Engelstalige wetenschappelijke artikelen is mijn
schrijftalent gevorderd van slecht tot matig of misschien wel tot redelijk goed. Al
heeft dat ons heel wat energie gekost, ik ben blij dat je (steeds maar weer) de tijd
hebt genomen om mij het proces van artikelen schrijven te leren. Zonder jouw
inzet (op alle fronten) was het nooit zover gekomen. Bedankt!
Het motto van de MMB luidt: “Ik werk gelukkig bij de Medische
Microbiologie!” Dat geldt voor mij zeker! Wij hebben een ontzettend leuke groep
waar het altijd erg gezellig is. Voor mij persoonlijk is er veel veranderd toen de aio-
kamer werd ingesteld. De vele uurtjes die ik daar heb doorgebracht met Laura
Bungener, Diana Spierings en Barry-Lee Waarts waren erg gezellig. Inmiddels
zitten we allemaal niet meer bij elkaar op de kamer, maar gelukkig is het contact er
niet minder om. Het volgende aio-etentje is bij mij! Barry, bedankt dat je mijn
paranimf wilt zijn! Natuurlijk wil ik ook alle andere kamerbewoners (Gerben
Koning, Jolanda Busscher, Jeroen Visser, Koen Glazenburg en de vissen)
bedanken voor de sfeer en gezelligheid. Ook op het lab is het altijd erg gezellig,
iedereen bedankt! Wouter wil ik graag nog bedanken voor de periode dat je bij mij
stagiaire bent geweest. Ik vond het leuk om jouw destijds te begeleiden.
Ook wil ik iedereen van het GUIDE-buro bedanken. Ik vond het altijd erg
leuk om actief mee te denken bij de  GUIDELines en GUIDE  early summer
meeting vergaderingen en om een voordracht te geven in Kloostenburen. Tip top
met chauffeur. Ik durf het haast niet meer te zeggen, maar jullie financiëleNawoord 191
ondersteuning voor cursussen, congressen en werkbezoeken heb ik altijd erg
gewaardeerd!
Daarnaast wil ik iedereen van het GAIOO bedanken voor het lekkere eten, de
gezellige vergaderingen en de gigantische hoeveelheid e-mails!
I would like to thank Prof. Robert Bittman for our collaboration. My boyfriend
and I really enjoyed the visit to your lab (including the spectacular view over
Manhattan and walking around China town). Also, I would like to thank you for
carefully reading our manuscripts.
The collaboration with Prof. Robert Johnston, Dr. William Klimstra, and Dr.
Kate Ryman was of great importance for my thesis. I learned a lot during my
short-term working period at your lab, thanks for your great hospitality. The
barbecue was lots of fun! We miss the beautiful weather of North Carolina, but we
are glad that we do not have hurricanes here.
Also, I would like to thank Prof. Richard Kuhn and Dr. Suchetana
Mukhopadhyay. Tuli, I am really glad that we met last year in Paris and later again
in Tilton. I really enjoy our scientific and social discussions via e-mail! I think that
the results we have already obtained are just the beginning of something
spectacular. I hope to see you again in the near future!
Furthermore, I would like to thank Prof. Diane Griffin and Dr. Peiyu Lee.
Peiyu, I enjoyed the time your were working in our lab.
Finally, I wish to thank Jeroen Corver, Koji Kimata, Ronald Knight, Ke-Chun
Lin, Gang Li, and Pieter Schoen for their contribution to this thesis.
Natuurlijk was het nooit zover gekomen als mijn lieve papa en mama mij niet
op deze wereldbol hadden gezet! Ik heb een fantastische jeugd gehad in Uitwierde,
waar ik alles had wat mijn hartje begeerde. Dat we vorig jaar nog weer vijf
maanden met plezier thuis hebben gewoond, laat maar weer eens zien dat we een
zeer hechte band met elkaar hebben. Bedankt voor ALLES!!
Tevens wil ik graag Erwin zijn ouders bedanken. Ook jullie staan altijd voor
ons klaar. Op de hondjes passen, meehelpen met wat dan ook, een belletje en jullie
staan er weer. Ik vond het heel leuk om jullie nog beter te leren kennen, in de
periode dat jullie bij ons hebben gewoond. Dat was erg gezellig.
Graag wil ik ook alle broers en zussen, zwagers en schoonzussen, neefjes en
nichtjes bedanken. We hebben inmiddels al een hele grote familie! Wij zien jullie
allemaal veel te weinig, maar ik hoop dat daar straks meer tijd voor is. Jan Pieter,
als mijn twee na grootste broer, wil ik nog speciaal bedanken voor zijn show in
rokkostuum! Bedankt dat je mijn paranimf wilt zijn!
      En dan valt er nog één iemand te bedanken: de liefde van mijn leven! Geukie,
samen lachen, samen huilen, samen staan we sterk, samen kunnen we de hele
wereld aan! De afgelopen maanden zijn een aaneenschakeling geweest van
deadlines, bedankt voor je geduld, de peptalks, je kokkerellen en de verwennerij!
De laptop gaat nu voor een lange tijd uit! Ik hou ontzettend veel van je. Altijd en
eeuwig!                                                                                                       JolandaStellingen
behorende bij het proefschrift
“ Mutational analysis of receptor interaction and
membrane fusion activity of Sindbis virus”
1.  De waarde van een  liposomaal modelsysteem voor het ontrafelen van de
fundamentele aspecten van virusfusie mag niet worden onderschat.
Dit proefschrift.
2.  De zinsnede: “exposure to an acid environment within the cell may not be an
obligatory step in the process of infection of cells by alphaviruses” is onjuist.
Hernandez et al., 2000, J. Virol. 75:2010-2013.
3.  De stelling van Hubbard en Ivatt dat: “the main outlines of the asparagine-
linked oligosaccharide synthesis are now clear” is een vereenvoudiging van de
werkelijkheid.
Hubbard and Ivatt, 1981, Ann. Rev. Biochem. 50:555-583.
4.  Alhoewel  flavi- en  alphavirussen beide zijn geclassificeerd als klasse II
membraanfusie-virussen, wil dit niet zeggen dat de fusiereacties van deze
virussen identiek aan elkaar verlopen, aangezien alleen de  membraanfusie-
activiteit van  alphavirussen strikt afhankelijk is van  sphingolipiden en
cholesterol in het doelmembraan.
Lescar et al., 2001, Cell 105:137-148.
5.  Adaptatie van het Sindbis virus aan de cellulaire receptor heparan sulfaat heeft
geen gevolgen voor de membraanfusie-aktiviteit van het virus.
Dit proefschrift.
6.  Als Fiedler en Simons hun stelling: “Among the molecular constituents of
cells,  carbohydrates have been  overshadowed  by  their more  glamorous
neighbors, the nucleic acids and proteins” anno 2002 hadden geformuleerd
zouden ze waarschijnlijk de nog minder tot de verbeelding sprekende lipiden
niet ongenoemd hebben gelaten.
Fiedler and Simons, 1995, Cell 81:309-312.
7.  Het tot stand komen van een proefschrift is als de voorbereiding op de
Olympische Spelen: 4 jaren intensief werken, gevolgd door een uiteindelijke
ultieme inspanning.8.  “Een blik deskundigen opentrekken….”
Tijdens het inblikken van zogenaamde deskundigen, die ogenblikkelijk na een
gebeurtenis vaak vruchteloos terugblikken, moet een selectievere blik
geworpen worden op hun houdbare (w)eetbaarheid.
9.  Het kleinere aantal parkeerplaatsen aan de Oostersingel zal, met het sluiten van
het Bodenterein, leiden tot een grotere incidentie van ochtendhumeur.
10. Het schrijven van medisch gerelateerde krantenartikelen dient voorbehouden
te worden aan deskundigen.
11. De naamgeving: “Are  you  surprised” van een  recovered tekstbestand van
msword verhoogt het frustratiegevoel van een gestreste promovendus en zou
vervangen moeten worden door: “I am sorry for this inconvenience.”
12. De faculteit of universiteit zou de drukkosten van een proefschrift volledig
moeten vergoeden.
Jolanda Smit
Groningen, 19 juni 2002